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ABSTRACT 
Dendritic cells (DC) are the most effective antigen presenting cells since they have the 
ability to stimulate naive T cells and induce a primary immune response. They also 
interact with a range of other immune cells and play an important role in the 
maintenance of immune tolerance. Within this lab, DC are produced continuously by a 
unique spleen-derived long-term culture (LTC) system in which haemopoiesis is 
supported by a splenic stromal layer in the absence of added growth factors. The non-
adherent cell population of LTC comprises two major cell subsets of small and large 
LTC-DC. The consistent presence of these subsets over five years indicates their 
importance to the structure and continuation of the L TC system. It was predicted that 
small LTC-DC were precursors of large LTC-DC. This study has characterised the 
small and large LTC-DC subsets by analysis of surface marker expression, gene 
expression, function and developmental capacity. The role of the stroma in L TC-DC 
development and survival has also been examined. All data suggest that the LTC system 
represents an in vitro model highly suitable for the study of development of DC from 
committed precursors. 
Large LTC-DC represent a homogeneous population of CDl lc+CDl lb+MHCII1°CD8a-
DC. They also express DC markers including CD205, 33Dl and CD86, and display 
properties characteristic of both immature and activated DC. Like immature DC, large 
LTC-DC were found to be highly endocytic, displayed short dendritic projections, 
expressed low surface MHC Class II and CD40 and were responsive to stimulation with 
lipopolysaccharide (LPS). However, they were also shown to be potent stimulators of 
both syngeneic and allogeneic MLR and expressed the costimulatory markers CD80 
and CD86, properties which reflect activated DC. 
The subset of small L TC cells represents a heterogeneous population containing 
committed DC precursors. They lack dendrites and display reduced functional capacity 
and DC marker expression. Most small LTC-DC express CDllb, CD16/32, MHC Class 
I and CD80, but only subsets of cells stain weakly for CDl lc, CD86 and MHC Class II. 
This study provides direct evidence that cells within the small subset differentiate into 
large LTC-DC. Upon transfer to a stromal cell layer small cells proliferated and 
developed large LTC-DC characteristics. Unlike large LTC-DC, small LTC-DC 
development is dependent on cell-to-cell contact with the stroma. Proliferation and 
differentiation were prevented when cells were physically separated from the stromal 
monolayer and a subpopulation of apoptotic cells unique to the small cell subset 
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increased in frequency when small LTC-DC were cultured without stroma. Expression 
of lineage markers and function by some small cells, as well as loss of self-renewing 
capacity places small L TC-DC late in the DC developmental pathway. This information 
has been used to build a model for cell development within L TC. 
Subtracted cDNA libraries were generated containing sequences differentially 
expressed in either small or large L TC-DC. This is the first time that the gene 
expression of DC precursors and progeny has been studied in the absence of cytokines. 
Known genes isolated from subtracted libraries were found to reflect stages in LTC-DC 
development, and supported and extended findings regarding the function of small and 
large LTC-DC. Large LTC-DC expressed higher levels of a number of immunologically 
important genes including CD86, MIP-1 a receptor, osteopontin and lysozyme. Small 
LTC-DC expressed higher levels of genes relating to the organisation of the 
cytoskeleton, regulation of antigen processing and a number of mitochondrial and 
ribosomal proteins. A number of novel transcripts were isolated from small and large 
LTC-DC subtracted libraries which encode potentially novel proteins important in LTC-
DC development and function. 
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CHAPTER 1 
General introduction 
1.1 UNIQUE PROPERTIES OF DENDRITIC CELLS (DC). 
DC were discovered in 1973 when Steinman and Cohn (1973), observing murine spleen 
cells, 'noticed a large stellate cell with distinct properties'. Almost thirty years on, DC 
are one of the most studied cells in immunology, partly because of their 
immunotherapeutic importance for malignancies (Boczkowski et al., 2000; Fields et al., 
1998; Mayordomo et al., 1995; Nestle et al., 1998; Reichardt et al., 1999), infectious 
agents (Bhardwaj et al., 1994; Takahashi et al., 1993) and autoimmune disease (Clare-
Salzler et al., 1992). A major role of DC is to acquire exogenous antigen in the 
peripheral tissues and to present antigenic peptide via major histocompatibility complex 
(MHC) Class I and II molecules to CD4 and CD8 T cells in secondary lymphoid organs. 
DC are the only antigen presenting cells that can stimulate naive T cells and induce a 
primary immune response (Levin et al., _1993). 
Dendritic cells are located in low numbers throughout the body (Hart, 1997). They are 
present in non-lymphoid sites like the blood and tissues such as liver, heart, mucosa and 
skin. Langerhans cells (LC) of the skin are distinguished by cell surface markers 
including E-cadherin, CD207 (langerin) and CD la (Borkowski et al., 1994; De Panfilis 
et al., 1988; Valladeau et al., 1999), and by their possession of a distinct organelle 
called the Birbeck granule (Birbeck et al., 1961). DC also exist in secondary lymphoid 
tissues such as lymph nodes (LN) and spleen. These DC can be divided into subsets that 
differ in phenotype and functional capacity (Henri et al., 2001; Maldonado-Lopez et al., 
1999b; Pooley et al., 2001; Vremec et al., 2000). DC within the thymus play an 
essential role in central tolerance by tolerising T lymphocytes to self-antigen (Brocker 
et al., 1997; Carlow et al., 1992). 
The DC lineage includes populations of cells with different properties and at this time, a 
specific DC marker remains elusive. As a result, DC are defined using a combination of 
properties. These include (1) morphology, (2) phenotype and (3) the ability to 
efficiently take up and present antigen to naive T cells. DC display cytoplasmic 
extensions that can be short or veil-like when cells are immature, but increase in length 
upon maturation (Nijman et al., 1995). Electron microscopic features include prominent 
mitochondria and the presence of endosomes and lysosomes essential for antigen 
processing (Hart, 1997). Murine DC are known to express a range of cell surface 
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markers including CDllc (Metlay et al.,1990), CDllb (Leenen et al., 1998; Pulendran 
et al., 1997), CD205 (Inaba et al., 1995; Kraal et al., 1986), MHC Class II (Coates et 
al., 1996; Pierre et al., 1997) and 33Dl (Nussenzweig et al., 1982). 
DC interact with a wide range of immune cells. They induce a cell-mediated immune 
response by presenting specific antigen to naive and memory CD4 and CD8 T cells 
(Ingulli et al., 1997; Levin et al., 1993; Roth and Spiegelberg, 1996; Albert et al., 2001; 
Norbury et al., 2002). Immature and mature monocyte-derived DC can induce the 
proliferation and activation of resting natural killer (NK) cells in vitro (Ferlazzo et al., 
2002; Gerosa et al., 2002) and DC also have the capacity to cluster and interact directly 
with B cells (Dubois et al., 1997; Kushnir et al., 1998). They can present unprocessed 
antigen to na1ve B cells and modulate naive B cell proliferation and differentiation into 
antibody secreting cells in a T cell-dependent manner (Dubois et al., 1997; Wykes et 
al., 1998). DC can also provide signals for isotype switching to immunoglobulin (Ig)G 
and IgA (Fayette et al., 1997; Wykes et al., 1998), suggesting that they can regulate the 
type of humoral response induced. 
It has recently been shown in vivo and in vitro that DC are the antigen presenting cell 
responsible for the phenomenon of cross-presentation whereby exogenous antigens gain 
access to the MHC Class I presentation pathway (Albert et al., 1998; Kurts et al., 2001). 
Immature· DC phagocytose apoptotic cells and upon maturation, present the processed 
peptides to CD8 T cells in the context of MHC Class I molecules (Albert et al., 2001; 
Albert et al., 1998; Kurts et al., 2001). Cross-priming results in the activation of 
responding CD8 T cells and generation of a cytotoxic lymphocyte (CTL) response. This 
has been demonstrated when DC present antigen acquired from tumour cells (Huang et 
al., 1994) and apoptotic influenza-infected cells (Albert et al., 1998). Cross-presentation 
is also thought to represent a means by which peripheral tolerance can be maintained in 
vivo. The cellular features that distinguish cross-priming and cross-tolerance remain 
unclear. Cross tolerance may be the result of presentation of self-antigen by immature 
DC lacking a second signal for T cell activation (Green and Beere, 2000; Mellman and 
Steinman, 2001), or presentation of self-antigen by mature DC in the absence of CD4 T 
cell help (Albert et al., 2001). 
1.2 FUNCTIONAL MATURATION OF DC. 
In fulfilling their function as professional antigen presenting cells, DC move through 
various stages of maturation. The terms 'immature' and 'mature' have been used, albeit 
loosely, to describe these stages. The term 'immature' was originally coined in the 
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literature to describe DC precursors which were usually blood monocytes or bone 
marrow (BM) precursors. For the purpose of this study, immature DC are defined as 
fully differentiated DC. DC which are immature take up and process antigen into 
peptides that are then loaded on to MHC molecules. Immature DC represent the 
immune steady-state, endocytic but not activated by exposure to antigen. Maturation or 
activation of DC occurs after exposure to pathogen or disease, when DC begin to 
express molecules that enable them to interact with T cells to initiate an immune 
response. Mature or activated DC are end-stage cells that cannot revert to an immature 
state. They become apoptotic after interaction with T cells (Matsue et al., 1999). 
Immature DC are located in the periphery or non-lymphoid organs. They capture 
antigen by three endocytic mechanisms. Constitutive, high level fluid uptake via 
macropinocytosis allows them to continually internalise large volumes of fluid (Sallusto 
et al., 1995). Phagocytosis of particles (Matsuno et al., 1996) leads to presentation of 
antigen in the context of MHC Class II (Inaba et al., 1998) while phagocytosis of 
apoptotic cells leads to cross-presentation of viral, tumour and self-antigens in the 
context of MHC Class I (Albert et al., 1998). Receptor-mediated endocytosis involves 
mannose receptors (Sallusto et al., 1995), CD205 (Jiang et al., 1995; Mahnke et al., 
2000) and Fey receptors (FcyR) (Sallusto and Lanzavecchia, 1994 ). Mannose receptors 
and CD205 release their captured ligands into acidified endosomes and then recycle to 
the cell surface. This allows them to deliver ligands in consecutive rounds and to 
capture antigen in amounts that far exceed the number of receptors (Mahnke et al., 
2000; Sallusto et al., 1995). FcyR may direct antigen to MHC Class I molecules and so 
contribute to cross-presentation (Regnault et al., 1999; Rodriguez et al., 1999). 
Macropinocytosis allows the continuous internalisation of soluble antigen, while 
endocytic receptors may give some degree of selectivity for non-self molecules. 
Freshly isolated non-lymphoid 'immature' DC express only low levels of MHC Class 
II/peptide complexes on their cell surface. However, abundant intracellular MHC Class 
II is present within specialised MHC Class II-rich endocytic compartments (MIIC) 
similar to those seen in B cells (Kleijmeer et al., 1995; Nijman et al., 1995; Pierre et al., 
1997). MIIC are positioned at the intersection of the biosynthetic route of MHC Class II 
and the endocytic route and are the site of antigen degradation and peptide loading of 
MHC Class II molecules (Kleijmeer et al., 1995). These compartments are 
multilaminar, acidic, LAMP-I+ and contain invariant chain (Ii), HLA-DM and cathepsin 
S (Nijman et al., 1995; Turley et al., 2000). Following endocytosis, antigen can reach 
MIIC within 30 minutes of contact (Kleijmeer et al., 1995). However, immature DC do 
not immediately demonstrate increased antigen presentation capacity upon contact with 
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antigen. In the absence of a signal to initiate maturation or activation of DC a majority 
of new MHC Class II/peptide complexes accumulate within MIIC where most are 
degraded and some stored for later presentation (Pierre et al., 1997; Turley et al., 2000). 
This mechanism appears to safeguard against an immune response to self antigen. 
Immature DC express inflammatory chemokine receptors such as CCRl, CCR2, CCR5, 
CCR6 and CXCR4 (Carramolino et al., 1999; Vecchi et al., 1999). These receptors 
account for the chemotactic response to the inflammatory chemokines CCL3 (MIP-1 ex), 
CCL4 (MIP-1~), CCL5 (RANTES), CCL7 (MARC), CCL20 (MIP-3cx) and CXCL12 
(SDF-1) (Sozzani et al., 1999; Vecchi et al., 1999), guiding DC to the site of 
inflammation where they can be triggered to mature by a number of different stimuli. 
DC maturation can be achieved in vivo and in vitro by exposing immature cells to 
soluble antigen (Nijman et al., 1995), necrotic cells (Gallucci et al., 1999; Sauter et al., 
2000), cytokines such as granulocyte/macrophage colony stimulating factor (GM-CSF) 
and tumour necrosis factor (TNF)-cx, microbial products such as lipopolysaccharide 
(LPS) and T cell signals such as CD40L (De Smedt et al., 1996; Hochrein et al., 2001; 
Pie1Te et al., 1997; Sallusto et al., 1995; Vecchi et al., 1999). In response to these 
maturation stimuli, DC in vivo transiently produce large amounts of inflammatory 
chemokines themselves (Sallusto et al., 1999), recruiting other antigen presenting cells 
and effector cells to the site of infection. Inflammatory chemokine receptors are then 
downregulated and constitutive chemokine receptors such as CCR7 are upregulated 
(Sallusto et al., 1999; Vecchi et al., 1999), allowing maturing DC to exit the 
inflammatory site and migrate to secondary lymphoid organs. 
The homing of DC to T cell areas in lymphoid tissues involves cell surface adhesins and 
chemotactic factors released by these tissues. CCR 7 allows DC to migrate from 
peripheral sites to lymphatic vessels where CCL21 (6Ckine, SLC) (Chan et al., 1999) is 
produced, and then to the T cell areas of secondary lymphoid organs where CCLI 9 
(MIP-3~, ELC) is produced by resident mature DC (Sallusto et al., 1999). The 
importance of CCR7 in immune regulation is demonstrated in CCR7-/- mice which 
have impaired migration of B cells, T cells and DC and lack secondary lymphoid organ 
structure (Forster et al., 1999). Within lymphoid organs, mature DC also produce a 
range of chemokines to attract naive or activated T cells to enhance interaction between 
antigen-bearing DC and antigen-specific T cells. These chemokines include CCL22 
(MDC), CCL 17 (T ARC) and DC-CK 1 (Adema et al., 1997; Lucy Tang and Cyster, 
1999; Sallusto et al., 1999). 
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Inflammatory signals not only initiate migration of DC, but also trigger irreversible 
phenotypic and functional changes. Maturing DC lose attributes associated with antigen 
capture and processing. Mannose receptors and FcyR are downregulated and 
biosynthesis of Ii and MHC Class II molecules ceases (Austyn, 1996; Sallusto et al., 
1995). MHC Class II/peptide complexes are transferred to LAMP-, non-lysosomal 
compartments termed CIIV (Turley et al., 2000) that also contain MHC Class I 
molecules and CD86. CIIV are intermediates in the transfer of MHC Class II/peptide 
from lysosomes to the cell surface. Once on the plasma membrane, MHC Class 
II/peptide complexes, MHC Class I and CD86 continue to co-localise (Turley et al., 
2000). These could form an immunological synapse for activating naive T cells. 
Costimulatory molecules such as CD80 (Larsen et al., 1992), CD86 (Inaba et al., 1994 ), 
CD40 (Caux et al., 1994; McLellan et al., 1996) and adhesion molecules like CD58 
(LFA-3) and CD54 (ICAM-1) are upregulated on the cell surface of mature DC 
(Sallusto et al., 1995). Costimulatory molecules provide signals to T cells in addition to 
signals through T cell receptor (TCR)-MHC/peptide engagement (McLellan et al., 
1996; Mondino and Jenkins, 1994). They may also influence the commitment of T cells 
to the T helper type (Th)l or Th2 pathways (Cella et al., 1996; Gause et al., 1997; 
Kuchroo et al., 1995). For example, CD40:CD40L interaction results in production of 
interleukin (IL)-12 which mediates development of Thl responses (Cella et al., 1996). It 
can also induce differentiation of naive CD40-activated B cells into IgM-secreting 
plasma cells (Dubois et al., 1998). 
Large clusters of naive CD4 or CD8 T cells form around individual antigen-presenting 
DC in vivo (Ingulli et al., 1997; Norbury et al., 2002), allowing small numbers of DC to 
stimulate many T cells in a short period of time. Few T cells are observed surrounding 
DC in the absence of relevant antigen (Ingulli et al., 1997; Norbury et al., 2002). This 
suggests that the interaction is only stabilised if the DC display appropriate 
MHC/peptide complexes, perhaps upregulating expression of adhesion molecules, such 
as CD1 la/CD18 (LFA-1) and CD58 (Mondino and Jenkins, 1994; Steinman, 1991) on 
the T cells. Cluster formation coincides with IL-2 production by T cells, followed by 
proliferation and differentiation into effector cells (Ingulli et al., 1997). 
1.3 DIFFERENT DC POPULATIONS. 
1.3.1 Mature DC subsets. 
A number of DC subsets or classes have been defined on the basis of cell surface 
marker expression and function. Cells commonly studied ex vivo are MHC Class Ir+ 
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mature DC, and subsets of these have been defined on the basis of surface marker 
expression of CD8cx, CD4, CD205 and CD 11 b. To date, three different murine DC 
subsets have been identified in spleen, two in thymus (Vremec et al., 2000) and five in 
LN, one of which is thought to represent mature LC (Henri et al., 2001). The 
relationship between these DC subsets remains unclear. The resemblance of CD8cx+ DC 
to thymic DC led to the proposal that CD8cx- and CD8cx+ DC represented separate 
myeloid and lymphoid lineages, respectively (Pulendran et al., 1997; Vremec and 
Shortman, 1997). Recent studies indicate that this is not the case (Manz et al., 2001; 
Traver et al., 2000). Current evidence suggests that DC subsets may either reflect 
different stages in maturation or may regulate different arms of the immune response 
(Hochrein et al., 2001; Maldonado-Lopez et al., 1999b; Martinez del Hoyo et al., 2002; 
Merad et al., 2000; Pooley et al., 2001). The function and origin of DC subsets is one of 
the most controversial areas of DC biology. Information generated is highly dependent 
on the way in which DC subsets are produced in vitro and handled during 
experimentation. In addition, selective techniques used to isolate DC ex vivo on the 
basis of marker expression sometimes excluded subsets of DC (Vremec and Shortman, 
1997; Vremec et al., 1992). 
Mature splenic DC can be divided into three CDI lc+MHCII+ subsets: CD4+CD8cx-
CD205-cD 11 b+ DC, CD4-CD8cx+CD205+CD 11 b- DC and CD4-CD8cx-CD205-CD 11 b+ 
DC (Vremec et al., 2000). Both the CD4+CD8cx-CD205-CD1 lb+ DC and CD4-CD8cx-
CD205-CD1 lb+ DC resemble myeloid-lineage cells since they express myeloid markers 
like CD 11 b, 33D 1, F4/80 and lack CD8cx (Pulendran et al., 1997; Vremec et al., 2000). 
They are located in the marginal zone between white and red pulp (Crowley et al., 
1989; Leenen et al., 1998; Pulendran et al., 1997; Vremec et al., 1992), but can migrate 
to T cell-dependent areas of spleen upon stimulation (De Smedt et al., 1996). 
CD4+CD8cx- differ from CD4-CD8cx- DC in the expression of CD4 itself, greater 
adhesion capacity, higher levels of F4/80 expression (Vremec et al., 2000) and lower 
cytokine production following stimulation (Hochrein et al., 2001). However, both 
CD8cx- DC subsets are efficient stimulators of CD4 and CD8 T cells and show efficient 
MHC Class II presentation to antigen-specific CD4 T cells (Kronin et al., 1996; Pooley 
et al., 2001; Suss and Shortman, 1996). Hereafter, both subsets will be referred to as 
CD8cx- DC. Other reports have shown that CD8cx- DC direct Th2 type immune 
responses since they stimulate cells that produce IL-4 and little IFN-y (Maldonado-
Lopez et al., 1999b). 
The CD4-CD8cx+CD205+CD1 lb- subset (hereafter referred to as CD8cx+ DC) resemble 
the lymphoid-like thymic DC and occupy the T cell areas of the spleen (Crowley et al., 
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1989; Leenen et al., 1998; Pulendran et al., 1997; Vremec and Shortman, 1997). CD8a+ 
DC exhibit very different functional capacity in comparison to CD8a- DC. Ex vivo 
CD8a+ DC have been shown to have regulatory effects on T cells. They activate both 
CD4 and CD8 T cells, but induce apoptosis in CD4 T cells (Suss and Shortman, 1996) 
and limit CD8 T cell proliferation by reducing IL-2 production (Kronin et al., 1996). In 
contrast, under conditions consistent with activation, such as prior exposure to GM-CSP 
(Maldonado-Lopez et al., 1999b; Pulendran et al., 1999) or the presence of IL-2 (Pooley 
et al., 2001), CD8a- DC exert different effects on CD8 T cells. They efficiently present 
antigen to CD8 T cells in the context of MHC Class I ( den Haan et al., 2000; Pooley et 
al., 2001) and so have capacity to cross-present exogenous soluble antigen for 
subsequent generation of cytotoxic T cell responses. Other studies have shown that 
CD8a+ DC induce Thl type immune responses in vivo, consistent with activated CD8a+ 
DC being the major producers of IL-12 (Hochrein et al., 2001; Maldonado-Lopez et al., 
1999a; Pulendran et al., 1999). This suggests that in the immune steady state, CD8a+ 
DC exert regulatory effects over T cells. However, once stimulated they can induce a 
Th 1 type immune response. 
It was initially proposed that CD8a- and CD8a+ DC represented cells of myeloid and 
lymphoid lineage, respectively. This concept relied heavily on the phenotype of ex vivo 
isolated DC and reports that precluded one subset from being the precursor of another 
(Karnath et al., 2000; Pulendran et al., 1997). CD8a+ DC were also defined as lymphoid 
on the basis of experiments showing that 'CD4 low' thymic precursors (Wu et al., 
1991) gave rise to only CD8a+ DC upon intrathymic transfer (Ardavin et al., 1993) and 
develop into DC independently of GM-CSP in vitro (Saunders et al., 1996). However, 
more recently it was demonstrated that 'CD4 low' precursors can generate both CD8a+ 
and CD8a- DC in vivo (Martin et al., 2000). The analysis of mice deficient for 
transcription factors affecting haemopoeisis was also used to assess the lineage 
relationship of CD8a- and CD8a+ DC. The conflicting nature of these reports did not 
allow strong conclusions to be drawn. For example, one report suggesting that RelB and 
PU.I selectively regulate development of CD8a- myeloid-like DC (Wu et al., 1998) 
was contradicted by another showing that PU.I deficient mice lack both CD8a- and 
CD8a+ DC (Anderson et al., 2000). It has also been suggested that the environmental 
defects in these knockout mice could contribute to the altered DC phenotypes observed 
(Ardavin et al., 2001; Traver et al., 2000). 
A more direct and definitive test of lineage relationships requires studies on cells 
developing from lineage-restricted progenitors. Committed lymphoid progenitors (CLP) 
from mouse BM of the phenotype lineage marker negative (Lin-)IL-7R+Thy-1-
7 
Sca-l 1°CD1 l 7(c-kit)10 produce T cells, B cells and NK cells (Kondo et al., 1997) while 
committed myeloid progenitors (CMP) or lL"-7R-CD34+FcyR10 cells produce 
monocytes/macrophages, granulocytes, megakaryocytes and erythrocytes (Akashi et al., 
2000). Both CMP and CLP can generate both CD8cx- and CD8cx+ DC subsets in vivo and 
in vitro (Manz et al., 2001; Traver et al., 2000; Wu et al., 2001). Both CMP and CLP 
give rise to mature CD8cx- and CD8cx+ splenic DC and CD8cx+ thymic DC in vivo. 
Furthermore, all DC subsets express RelB and PU.I while only CD8cx+ DC express IL-
12 (Manz et al., 2001; Traver et al., 2000). By examining the number of DC produced 
from single progenitor cells and the abundance of CMP and CLP within BM, it has been 
calculated that a majority (up to 90%) of splenic DC and approximately half of thymic 
DC are derived from the myeloid lineage (Manz et al., 2001). 
Clonogenic studies indicate that cell surface phenotypes alone cannot be used to define 
lineage. The role of the CD8cx molecule itse_lf remains unclear. It is not a marker of the 
lymphoid lineage and does not appear to have a functional role in DC (Kronin et al., 
1997). Some evidence suggests that CD8cx may be a marker of DC maturation since 
maturing LC en route to the LN upregulate CD8cx (Merad et al., 2000), as do BM-
derived DC activated with LPS or IFN-cx (Brasel et al., 2000). Recently it was shown 
that a majority of purified CD8cx- DC upregulate CD8cx, CD205 and CD24 following 
intravenous injection into mice (Martinez del Hoyo et al., 2002). Furthermore, most 
splenic CD8cx- but not CD8cx+ DC express CCR6 (Kucharzik et al., 2002), a chemokine 
receptor associated with immature DC (Carramolino et al., 1999). These results suggest 
that CD8cx+ DC could represent a final stage in DC differentiation, playing an important 
role in the induction of immune responses through T cell stimulation, cross-priming and 
production of cytokines including IL-12. 
Recent evidence now suggests that CD8cx- DC and CD8cx+ DC do not represent separate 
lineages of DC, but do represent DC of distinct functional capacity. The presence of 
functionally distinct DC subsets would help to explain the wide range of DC activities 
described in vivo. The question remains as to the triggers which induce formation of 
these distinct subsets. It is possible that DC phenotype and function reflects different 
maturational states. Another possibility is that distinct DC subsets are involved in the 
immune response to pathogens and the maintenance of self tolerance. Development of 
these subsets could be dictated by specific cytokines and cell types present in tissue 
microenvironments. 
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1.3.2 DC progenitors. 
DC can be generated from a number of different progenitor or precursor cells. These 
include Lin-CDl 17+ BM and fetal liver cells (Zhang, Y. et al., 1998; Zhang et al. , 
2000), peripheral blood monocytes (Schreurs et al., 1999) and 'CD4 low' cells in the 
thymus (Ardavin et al., 1993). Progeny DC have been derived from purified, primitive 
self-renewing haemopoietic stem cells (HSC) as well as lineage-restricted CLP, CMP, 
granulocyte/macrophage-restricted precursors, and pro-T cells (Manz et al., 2001). 
These studies have not yet revealed a DC-committed progenitor. Most cytokine 
supplemented in vitro cultures drive progenitors quickly through to mature DC, 
preventing the characterisation of intermediate precursors . A CD1 lc+MHCir-
B220+CD19- DC precursor population was recently isolated from mouse blood (del 
Hoyo et al., 2002). These cells appear to represent committed precursors since they can 
reconstitute all splenic DC subsets, but not other lymphomyeloid compartments. 
CD1 lc+MHCifB220+CD19- precursors may represent cells downstream in development 
from CMP and CLP. Resident DC progenitors in spleen have not yet been reported. 
Most research has focused on the study of mature MHC Class II+ splenic DC, 
conforming with the concept that maturing DC migrate to this secondary lymphoid 
organ from the periphery. However, DC progenitors must exist in spleen since Lu et al. 
demonstrated that DC can be generated from proliferating MHC Class If splenic 
progenitors when cultured in the presence of GM-CSF (Lu et al., 1995). 
1.4 USE OF CYTOKINES TO CULTURE DC IN VITRO. 
DC are commonly generated in vitro from progenitor cells using cocktails of cytokines 
since they represent a trace population of cells in vivo. GM-CSF has been the most 
co1mnonly used cytokine for in vitro culture of DC. Initially it was demonstrated that 
GM-CSF could enhance survival and differentiation of MHC Class n+ blood DC for up 
to 6 weeks (Markowicz and Engleman, 1990). Since mature DC cannot divide (Bowers 
and Berkowitz, 1986), amplification of DC numbers was achieved by culture of 
replicating MHC Class If precursors in mouse blood (Inaba et al., 1992b) and BM 
(Inaba et al., 1992a) in medium supplemented with GM-CSF. These cultures generated 
granulocytes and macrophages in addition to mature DC and early stages featured 
aggregates of DC affixed to a stromal monolayer comprising macrophages and 
fibroblasts (Inaba et al., 1992a; Inaba et al. , 1992b ). It is highly likely that in addition to 
GM-CSF, stromal-derived cytokines were important in the generation of DC. 
GM-CSF supplemented cultures (Inaba et al., 1992a; Inaba et al., 1992b) do not 
produce a pure population of DC. More recently, greater numbers of DC have been 
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generated from in vitro culture systems that use defined progenitor starting populations 
and combinations of cytokines. Some of these culture systems use a set of specific 
cytokines to support an initial phase of proliferation producing 'immature DC', 
followed by a second phase of culture with a different set of cytokines to induce DC 
'maturation' (Hausser et al., 1997; Zhang, Y. et al., 1998; Zhang et al., 1999). 
However, most in vitro cultured cells resemble mature DC on the basis of MHC Class II 
and costimulatory molecule expression as well as T cell stimulatory capacity, 
suggesting that the immature DC stage has been bypassed in culture. Alternatively, 
some intermediate 'immature DC' retain capacity to form macrophages when exposed 
to mediators such as macrophage colony-stimulating factor (M-CSF). These bipotential 
cells appear to represent intermediate precursors rather than fully differentiated 
immature DC. Figure 1.1 summarises the in vitro culture systems used to generate DC 
from various progenitor populations. Intermediate cell types in Figure 1.1 are indicated 
'precursor' or 'mature' based on the above rationale. 
Culture of monocytes or BM cells with GM-CSF, TNF-a and IL-4 or stem cell factor 
(SCF) represent the most common procedures used to derive DC in vitro. Mouse 
peripheral blood mononuclear cells and Lin- BM cells can be induced to become MHC 
Class Ir+ mature DC if cultured with a combination of GM-CSF and IL-4 (Schreurs et 
al., 1999) (Fig I. IA). In some cultures, TNF-a is added to induce further activation 
(Hausser et al., 1997). TNF-a alone provides no growth promotion for haemopoeitic 
progenitor cells (HPC), but assists in the develop1nent of mature DC (Caux et al., 1992). 
By comparison, IL-4 maintains DC in an immature state, capable of antigen capture and 
processing (Sallusto and Lanzavecchia, 1994 ). SCF was incorporated into in vitro 
culture systems after it was shown to increase DC yield from human CD34+ HPC 
(Young et al., 1995). When cultured with SCF in combination with GM-CSF and TNF-
a, Lin-CD 117+ BM cells proliferate and develop into two distinct dendritic precursor 
populations (Zhang, Y. et al., 1998) (Fig 1. IB). In a second period of non-proliferative 
differentiation, GM-CSF and TNF-a are used to generate mature LC from DC-
committed precurso!s (CDI lb1°CDI lc+) or mature DC from bipotent myeloid 
precursors (CDI lbhiCDl lc+). Similar cells are generated from human CD34+ HPC 
using GM-CSF and TNF-a (Caux et al., 1996). 
Transforming growth factor (TGF)-~ has a specific role in LC development. It is 
essential for the differentiation of LC in vivo (Borkowski et al., 1996) and has been used 
in combination with GM-CSF, SCF and TNF-a to generate LC in vitro from Lin-
CDI 17+ BM cells (Zhang 99) (Fig I.IC). TGF-~ appears to be effective in DC culture 
only when TNF-a is also present, otherwise it inhibits DC production (Riedl et al., 
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Figure 1.1. Cytokine-dependent cultures used to generate DC from precursors in 
vitro . Starting precursor populations, intem1ediate cells and end-stage cells are indicated in 
black text. Starting populations include lineage 1narker negative (Lin-) bone marrow (BM), 
peripheral blood 1nononuclear cells (PBMC), Lin-CD 117+ BM, thyn1ic 'CD4 low' 
precursors, corrunon lymphoid progenitors (CLP) and common myeloid progenitors 
(CMP). Cytokine combinations used for culture are indicated in red text. Referenced from 
(A) Schreurs et al., 1999; Hausser et al., 1997, (B) Zhang et al., 1998; Caux et al., 1996, 
(C) Zhang et al., 1999, (D) Brasel et al., 2000, (E) Saunders et al., 1996, (F) Manz et al ., 
2001 and (G) Manz et al., 2001. Figure adapted from Ardavin et al. (2001). 
(A) 
(B) 
Lin- BM; 
PBMC 
Lin-CD 117+ BM 
GM-CSF 
IL-4 
GM-CSP 
SCP 
TNF-a 
GM-CSP 
SCP 
Mature DC 
CD1 lb1°CD1 lc+ 
precursor 
CDl lbhiCDl le+ 
precursor I 
GM-CSF 
TNF-a 
GM-CSP 
TNF-a 
GM-CSP 
TNP-a 
M-CSP 
Activated DC 
Mature 
Langerhans-like DC 
Mature DC 
Macrophage 
(C) Lin-CD 117+ BM TGP-~ Monocyte/macrophage 
precursor 
GM-CSP 
TNP-a 
Langerhans-like DC 
(D) Lin- BM 
(E) CMP 
(F) Thymic 'CD4 low' 
precursor 
(G) CLP 
Plt3L 
IPN-a or 
LPS CDl lbhiCDl le+ 
mature DC 
---- CD8a- activated DC 
IPN-a or 
LPS CD1 lb1°CD1 le+ 
mature DC 
----CD8a+ activated DC 
IL-3 
SCP 
TNP-a 
IL-4 
Flt3L 
GM-CSP 
IL-1~ IL-3 
IL-7 SCP 
TNP-a Plt3L 
Anti-CD40 mAb 
IL-1~ 
IL-4 
SCP 
TNP-a 
IL-3 
IL-7 
Plt3L 
Mature CD8a-
DC 
Mature CD8a-
DC 
Mature CD8a-
DC 
1997). Flt3L can be used to expand DC numbers in vivo (Maraskovsky et al., 1996), 
although it does not act specifically on DC. When injected into mice, it expands many 
haemopoietic cell types, including lymphocytes, NK cells, erythroid cells, monocytes 
and granulocytes (Brasel et al., 1996; Shaw et al., 1998). Flt3L can generate both 
CD8a- and CD8a+ DC in vitro from Lin- BM when activated with IFN-a or LPS 
(Brasel et al., 2000) (Fig 1. lD). However, Flt3L is not solely responsible for the 
development of DC from Lin- BM cells because DC grow from aggregates associated 
with adherent macrophages and endogenously produced IL-6 is also important in their 
development (Brasel et al., 2000). 
There is now evidence to suggest that GM-CSF is essential only for the development of 
myeloid DC. CMP in BM, like other lin- BM populations require GM-CSP for DC 
production (Manz et al., 2001) (Fig 1.lE). Lymphoid DC have different cytokine 
requirements. Colonies of thymic DC have been generated by culture of 'CD4 low' 
thymic precursor cells in a cocktail of seven growth factors including IL-1 ~' TNF-a, 
IL-3, IL-7, SCP, Flt3L and anti-CD40 monoclonal antibody (Saunders et al., 1996) (Fig 
1.lF). IL-7 and not GM-CSP is the essential factor for development of thymic DC. Cells 
produced are functional, mature DC. However, in contrast to normal thymic DC, they 
do not express CD8a and BP-1, suggesting that this culture may not mimic in vivo 
conditions for thymic DC development (Saunders et al., 1996). Consistent with this, IL-
7 is essential for the generation of DC from CLP in BM (Manz et al., 2001) (Fig 1.lG). 
These studies confirm that myeloid and lymphoid progenitors have different cytokine 
requirements for the generation of DC. 
Cytokine supplementation can be used to generate high numbers of DC in vitro for 
experimentation. These studies have defined stages in DC development and maturation 
as well as lineage. However, a number of limitations are associated with the use of 
cytokines. They are used in concentrations higher than would be expected in vivo and 
could direct development along pathways that are not physiologically normal. In vitro 
generated DC have been shown to have different marker expression, in comparison with 
their ex vivo counterparts. DC generated in vitro survive for only a limited period of 
time and the purity of DC in these cultures is also questionable. Furthermore, DC 
produced from monocytes and BM or cord blood HPC vary in their functional capacity 
(Herbst et al., 1997; Schreurs et al., 1999; Triozzi and Aldrich, 1997). Different sources 
of precursor cells and methods of culture can generate different DC. This is an 
important consideration when preparing a DC population for study or for use as an 
immunotherapeutic tool. 
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1.5 ANALYSIS OF GENE EXPRESSION IN DC. 
DC gene expression analysis offers the opportunity to study genetic changes that 
underlie DC development from progenitors. It offers enormous potential for 
investigation of DC lineage and function through the generation of gene expression 
profiles and identification of novel genes. The identification of novel DC-associated 
genes has led to the characterisation of novel proteins that contribute to the unique 
function of DC. A variety of procedures have been employed to detect DC-associated 
genes, including the random sequencing of cDNA libraries (Adema et al., 1997; Vicari 
et al., 1997), screening cDNA libraries for sequences homologous to known molecules 
(Chapoval et al., 2001) and the generation and screening of subtracted libraries 
(Diatchenko et al., 1996; Tiefenthaler et al., 1999). Subtracted libraries have been used 
to isolate genes specifically expressed in DC and not macrophages. They have also been 
used to isolate genes associated with DC activation. One study comparing CD8cx- and 
CD8a+ DC has led to the isolation of the novel C-type lectin CIRE (Caminschi et al., 
2001). To date, novel genes have been isolated from both human and mouse DC 
populations including spleen and germinal centre DC, as well as BM-, cord blood- and 
monocyte-derived DC and DC lines like XS52 (Table 1. 1). 
A list of novel DC-associated proteins is presented in Table 1.1. It includes proteins 
involved in antigen capture such as Dectin-2 (Ariizumi et al., 2000) and DORA (Bates 
et al., 1998), chemokines such as DC-CKl (Adema et al., 1997) and TECK (Vicari et 
al., 1997), costimulatory molecules like B7-DC (Tseng et al., 2001) and molecules that 
assist antigen presentation including PI-11 (Mueller et al., 1997 a) and Decysin (Mueller 
et al., 1997b). Proteins essential to DC function like DC-CKl, Fascin and DC-SIGN 
were isolated after identification of unique genes (Adema et al., 1997; Geijtenbeek et 
al., 2000b; Ross et al., 1998). DC-CKl is a chemokine produced by mature DC in 
secondary lymphoid organs which functions by attracting naive CD4 and CDS T cells to 
facilitate antigen presentation (Adema et al., 1997). The expression of Fascin, an actin 
bundling protein, coincides with the formation of dendritic projections in LC (Ross et 
al., 1998). DC-SIGN is expressed on the surface of DC and mediates DC migration 
through interaction with CD102 (ICAM-2) (Geijtenbeek et al., 2000a) and transient 
clustering between DC and T cells through interaction with CD50 (ICAM-3) 
(Geijtenbeek et al., 2000b ). 
Gene expression studies using serial analysis of gene expression (Hashimoto et al. , 
1999; Hashimoto et al., 2000) or oligonucleotide microarrays (Granucci et al., 2001; 
Huang et al. , 2001; Le N aour et al., 2001) have generated profiles of genes unique to 
different DC populations. By identifying clusters of genes that identify a particular cell 
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T i e f e n t h a l e r  e t  a l . ,  1 9 9 9  
T s e n g  e t  a l . ,  2 0 0 1  
M a s u d a  e t  a l . ,  2 0 0 2  
M u e l l e r  e t  a l . ,  1 9 9 7  
L i  e t  a l . ,  2 0 0 0  
U 9 3 7  m a c r o p h a g e  c e l l  l i n e  M u e l l e r  e t  a l . ,  1 9 9 7  
F r e s h l y  i s o l a t e d  L C  R o s s  e t  a l . ,  1 9 9 8  
A l - A l w a n  e t  a l . ,  2 0 0 1  
C h a p o v a l  e t  a l . ,  2 0 0 1  
A d e m a  e t  a l . ,  1 9 9 7  
G e i j t e n b e e k  e t  a l . ,  2 0 0 0 ;  
G e i j t e n b e e k  e t  a l . ,  2 0 0 0  
V i c a r i  e t  a l . ,  1 9 9 7  
population, comparison can be made of gene expression changes upon differentiation, 
under altered conditions or between different cell types. Two studies have profiled 
changes in gene expression during DC differentiation from monocytes (Hashimoto et 
al., 1999; Le Naour et al., 2001) to identify genes unique to monocyte-derived DC. 
Genes identified are expressed or upregulated as DC differentiate. These genes encode 
proteins associated with cell structure such as vinculin and chemokines including T ARC 
and MDC (Hashimoto et al., 1999). At this stage, the only studies on DC development 
from progenitors involve DC derived from monocytes after culture with cytokines. It 
will be important to identify gene expression changes as DC develop from other 
progenitors, such as BM or thymic precursors. However, the difficulty of cell isolation 
has so far precluded these studies. Phenotypic and functional analyses indicate that 
pathways for DC development are numerous, leading to production of DC with different 
functions and properties. Gene profiling studies could be used to test this hypothesis and 
define the genetic changes that underlie different pathways of development. 
Some studies have attempted to profile gene expression upon DC maturation or 
activation. DC lines or monocyte- and BM-derived DC have been activated in various 
ways by exposure to LPS (Chen et al., 2002; Hashimoto et al., 2000), inflammatory 
cytokines (Dietz et al., 2000; Granucci et al., 2001) or whole microbes (Huang et al., 
2001). Many of the genetic changes that occur with activation are consistent with those 
predicted from functional studies. For example, the CCR 7 gene is upregulated in LPS-
activated BM-derived DC, while CCRl is downregulated during activation (Chen et al., 
2002). 
1.6 ANALYSIS OF DC PRODUCED IN LONG-TERM CULTURE (LTC). 
1.6.1 L TC of haemopoietic cells in vitro. 
LTC 1nethods are useful for studying haemopoiesis in vitro. In LTC, haemopoiesis is 
dependent on the establishment of an adherent layer of stromal cells which provide an 
appropriate environment for stem cell survival, self-renewal and differentiation (Dexter, 
1979; Dexter and Testa, 1980). Haemopoietic cell development occurs through cell-to-
cell interactions and the secretion of cytokines (Whetton and Dexter, 1993). Typically, 
LTC simulate development under conditions closer to normal physiological conditions 
than do cultures supplemented with cytokines. They also allow observation of cell 
behaviour and function in vitro. Dexter and Lajtha (1974) first established haemopoiesis 
in LTC in vitro, in a BM culture system in which granulopoiesis predominated. Stem 
cells were induced to proliferate in cultures containing an adherent layer of BM stromal 
cells and haemopoiesis was maintained for several months (Dexter and Testa, 1980). 
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Whitlock and Witte developed a LTC along Dexter's model which supported 
production of cells representing early stages in B cell development (Whitlock et al., 
1984). LTC systems provide the opportunity to study early stages in the development of 
haemopoietic cells. 
1.6.2 Long-term cytokine-dependent DC lines. 
A long-term spleen-derived culture system has been established by culturing 
splenocytes in medium supplemented with GM-CSF and conditioned medium from 
fibroblasts (Winzler et al., 1997). Cell growth is maintained for more than 12 months, 
but is strictly dependent on cytokines. The homogeneous population of DC produced in 
these cultures, named D 1, display an immature DC phenotype. Cells express moderate 
levels of MHC Class II and CD86, but have inefficient allostimulatory activity. 
However, they can be activated by microbes, LPS and cytokines like TNF-a or IL-1~ to 
display mature or activated DC characteristics. D 1 cells have been used as a model for 
studying DC activation (Granucci et al., 1999; Granucci et al., 2001). 
Two 'immature' DC lines have been established from fetal or newborn mouse skin. The 
first of these is a GM-CSP-dependent MHC Class I+/If cell line that can stimulate 
allogeneic CD8 T cells (Elbe et al., 1994 ). The second DC line, named XS, requires 
GM-CSF, supernatant from the Pam 212 keratinocyte cell line and supernatant from the 
NS fibroblast cell line for optimum growth (Xu et al., 1995). The homogeneous 
population of cells produced resembles freshly isolated LC and weakly activates naive 
T cells. Both DC lines are phenotypically stable, retaining immature DC characteristics 
after one (Xu et al., 1995) or two years (Elbe et al., 1994) of in vitro culture. 
Furthermore, MHC Class I+/If cells do not upregulate MHC Class II following 
exposure to GM-CSF or IFN-y, or after co-culture with allogeneic T cells (Elbe et al., 
1994). Like short-term cytokine-dependent cultures, these cytokine-dependent LTC and 
DC lines are established and maintained in a very selective and artificial environment. 
In addition, these systems do not offer the potential to study stages in DC development 
from progenitors. 
1.6.3 L TC which support DC development in vitro. 
DC have been produced continuously in a unique spleen-derived LTC system in which 
haemopoiesis is supported by an adherent stromal cell layer in the absence of exogenous 
growth factors (Ni and O'Neill, 1997). The confluent growth of a stromal layer occurs 
within 4 weeks and this comprises endothelial cells, fibroblasts and some isolated fixed 
macrophages (Ni and O'Neill, 1998). After a further 2 weeks, small non-adherent cells 
can be observed in LTC and within a further 2-3 weeks, larger non-adherent cells with 
14 
cytoplasmic extensions are produced (Ni and O'Neill, 1997). These non-adherent cells 
are easily collected for experimentation by removal of medium. Before release into 
medium, the non-adherent cells cluster above foci of endothelial cells that are connected 
to networks of fibroblasts and macrophages. Stable productive cultures are associated 
with foci of replicating cells and the maintenance of low numbers of small-sized cells 
above the stromal cell layer (Ni and O'Neill, 1998). 
The non-adherent cells produced by LTC have been characterised as DC. Established 
LTC do not produce T or B lymphocytes, macrophages, granulocytes or mast cells (Ni 
and O'Neill, 1999; Ni and O'Neill, 1997; Ni and O'Neill, 1998). This has been 
demonstrated by electron microscopy, cell surface marker expression, histochemistry 
analysis and functional studies. Non-adherent cells possess dendritic-like morphology 
exemplified by the presence of cytoplasmic projections. They also possess large 
numbers of mitochondria and vacuoles or endosomes in the cytoplasm (Ni and O'Neill, 
1997). Non-adherent LTC cells express markers associated with DC, including CDI lc, 
CD 11 b, CD205 and 33D 1. Histochemical analysis has confirmed that non-adherent 
LTC cells are not mast cells and are distinct from monocytes, macrophages and 
granulocytes (Ni and O'Neill, 1997). Non-adherent LTC cells have also demonstrated a 
potent stimulatory capacity in mixed lymphocyte reaction (MLR) with both syngeneic 
or allogeneic spleen responders. They are also able to present antigen to the I-Ak 
restricted conalbumin-specific Th cell clone D 1 0.G4.1 (Ni and O'Neill, 1997; O'Neill et 
al., 1999b). Production of cells has continued for 9 years for some LTC (O'Neill et al., 
1999b). 
Maintenance of a stromal layer within L TC is essential for production of non-adherent 
DC. New cultures can only be established when a mixture of stromal cells and non-
adherent cells are transferred to a new flask. Non-adherent DC do not survive past 7 
days if cultured in medium only (Wilson et al., 2000). Stromal cells or LTC-conditioned 
medium (LTC-CSN) are required for cluster formation from single LTC-derived DC 
(LTC-DC) in colony assays. Combinations of recombinant cytokines including GM-
CSF, IL-I, IL-3, IL-6, IL-7, SCF, TNF-cx and Flt3L (Wilson et al., 2000) do not 
substitute for stroma or LTC-CSN in colony assays. IL-3 and IL-6 are the only 
cytokines detected so far in LTC-CSN (Ni and O'Neill, 1997) and these alone do not 
support LTC-DC proliferation. LTC-CSN may contain undefined growth factor(s), or 
the stroma may provide critical cell-to-cell signalling and a stable environment for the 
production of progenitor cells. 
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The long-term nature of this culture system implies that long-term self-renewing 
progenitors are maintained within it. To date, no HSC have been identified amongst the 
non-adherent cell population. This population contains replicating precursors that 
appear to be committed to the DC lineage since only clusters of undifferentiated cells or 
differentiated DC develop in in vitro colony assays (Wilson et al., 2000). LTC provides 
a unique model system for investigating DC development since it produces DC without 
the addition of exogenous cytokines. Development of DC in contact with stromal cells 
more closely mimics in vivo development. Many different LTC have been established 
from a number of inbred mouse strains, including B 10.A(2R) and C57BL/6J, and have 
consistently generated non-adherent cells with dendritic morphology, phenotype and 
function (O'Neill et al., 1999b). The LTC system is a reliable source of DC and an 
efficient system for production of cells for experimentation. Finally, preliminary 
experiments have shown that L TC-DC can migrate and show antigen presenting 
capacity when adoptively transferred into animals (O'Neill et al., 1999a). 
1.7 OBJECTIVES OF THIS STUDY. 
DC are the most effective antigen presenting cells. Many studies generate DC from the 
in vitro culture of BM or monocyte precursors in the presence of combinations of 
reco1nbinant cytokines. However, these cultures do not sustain DC production for long 
periods and do not allow the study of intermediate DC progenitors. DC lines are also 
limited in that they are cytokine-dependent and generate homogeneous, differentiated 
DC populations. The spleen-derived LTC system is unique in that it continuously 
produces DC in the absence of exogenous cytokines. Two major cell subsets are 
produced and can be collected as non-adherent cell populations. These have been named 
'small' and 'large' LTC-DC. Cells of the large LTC-DC subset are large in size and 
possess distinct cytoplasmic projections and intracellular bodies. Small LTC-DC have 
an average diameter three-fold smaller and display undifferentiated morphology. They 
lack cytoplasmic projections and intracellular bodies. These cell subsets are consistently 
produced over time and in many individual LTC. Stable productive cultures are 
associated with maintenance of small numbers of small-sized cells above the stromal 
cell layer. 
It is hypothesised that cells of the small L TC-DC subset are precursors of the large 
subset. This represents the first time that DC and their precursors have been identified 
within an in vitro culture system both simultaneously and in the absence of added 
cytokines. Additionally, little is known about DC differentiation from precursors 
derived from spleen. This system represents a unique opportunity to study the 
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development of DC from precursors as well as the role that stromal cells play in this 
process. To date, there is no reported study of gene expression relating to DC 
development from precursors in the absence of cytokine-induced activation. A 
comparison of the gene expression of small and large L TC-DC could identify genes 
related to DC development and function. This system represents an opportunity to 
identify these genes in distinct cell populations maintained within the same culture, 
eliminating gene expression relating to background or common cell functions. 
The aims of this study are: 
1. To further define the two L TC-DC subsets by surface marker expression, 
function and developmental potential. 
2. To delineate the role of stroma in development and survival of cells within 
LTC. 
3. To isolate differentially expressed genes which identify developmental stage 
and function of small and large LTC-DC. 
4. To identify novel genes and proteins related to DC development. 
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CHAPTER2 
Materials and methods 
The compositions of commonly used solutions are included in Appendix A. Details of 
suppliers of antibodies, reagents and equipment are listed in Appendix B. 
2.1 PRODUCTION OF DC IN LTC. 
2.1.1 Establishment of LTC-DC from B10.A(2R) mice. 
Cells were cultured in supplemented Dulbecco's Modified Eagle's Medium (sDMEM). 
The composition of sDMEM is given in Appendix A. Prior to use sDMEM was 
con1pleted with Hepes buffer (CSL Biosciences), fetal calf serum (FCS; CSL 
Biosciences), 2-mercaptoethanol (BDY Chemicals) and antibiotics as described in 
Appendix A. Procedures for the establishment of stroma-dependent LTC from 
B 10 .A(2R) mice have been described previously (Ni and O'Neill, 1997; O'Neill et al., 
1999a). Cells were obtained from the spleens of 6-8 week old female mice. Spleens 
were asceptically removed, the tissue homogenised in sterile culture medium and cells 
filtered through a fine wire sieve into 5ml sterile medium. Cell clumps were dispersed 
or removed by pipetting and filtration through a 200G nylon filter. Filtered cells (2xl06 
cells/ml) were cultured in 25cm2 or 75cm2 tissue culture flasks (TPP) and maintained at 
37°C in 5% CO2 in air. Culture medium was changed once every 2-4 days or when 
cultures became acidic. 
2.1.2 Collection of non-adherent DC from LTC. 
LTC-DC were collected from culture flasks without disturbing the stroma by removing 
supernatant by pipetting. Fresh culture medium was added back and the flask gently 
rocked to collect any loosely adherent cells. Medium was again removed by pipetting. 
After collection of cells by centrifugation (300g, 5 minutes) (Beckman TJ6), the cell 
suspension was filter~d through a 200G nylon filter to remove cell aggregates and 
resuspended at an appropriate concentration. 
2.1.3 Cultivation of the ST-X3 stromal cell line. 
ST-X3 is a Bl0.A(2R) spleen stromal cell line derived from a LTC which had ceased 
production of DC (Ni and O'Neill, unpublished data). Stromal ST-X3 were established 
through a se1ies of passages from a DC-producing LTC, established as described in 
Section 2.1.1. Those LTC that developed a confluent stromal cell layer but were 
unproductive in terms of non-adherent cell production were passaged by scraping a DC-
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free section of stroma and transferring cells to a new flask of fresh medium. These 
stromal cell cultures were observed and passaged again in the same manner. This 
procedure was repeated several times until stromal cultures were established that 
produced few, if any, non-adherent DC. Maintenance of spleen stromal cell cultures 
required a medium change every 5-7 days which involved washing away any non-
adherent cells from the stroma. 
2.2 FLOW CYTOMETRIC ANALYSIS OF CELL SURFACE MARKER 
EXPRESSION. 
2.2.1 Crystal Violet (CV) treatment of LTC-DC. 
Prior to staining with fluorescent antibodies, L TC-DC were incubated with CV (Sigma) 
to quench background autofluorescence. This procedure, developed specifically for 
LTC-DC, has been shown to assist marker analysis by lowering fluorescent background 
levels by 10-fold (Ni and O'Neill, 2000). Non-adherent LTC-DC were collected as 
described in Section 2.1.2 and pelleted by centrifugation at 300g for 5 minutes. Excess 
supernatant was removed and the cell pellet resuspended in the remaining small volume 
of fluid. CV solution (500µ1 of 2mg/ml in saline) was added to cells at room 
temperature. After incubation for 7 minutes on ice, cells were washed three times by 
resuspension in 1.5ml incomplete sDMEM/1 % FCS/0.1 % NaN3 (staining medium) 
followed by centrifugation at 300g for 5 minutes. Cells were then resuspended in 
staining mediu1n in preparation for fluorescent antibody staining. 
2.2.2 Blocking Fey receptors. 
In some antibody staining experiments, cells were incubated with 1 0µl of FcyR block 
(anti-CD16/32) for 15 minutes on ice prior to addition of primary antibody. FcyR block 
was not used with goat anti-rat or goat anti-hamster second stage antibody since these 
preparations bound to FcyR block. 
2.2.3 Antibody staii:iing of cells in suspension - single-colour staining. 
Specific antibody was absorbed to cells (2-5xl05) in a 100µ1 volume in 1.5ml 
microcentrifuge tubes (Sarstedt). Details of the specific antibodies used are shown in 
Table 2.1. After incubation for 30 minutes on ice, cells were diluted with 250µ1 of 
staining n1edium and washed once using an underlay of 600µ1 FCS followed by 
centrifugation at 300g for 10 minutes. Cells were then washed twice by resuspension in 
1ml of staining medium and centrifugation at 300g for 5 minutes. The same incubation 
and washing procedure was repeated for addition of 100µ1 of the diluted fluorochrome-
conjugated second stage reagent. Details of fluorochrome-conjugated second stage 
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Table 2.1 Specific antibodies and isotype control antibodies. 
Antigen Clone name Preparation a b Isotype 
specificity 
CD8cx 53-6.7 Purified PE-conjugated Rat IgG2a 
CDllb Ml/70 Purified and biotinylated Rat IgG2b 
CDllc HL3 Purified and biotinylated Hamster IgG 
CD16/32 2.4G2 Purified Rat IgG2b 
CD40 3/23 Purified Rat IgG2a 
CD44 IM-7.8.1 Supernatant Rat IgG2b 
CD80 (B7-l) IGI0 Purified and biotinylated Rat IgG2a 
CD86 (B7-2) GLI Purified and biotiny lated Rat IgG2a 
CD117 2B8 Purified and biotinylated Rat IgG2b 
CD205 NLDC-145 Purified Rat IgG2a 
macrophages F4/80 Supernatant Rat IgG2b 
MHCI TIB126 Supernatant Rat IgG2a 
MHCII AF6-120.l Purified FITC-conjugated Mouse IgG2a 
dendritic cells 33D1 Ascites Rat IgG2b 
BrdU B44 Purified FITC-conjugated IgG1 
Isotype Control Antibodies 
T200 30G-l.2 Supernatant 
B220 6B2 Supernatant 
CD3E 145-2Cl I Supernatant 
a Pu1ified primary antibodies were affinity purified. 
b FITC - Fluorescein isothiocyanate, PE - Phycoerythrin. 
I Pharmingen 
2 Serotec 
Rat IgG2a 
Rat IgG2b 
:Hamster IgG 
3 Supernatant was collected from in vitro grown hybridoma cells (O'Neill lab). 
4 Becton Dickinson 
Source 
1 
I 
I 
I 
I 
3 
I 
I 
I 
2 
3 
3 
I 
3 
4 
3 
3 
3 
reagents are shown in Table 2.2. This was followed by a single wash with 1ml of ice-
cold Phosphate Buffered Saline (PBS)/0.1 % NaN 3. Cell pellets were resuspended in 
300-500µ1 PBS/0.1 % NaN3 and transferred into tubes for immediate analysis of 
fluorescence using a fluorescent activated cell sorter (FACS) (FACSort: Becton 
Dickinson). 
2.2.4 Antibody staining of cells in suspension - two-colour staining. 
Labelling with first antibody: Specific antibody was absorbed to cells in a I 00µ1 volume 
in 1.5ml tubes. Details of antibodies used are shown in Table 2.1. After incubation for 
30 minutes on ice, cells were diluted with 250µ1 staining medium and washed once 
using an underlay of 600µ1 FCS followed by centrifugation at 300g for 10 minutes. 
Cells were then washed twice by resuspension in 1ml staining medium and 
centrifugation at 300g for 5 minutes. The same incubation and washing procedure was 
repeated for addition of 100µ1 of the diluted fluorochrome-labelled secondary antibody. 
Details of fluorochrome-conjugated secondary antibodies are shown in Table 2.2. 
Isotype control antibodies were used as a control for specific binding at the same 
concentration as the first stage antibody. Details of isotype control antibodies are listed 
in Table 2.1. When goat anti-rat or goat anti-hamster secondary antibodies were used in 
the first antibody step, FcyR block was absorbed to cells prior to the second antibody 
step in the same manner described in Section 2.2.2. 
Labelling with second antibody: The same incubation and washing procedures 
described for first antibody labelling were used for absorption of 100µ1 of primary 
followed by labelled secondary antibodies. This was followed by a single wash with 
1ml of ice-cold PBS/0.1 % NaN3 . Cell pellets were resuspended in 300-500µ1 PBS/0.1 % 
NaN3. Cells were transferred into appropriate tubes for FACS analysis and analysed 
in1IIlediatel y. 
When a directly conjugated primary antibody was used in a two-colour staining 
experiment, the procedure was the same as that used for single-colour staining except 
that a directly conjugated antibody and a second primary antibody were absorbed to 
cells at the same time. 
2.2.5 Antibody staining of small numbers of cells in microtitre plates. 
When only small numbers of non-adherent LTC-DC were available, staining was 
carried out in wells of a U-bottomed PVC microtitre plate (Biofusion). Specific 
antibody was absorbed to cells (0.5-lxl05) in a 50µ1 volume in separate wells of a 96-
well plate. Details of the specific antibodies used are shown in Table 2.1. After 
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Table 2.2 Secondary fluorochrome-conjugated antibodies. 
Reagent Specificity 
Goat IgG F( ab1)2 fragment . Rat IgG 
Goat IgG Hamster IgG 
Avidin Biotin 
Avidin Biotin 
1 Southern Biotechnology 
2 Kirkegaard and Perry Laboratories 
3 Becton Dickinson 
4 Phanningen 
Label 
FITC 
FITC 
FITC 
PE 
Source 
1 
2 
3 
4 
incubation for 30 minutes on ice, cells were diluted to 250µ1 volumes in staining 
medium followed by centrifugation at 300g for 5 minutes. Cells were then washed twice 
by resuspension in 250µ1 staining medium and centrifugation at 300g for 5 minutes. The 
same incubation and washing procedure was repeated for addition of 20µ1 of the 
fluorochrome-conjugated second stage reagent. Details of these reagents are shown in 
Table 2.2. This was followed by a single wash with 250µ1 of ice-cold PBS/0.1 % NaN3 . 
Cell pellets were resuspended in 300µ1 PBS/0.1 % NaN3 . Flow cyto1netric analysis was 
can·ied out immediately. 
2.2.6 Flow cytometry settings. 
Analysis of fluorescence was performed on the FACSort (Becton Dickinson) in the 
School of Biochemistry and Molecular Biology, Australian National University (ANU). 
Debris was gated out during acquisition on the basis of the Forward Scatter reading 
using a threshold of 50, unless otherwise indicated. For analysis, 1-2xl04 events were 
collected for each cell sample. Data collected included Forward Scatter, Side Scatter, 
green fluorescence (FLl channel) and red fluorescence (FL2 channel). CellQuest 
software (Becton Dickinson) was used to aquire and analyse data. Data analysis 
involved post-acquisition gating to obtain information on cell subsets. An example of 
the instrument settings co1nmonly used is shown in Table 2.3. 
2.3 CELL FUNCTION ASSAYS. 
2.3.1 Flow cytometric analysis of endocytosis. 
Capacity for endocytosis by non-adherent LTC-DC was assessed by pulsing cells with 
fluorescein isothiocyanate-conjugated ovalbumin (OV-FITC, Molecular Probes). This 
was used at a concentration of l00µg/ml in 50% sDMEM/50% LTC-CSN. LTC-CSN 
was collected from LTC at 48 hours post medium change. The medium was centrifuged 
at 2000g for 5 minutes to remove cells and debris then poured off into a sterile tube. 
LTC-CSN was stored at -20°C until required. Non-adherent cells were collected as 
described in Section 2.1.2. OV-FITC was added to 1.2xl06 cells kept on ice for 10 
minutes. The mixture was then incubated at 37°C for various times (0.5 - 24 hours). 
Control cells incubated with the same concentration of OV-FITC were kept on ice over 
the same period of time. At each time point, 100µ1 of cell suspension (2xl05 cells) was 
removed from the mixture. OV-FITC uptake was halted by addition of ice-cold 
PBS/0.1 % NaN3 . Subsequently, cells were washed three times with PBS/0.1 % NaN3 , 
resuspended in PBS/0.1 % NaN3 and analysed immediately by flow cytometry. Controls 
included untreated cells and cells exposed to OV-FITC at 4 °C. Flow cytometry was 
performed as described in Section 2.2.6. 
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Table 2.3 Instrument settings used for acquisition of flow cytometric data. 
Parameter Voltage Amplification Scale 
. gain 
FSc a E00 b 1.00 Lin 
SSc a 218 1.00 Log 
FLl 440 1.00 Log 
FL2 430 1.00 Log 
a FSc = Forward Scatter, SSc = Side Scatter 
b E00 is an exponential function representing the amplification gain in electrical signal. It 
is used for larger cells and represents an increase in base level by 10. 
During 2-colour analysis, compensation was required to allow for overlap in wavelengths 
of FITC and PE. Commonly used values were: FLl 1.0-5.4% FL2 and FL2 27.3-31.3% 
FLl. 
2.3.2 Sorting LTC-DC into s1nall and large cell subsets. 
Non-adherent cells were collected from LTC as described in Section 2.1.2. After 
centrifugation (300g, 5 minutes), the supernatant was carefully removed by pipetting. 
Cells were resuspended to approximately 5ml in Hanks Balanced Salt Solution 
(HBSS)/5% FCS. The composition of HESS is detailed in Appendix B. Cells were 
sorted into small and large cell subsets using the FACStar Plus machine (Becton 
Dickinson) located in the John Curtin School of Medical Research (JCSMR), ANU. 
These two subsets were gated on the basis of Forward Scatter (amplification gain of 2.0 
with a lX neutral density filter) and Side Scatter (log scale, 167-l 72V). Sorted cells 
were deposited into tubes containing sDMEM/25 % FCS to maintain viability. Cell 
viability was checked by two-fold dilution of an aliquot of sorted cell suspension with 
0.4% trypan blue stain (Gibco BRL) and examination of cells for trypan blue 
penetration. 
2.3.3 Antigen presentation by LTC-DC in the MLR. 
The antigen presenting capacity of LTC-DC was assessed by using them as stimulators 
in an MLR, as described previously (Ni and O'Neill, 1997). Proliferation of syngeneic 
and allogeneic splenocytes was measured after coculture with in·adiated LTC-DC or 
syngeneic spleen stimulator cells as a control. Mouse strains used and their H-2 
haplotype are shown in Table 2.4. Non-adherent LTC-DC were collected as described 
in Section 2.1.2. In some experiments, LTC cells were sorted into small and large cell 
subsets as described in Section 2.3.2. A single cell suspension of B 10.A(2R) spleen was 
also prepared, as described in Section 2.1.1. Stimulator cell populations, prepared at 
lxl05 cells/ml for LTC-DC and lxl06 cells/ml for spleen cells, were irradiated (20 Gy 
137Cs; Division of Plant Industry, CSIRO). Responder spleen cells were adjusted to 
lxl05 cells/ml. All prepared suspensions were incubated at 37°C until required. In some 
experiments, stimulators were incubated with 1 0µg/ml LPS (Sigma) in sDMEM at 
37°C, 5% CO2 in air for 24 hours. Untreated control cells were incubated for 24 hours 
with sDMEM only. After 24 hours, LPS was removed by washing three times with 
sDMEM and centrifugation. 
Three-fold dilutions of stimulators from lxl04 LTC-DC and lxl05 spleen cells were 
added to wells of 96-well U-bottom microtitre plates (Linbro) in 100µ1 volumes. 
Responders were then added at lxl04 cells in 100µ1 volumes. Triplicate wells were 
plated for each treatment. Controls included responders alone or different dilutions of 
stimulators alone. Plates were incubated at 37°C, 5% CO2 in air. Over the final 6 hours 
of a 72 hour incubation, 1 µCi thymidine (3HT) (Amersham Pharmacia Biotech) was 
added to each well. 3HT-labelled DNA was then harvested using a Packard Filtermate 
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Table 2.4 H-2 haplotype of mouse strains. 
Strain Haplotype H-2 locus a 
K Ab Aa Eb Ea 
(A/3) (Aa) (E/3) (Ea) 
Bl0.A(2R) h2 k k k k k 
C57BL/6J b b b b b -
a Kand D genes encode MHC I molecules, Ab and Eb encode ~ chains of MHC II 
molecules and Aa and Ea encode a chains of MHC II. 
D 
b 
b 
196 cell harvester (Canberra Packard) on to a glass fibre filter (Canberra Packarq). The 
filter was placed into a 96-well cassette and 20µ1 of Microscint scintillation fluid 
(Canberra Packard) added to each well. After sealing plates with Topseal plastic 
adhesive sheets (Canberra Packard), 3HT-incorporation was measured using the 
TopCount NXT scintillation counter (Canberra Packard). 
2.3.4 Statistical analysis. 
Data have been presented as mean + standard error (SE) for sample size n. This statistic 
represents an informative way to present non-normal data of sample size n < 5. For 
sample sizes of n < 5, where a normal distribution cannot be assumed, the Wilcoxon 
Rank Sum test has been used to test significance (p<0.05). For sample sizes of n > 5, the 
Student's t Test has been used to determine significance. 
2.4 ANALYSIS OF DC DEVELOPMENT WITHIN LTC. 
2.4.1 Detection of apoptotic and necrotic cells using an Annexin-V assay. 
The detection of apoptotic and necrotic cells within LTC involved the Annexin-V Fluos 
Kit (Roche Diagnostics). This kit includes Annexin-V-Fluos which is a fluorescent-
conjugated phospholipid binding protein with high affinity for phosphatidylserine. 
Phosphatidylserine appears on the outer cell surface of early apoptotic cells. Necrotic 
cells also expose phosphatidy lserine due to loss of membrane integrity and so 
propidium iodide (PI; Sigma) co-staining is used to differentiate necrotic cells from 
apoptotic cells. 
Non-adherent LTC-DC were collected as described in Section 2.1.2. Quenching with 
CV was a necessary step for visualisation of Annexin-V+ cells. The cell suspension was 
centrifuged (300g, 5 minutes) and CV added to a concentration of 670 µg/ml. CV 
(2mg/ml) reduces cell viability by approximately 15% (Ni, unpublished data (O'Neill 
lab)). To maintain cell viability, CV was diluted before addition to cells, reducing loss 
in viability to approxi~ately 10%. Cells were then incubated at room temperature for 5 
minutes, washed twice in sDMEM and then once in PBS. Cells were resuspended in the 
kit Binding Buffer and aliqoted into 1.5ml tubes giving l-2xl05 cells/tube. Annexin-V-
Fluos (3µ1) and PI (lµl of 200µg/ml) were added to appropriate tubes. After an 
incubation period of 10-15 minutes at 20°C, 400µ1 of incubation buffer (l0mM 
Hepes/NaOH (pH 7.4), 140mM NaCl, 5mM CaCl) was added. Flow cytometric analysis 
of cells was carried out immediately as described in Section 2.2.6. 
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2.4.2 Cell cycle analysis using PI staining. 
The method used to analyse cell cycle was adapted from Current Protocols in 
Immunology, 1999 (Coligan et al., 1999). Non-adherent LTC-DC were collected as 
described in Section 2.1.2. Cells were washed twice with PBS to remove debris and 
serum proteins. Cells were fixed in 1ml ice-cold 70% ethanol and incubated for 18 
hours at 4 °C. Following centrifugation at 450g for 5 minutes, ethanol was decanted and 
cells resuspended to 500µ1 in PI staining solution (50µg/ml PI, l00U/ml RNase A 
(Progen)). Samples were incubated at 20°C for 3.5 hours. Flow cytometric analysis was 
ca1Tied out as described in Section 2.2.6. PI was detected in the FL2 channel. Debris 
was removed by using an FL2 threshold of 20 thereby eliminating events with very low 
red fluorescence. Data was acquired using the CellQuest software (Becton Dickinson) 
and analysed using ModFit LT software (Verity Software House). This computer 
program models the distribution of cells within different stages of cell cycle based on 
histograms produced at data acquisition. Areas under different parts of the curve 
represent the percentage of cells at GoG1, S and G2M phases of cell cycle. 
2.4.3 Bro1nodeoxyuridine (BrdU) incorporation as a measure of cell proliferation 
and turnover. 
Two protocols were adopted. To examine cell turnover, BrdU (12.5µg/ml in sDMEM) 
(Zhang, X. et al., 1998) was added into the medium of LTC daily. To pulse cells with 
BrdU, non-adherent cells were collected and incubated with BrdU (30µg/ml in 
sDMEM) (Carayon and Bord, 1992) for 1 hour before they were washed with sDMEM 
and returned to flasks. Non-adherent LTC-DC were collected at 1, 2, 3 and 4 days 
following addition of BrdU, as described in Section 2.1.2. Antibody staining was 
ca1Tied out as described by Karnath et al. (2000). Cells were washed once using 500µ1 
of PBS and centrifugation (300g for 5 minutes). The cell pellet was resuspended to 
250µ1 of ice-cold 0.15M NaCl and fixed by dropwise addition of 600µ1 of 95 % ethanol, 
while vortexing. After incubation for 30 minutes on ice, cells were washed with 1ml of 
PBS followed by centrifugation (450g for 5 minutes). Cells were permeabilised using a 
30 minute room temperature incubation in 500µ1 of 1 % paraformaldehyde/0.01 % 
Tween-20/PBS. Cells were pelleted (450g for 5 minutes) and incubated in 200µ1 of 
DNase solution (0.15M NaCl, 4.2mM MgCl, l0mM HCl and 50 Kunitz units/ml DNase 
(An1ersham Pharmacia Biotech)) for 10 minutes. After one wash in 400µ1 of PBS 
followed by centrifugation ( 450g for 5 minutes), cells were stained with FITC-
conjugated anti-BrdU antibody (see Table 2.1 ). Antibody was absorbed in a 50µ1 
volun1e for 30 minutes at 20°C. A final wash was carried out using 500µ1 of PBS 
followed by cent1ifugation ( 450g for 5 minutes) . Cells were resuspended in 300-500µ1 
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of PBS and flow cytometric analysis carried out immediately as described in Section 
2.2.6. 
2.4.4 Development of isolated small and large LTC-DC on ST-X3 stromal cells. 
ST-X3 stromal monolayers were cultivated as described in Section 2.1.3. Selected 
1ninin1ally confluent ST-X3 stromal layers were washed 3 times with HESS to remove 
any non-adherent cells. Stromal layers were i1Tadiated (20 Gy 137Cs) and the HESS 
replaced with sDMEM. I1Tadiated ST-X3 were incubated for 2 hours at 37°C, 5% CO2 
in air. Non-adherent cells were collected from LTC and sorted into small and large cell 
subsets as described in Section 2.3.2. After sorting, small and large cells were 
centrifuged (300g, 5 minutes) and resuspended in sDMEM. Small or large cells (l-
2xl05) were transfe1Ted on to irradiated ST-X3 stroma in individual 25cm2 flasks 
containing fresh sDMEM. Control flasks were established by addition of medium only 
on to irradiated stroma in order to measure endogenous production of non-adherent 
LTC-DC. Cultures were incubated at 37°C in 5% CO2 in air for up to 35 days. Medium 
was changed when cultures became acidic. 
Cultures were analysed for changes in non-adherent cell production and composition 
over time. This was done in two ways: (1) Flasks were observed and photographed 
under a Leitz Wetzlar Fluovert inverted phase microscope (Leica Microsystems) 
equipped with a Leica Wild MPS48 camera (Leica Camera). (2) Non-adherent cells 
were analysed by flow cytometry for Forward Scatter, Side Scatter and fluorescent 
antibody detection of DC cell surface markers as described in Sections 2.2.5 and 2.2.6. 
2.4.5 Colony assays. 
The development of colony assays for L TC-DC has been described previously (Wilson 
et al., 2000). Since growth of LTC-DC is stroma-dependent, it was necessary to prepare 
a stromal monolayer of ST-X3 cells over which L TC-DC were layered in agar. ST-X3 
stromal cells were mechanically separated and a single cell suspension prepared by 
repeated pipetting. The cell suspension was filtered through a 200G nylon mesh to 
remove cell clumps. Two ml of this single cell suspension was added to 35mm gridded 
petri dishes (Nunc), and incubated at 37°C, 5% CO2 in air. Stromal layers were grown 
for 7 days or until minimally confluent and then washed with sDMEM prior to use in 
colony assays to remove any non-adherent cells. Non-adherent LTC-DC were sorted 
into small and large cell subsets, as described in Section 2.3 .2. Either small or large 
LTC-DC were then plated at low density (5xl04 cells/plate) on to the stroma. To do this, 
100µ1 of cell suspension (2xl06 cells/ml in sDMEM) was combined with 1ml of 2X 
sDMEM, 1.9ml of LTC-CSN and 1ml of 4X Seaplaque agarose (l.6%w/v, 45°C) (FMC 
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Bioproducts). After mixing briefly, 1ml of cell/agarose mixture was pipetted over the 
stroma. This procedure was carried out for each of 3 replicates containing small L TC-
DC, large LTC-DC, or medium alone as a control. Plates were placed at 4°C for 5 
minutes to induce gelling of agarose, then incubated at 37°C, 5% CO2 in air thereafter. 
When medium became slightly acidic, an extra 1.5ml sDMEM was overlaid on top of 
the agarose. 
At 7 and 14 days after plating, agar plates were examined under an inverted phase 
microscope to quantitate colony number and to examine morphology of cells within 
colonies. At 19 days, plate examination was preceded by Wright-Giemsa staining. Cells 
were fixed by overlaying the agarose surface twice with 1ml of methanol for 15 minutes 
and then with 1ml of acetone for 15 minutes. Wright-Giemsa stain (1ml) (Sigma) was 
then added to the fixed agarose surface. After 2 minutes, 1ml of double distilled water 
( ddH20) was added. After a further 2 minutes, the plate was washed with ddH20 in 
preparation for microscopic analysis of cell morphology. 
2.4.6 Transwell assays. 
Minimally confluent monolayers of ST-X3 stromal cells were prepared in the wells of a 
6-well tissue culture plate (TPP) as described in Section 2.1.3. Plates were incubated at 
37°C, 5% CO2 in air, for 7 days. Stromal layers were washed with HBSS to remove any 
non-adherent cells and iiTadiated (20 Gy 6°Co; Division of Plant Industry, CSIRO). 
HBSS was replaced with fresh sDMEM and stromal layers incubated at 37°C, 5% CO2 
in air for 2 hours. Non-adherent LTC-DC were sorted into small and large cell subsets, 
as described in Section 2.3.2. Stromal layers were overlaid with 4ml sDMEM 
containing lxl05 FACS-sorted small or large cells from LTC. Medium alone was used 
as a control. In some cases, a Millicell-CM transwell (Millipore) was placed carefully 
over the stroma in the well. Medium was pipetted gently within and around the 
transwell. Sorted small or large cells (lxl05) were then aliqoted into the transwell. The 
6-well plates were incubated at 37°C, 5% CO2 in air. Cell growth within wells was 
examined microscopically for colony number and number of cells within colonies. Cells 
were photographed using a camera attached to an inverted microscope. 
2.5 PREPARATION AND AMPLIFICATION OF cDNA FROM CELL SUBSETS 
IN LTC. 
2.5.1 Isolation of total RNA from subsets of LTC-DC. 
Non-adherent LTC-DC were sorted into small and large cell subsets on the basis of 
Forward and Side Scatter characteristics as described in Section 2.3.2. After 
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centrifugation (300g, 5 minutes), cells were resuspended in 500µ1 of ice-cold PBS and 
transferred to labelled screw cap 'cryotubes' (Nunc). Cells were centrifuged again 
(300g, 5 minutes) and excess supernatant removed by pipetting. Cryotubes containing 
cell pellets were immersed into liquid nitrogen for 15 minutes to quickly freeze them 
and then transferred into liquid nitrogen storage until required. 
Total RNA was isolated from cells using the TRizol Reagent (Gibco BRL) according to 
the manufacturer's instructions. In brief, tubes containing sorted cells were removed 
fro1n liquid nitrogen storage and TRizol Reagent added directly to the frozen cell pellet. 
Cells were lysed by repetitive pipetting and incubation for 5 minutes at 20°C. Phase 
separation using chloroform was then performed. Chloroform (0.2ml/1.0ml TRizol 
Reagent) was added and the sample shaken vigorously for 15 seconds. Following 
incubation at 20°C for 2-3 minutes, the cell lysate was centrifuged at 12,000g for 15 
1ninutes at 4 °C. The resultant aqueous phase was transferred to a fresh tube and RNA 
precipitated by addition of isopropyl alcohol (0.5ml/1.0ml TRizol Reagent). Following 
incubation for 10 minutes at 20°C, the sample was centrifuged (12,000g) at 4 °C for 10 
1ninutes. Supernatant was carefully removed and the RNA pellet washed once with 75% 
ethanol (1.0ml/1.0ml TRizol reagent). The RNA pellet was vacuum-dried, dissolved in 
RNase-free ddH20 and incubated for 10 minutes at 55-60°C to aid dissolution. RNase 
inhibitor (RNAguard, Pharmacia Biotech) was added to the final sample (1 U/10µ1) for 
storage at -80°C. The quality of total RNA was examined using agarose gel 
electrophoresis (1 % agarose). The quantity of total RNA was assessed by UV 
spectrophotometry at 260nm. 
2.5.2 Analysis of RNA/cDNA quality and yield. 
RNA/cDNA san1ples were run in 1.2-2.0% SeaKem GTG (FMC Bioproducts) agarose 
gels in IX TAE buffer (Appendix B) at l00V, unless otherwise specified. Samples were 
run alongside GeneRuler lKb DNA ladder (Fermentas) to estimate size. The gel was 
stained for 10-20 minutes using a 5µg/n1l solution of Ethidium Bromide (EtBr) (ICN 
Biomedicals Inc.), followed by destaining in distilled water for 10-15 minutes. Gels 
were examined and photographed under ultraviolet (UV) light using a closed circuit 
camera (Cohu). Images were analysed using NIH Image 1.57 software (National 
Institutes of Health). 
The yield of RNA/cDNA was assessed by UV spectrophotometry using an Ultrospec III 
(Pharmacia LKB Biotechnology). Aliquots of RNA/cDNA were diluted to 50µ1 in 
0.22µm filtered ddH20 and analysed at 260nm against a 0.22µm filtered ddH20 blank. 
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The yield was calculated using the following equations: 
Concentration of single-stranded RNA (µg/ml) = Absorbance (260nm) x dilution 
0.025 
Concentration of double-stranded DNA (µg/ml) = Absorbance (260nm) x dilution 
0.020 
RNA quality was also assessed using the A260/ A280 ratio. A ratio of 1.8 to 1.9 and 1.9 to 
2.0 represent highly purified preparations of DNA and RNA, respectively (Ausubel et 
al., 2000). 
2.5.3 cDNA synthesis and amplification. 
The SMART PCR cDNA Synthesis Kit (Clontech Laboratories) was used to amplify 
starting 1naterial for use in the subtraction procedure. Reagents supplied in the SMART 
PCR cDNA Synthesis Kit are listed in Table 2.5. Manufacturer's instructions were 
followed for synthesis and amplification of cDNA. A modified oligo(dT) primer (CDS 
primer: refer to Table 2.6 for sequence) was used to prime the first strand synthesis 
reaction (Fig 2.1). When the enzyme reaches the 5' end of the mRNA, reverse 
transcriptase then adds a few additional nucleotides, mainly deoxycytidine. This allows 
the SMART II Oligonucleotide (refer to Table 2.6 for sequence), containing an oligo(G) 
sequence at its 3' end, to bind these deoxycytidine residues and extend the template. 
The reverse transcriptase then switches templates and continues replicating to the end of 
the SMART II Oligonucleotide. This creates full length single-stranded cDNA that 
contains SMART PCR primer sites (refer to Table 2.6 for sequence) and RsaI digestion 
sites at its ends (Fig 2.1). 
First Strand Synthesis 
For sa1nples and controls, 1-3µ1 total RNA, lµl CDS primer (l0µM), lµl SMART II 
Oligonucleotide (l0µM) made up to 5µ1 in deionised water, were combined and 
incubated at 70°C for 2 minutes. Each sample was then combined with 2µ1 5X First 
strand buffer, lµl Dithiothreitol (DTT, 20mM), lµl 50x dNTP (l0mM) and lµl MMLV 
RNase H- point mutant reverse transcriptase (200U/µl Superscript II, Gibco BRL). 
Samples were incubated at 42°C for 1 hour. The first strand reaction product was diluted 
with 40µ1 of IX TE buffer (Appendix B). Samples were heated at 72°C for 7 minutes 
before storage at -20°C. 
cDNA Aniplification 
To 5-10µ1 of first strand cDNA product was added: 74µ1 deionised water, 10µ1 l0X 
Advantage PCR buffer, 2µ1 SOX dNTP (l0mM), 2µ1 SMART PCR primer ( l0µM ) and 
2µ1 SOX Advantage Polymerase Mix. Polymerase chain reaction (PCR) was carried out 
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Table 2.5 Reagents supplied in the SMART PCR cDNA Synthesis Kit (Clontech 
Laboratories, Cat# K1052-1). 
Reagent 
cDNA synthesis: 
SMART II oligonucleotide 
CDS pri1ner 
SX First-strand buffer 
dNTP mix 
DTT 
Control human placental total RNA 
cDNA Amplification: 
SMART PCR primer 
SOX Advantage polymerase mix 
1 OX Advantage PCR buffer 
SOX dNTP mix 
PCR-grade water 
cDNA Purification: 
Chro1na-Spin 1000 columns 
Microfiltration colu1nns 
Concentration and composition 
lOµM, Refer to Table 2.6 for sequence 
lOµM, Refer to Table 2.6 for sequence 
2SOmM Tris-HCl (pH 8.3), 37SmM KCl, 30mM 
MgC12 
lOmM of each dATP, dCTP, dGTP, dTTP 
20mM 
lµg/µl 
lOµM, Refer to Table 2.6 for sequence 
lOmM of each dATP, dCTP, dGTP, dTTP 
0.4Sµm 
Table 2.6 Prin1ers used during the generation of subtracted cDNA libraries. 
Primer name 
SMART II 
Oligonucleotide 
CDS Primer 
SMARTPCR 
Primer 
PCR Primer 1 
Nested Primer 1 
Nested Primer 2R 
G3PDH 5' Prin1er 
G3PDH 3' Primer 
UDG Primer 1 
UDG Primer 2R 
Primer sequence 
5'-AAGCAGTGGTAACAACGCAGCGTACGCGGG-3' 
5' -AAGCAGTGGTAACAACGCAGAGTACT(30)N-1N-3' 
(N=A, C, G or T; N-1=A, G or C) 
5'-AAGCAGTGGTAACAACGCAGAGT-3' 
5'-CTAATACGACTCACTATAGGGC-3' 
5' -TCGAGCGGCCGCCCGGGCAGGT-3' 
5'-AGCGTGGTCGCGGCCGAGGT-3' 
5'-ACCACAGTCCATGCCATCAC-3' 
5'-TCCACCACCCTGTTGCTGTA-3' 
5'-CUACUACUACUATCGAGCGGCCGCCCGGGCAGGT-3' 
5'-CUACUACUACUAAGCGTGGTCGCGGCCGAGGT-3' 
Figure 2.1. Synthesis and amplification of cDNA using the SMART PCR cDNA 
Synthesis Kit. The CDS primer (a rnodified oligo(dT) primer) primes the first strand 
synthesis reaction. Reverse transcriptase (RT) adds a few additional deoxycytidine 
residues when it reaches the 5' end of the rnRNA. The SMART II Oligonucleotide, which 
contains an oligo(G) sequence at its 3' end, binds to the deoxycytidine residues and 
extends the template. RT switches templates and continues replicating to the end of the 
SMART II Oligonucleotide, creating full length single-stranded cDNA that contains 
SMART PCR primer sites . This cDNA is amplified by PCR using the SMART PCR 
pnn1er. 
P'oly A+ !RNA 
5'' _ potyA 3,1 
~ 
' CDS !Primer 
olig1onude·otide l Fi·rs.t•strand 
synthesis. by RT 
51 . -- __ _ 1POiyA 
. dC ·taiUng by RT 
-polyA 
Temp:late switching 
and exte1nsio1n by RT 
.Am:plify cDNiA by LD PCR 
with PCR primer -•1- •- • 
Doubie•stranded cDNA 
From SMART PCR cDNA Synthesis Kit User Manual 
(Clontech Laboratories, Cat# K1052-1) 
Single 
1 step 
in a thermal cycler (Perkin Elmer 2400 Gene Amp System) using the fallowing 
program: 95 °C for 1 minute, followed by 18-24 cycles of: 95 °C for 5 sec, 65 °C for 5 sec 
and 68 °C for 6 minutes. The optimal number of cycles was assessed by testing aliquots 
at 15, 18, 21 and 24 cycles. To terminate this reaction, 2µ1 of 0.5M EDTA was added to 
each sample. Gel electrophoresis (1.2% agarose) was used to test and confirm optimal 
cycle number. Samples were stored at -20°C. 
Purification of cDNA 
For purification, PCR products were extracted with an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24: 1). A butanol extraction was then performed 
to concentrate the PCR product to a volume of 40-70µ1. A volume of 700µ1 of butanol 
was added to each sample and mixed thoroughly, followed by centrifugation at 13,500g 
for 1 minute. Each sample was then loaded on to a Chroma-Spin 1000 column and the 
larger fragments eluted with IX TNE buffer (Appendix B) according to the 
manufacturer's instructions. Gel electrophoresis was used to confirm the presence of 
PCR product in column fractions as described in Section 2.5 .2. 
2.6 PREPARATION OF cDNA FOR SUBTRACTION. 
cDNA was prepared for the subtraction procedure using both the SMART PCR cDNA 
Synthesis Kit and the PCR-Select cDNA Subtraction Kit (Clontech Laboratories) 
following manufacturer's instructions. Reagents supplied in the PCR-Select cDNA 
Subtraction Kit are listed in Table 2.7. The cDNA that contains the differentially 
expressed sequences is referred to as 'tester' and the reference cDNA as 'driver'. 
2.6.1 Endonuclease restriction digest of cDNA with Rsal. 
To 350-400µ1 of purified PCR product, 36-40µ1 1 OX Rsal restriction buffer and 1.5 µI 
Rsal (IOU/µl) was added. Samples were incubated at 37°C for 3 hours. To confirm 
complete digestion, 5µ1 of uncut cDNA was electrophoresed as a control along with 5µ1 
of Rsal digested cDNA. To terminate the reaction, 8µ1 of 20X EDT A/glycogen mix was 
added. 
2.6.2 Nucleotrap purification of RsaI-digested cDNA. 
Rsal-digested cDNA was purified using the Nucleotrap Purification System (Clontech 
Laboratories). This is a silica matrix-based PCR purification system and was employed 
by following the manufacturer's instructions. Rsal-digested cDNA was separated into 2 
tubes and combined with 17µ1 of Nucleotrap Suspension and 680µ1 of NT2 buffer. 
Tubes were left to stand at 20°C for 10 minutes , then centrifuged at 8000g for 1 minute. 
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Table 2.7 Reagents supplied in the PCR-Select cDNA Subtraction Kit (Clontech 
Laboratories, Cat# K1804-1). 
Reagent 
Endonuclease Digestion: 
1 OX Rsal restriction buffer 
Rsal 
Adaptor Ligation: 
T4 DNA ligase 
SX DNA ligation buffer 
Adaptor 1 
Adaptor 2R 
Subtractive Hybridisation: 
4X hybridisation buffer 
Dilution buffer 
PCR Amplification: 
PCR primer 1 
Nested PCR primer 1 
Nested PCR primer 2R 
Control Reagents: 
Control poly A+ RNA 
Control DNA 
G3PDH 5' Primer 
G3PDH 3' Primer 
General Reagents: 
dNTP n1ix 
20X EDTA/glycogen mix 
NH,Oac 
Concentration and Composition 
l00mM Bis Tris Propane-HCl (pH 7.0), l00mM 
MgCl2, lmM DTT 
10 U/µl 
400 U/µl, contains 3mM ATP 
250mM Tris-HCl (pH 7.8), SOmM MgC12, l0mM 
DTT, 0.25mg/ml BSA 
l0µM, refer to Table 2.6 for sequence 
l0µM, refer to Table 2.6 for sequence 
20mM Hepes-HCl (pH 8.3), 50mM NaCl, 0.2mM 
EDTA (pH 8.0) 
l0µM, refer to Table 2.6 for sequence 
l0µM, refer to Table 2.6 for sequence 
l0µM, refer to Table 2.6 for sequence 
1 µg/µl, from human skeletal muscle 
3ng/µl, HaeIII-digested bacteriophage ¢Xl 74 DNA 
l0µM, refer to Table 2.6 for sequence 
l0µM, refer to Table 2.6 for sequence 
l0mM each dATP, dCTP, dGTP, dTTP 
0.2M EDTA, lmg/ml glycogen 
4M 
The supernatant was discarded. The remaining pellet containing bound cDNA was 
washed once with NT2 buffer and twice with NT3 buffer. After the final wash, the 
pellet was centrifuged a second time and supernatant removed completely. The pellet 
was resuspended to 50µ1 of IX TE buffer (pH 8.0) and two pellets of the same sample 
type were combined. cDNA was eluted by incubation at 50QC for 5 minutes. Samples 
were centrifuged at 8000g for 30 sec. The supernatant containing cDNA was transfe1Ted 
into a clean 1.5ml tube and elution steps were then repeated with the remaining pellet. 
The combined supernatant ( 120-150µ1) was applied to a microfiltration column inserted 
into a 1.5ml tube and centrifuged at 8000g for 5 minutes. 
To precipitate cDNA, 75µ1 of 4M ammonium acetate, 562.5µ1 96% ethanol and 2.5µ1 
glycogen (lmghnl) was added. After incubation at -70QC for 2 hours, samples were 
centrifuged for 20 minutes at 13,500g at 4 QC. The pellet was washed with 200µ1 ice-
cold 80% ethanol by centrifugation for 10 minutes at 13,500g at 4 QC, air-dried, 
redissolved in 6.7µ1 of sterile ddH20 and stored at -20QC. The presence of cDNA 
following digestion and purification was assessed using gel electrophoresis (1.2% 
agarose) and UV spectrophotometry as described in Section 2.5 .2. 
2.6.3 Ligation of adaptors to tester cDNA. 
Aliquots of tester cDNA were ligated with different cDNA adaptors. Adaptors I and 2R 
both contain sequences which allow annealing of PCR primer I (refer to Table 2.6 for 
sequence). However, they differ in that they contain sequences for binding either Nested 
prin1er I or Nested primer 2R (refer to Table 2.6 for sequences). An aliquot of lµl of 
Rsal-digested tester cDNA was diluted in 5µ1 of sterile ddH20. Two tubes were 
prepared for each tester sample. Each tube contained 3µ1 sterile ddH20, 2µ1 5X ligation 
buffer, lµl T4 DNA ligase (400U/µl) and 2µ1 of diluted tester cDNA. Then 2µ1 of 
Adaptor I ( I 0µM) was added to the first tube (henceforth referred to as Tester I) and 
2µ1 of Adaptor 2R (I0µM) to the second tube (henceforth referred to as Tester 2R). 
Contents were mixed thoroughly. For each tester sample, a third tube was prepared by 
combining 2µ1 from ea~h of Tester I and Tester 2R. This was the 'unsubtracted' tester 
sample. Unsubtracted tester cDNA would possess different adaptors at each end without 
undergoing subtractive hybridisation. All tubes (a total of three for each tester sample) 
were incubated overnight at 16QC. Enzyme was inactivated by heating at 72QC for 5 
minutes. 
The efficiency of adaptor ligation was verified using cDNA produced for the house-
keeping gene G3PDH. It was important to verify that at least 25 % of cDNAs had 
adaptors at both ends. G3PDH cDNA was amplified in two reactions using (1) both the 
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internal G3PDH 3' and 5' primers, and (2) the G3PDH 3' primer and PCR primer 1 
which binds to a sequence found within both adaptors (refer to Table 2.6 for primer 
sequences). Adaptor ligation was judged successful if the band produced by 
amplification using G3PDH 3' primer and PCR primer 1 was at least 0.25 times the 
intensity of the band amplified using G3PDH 3' and 5' primers. 
For PCR reactions, 1 µl of Tester 1 or Tester 2R samples were diluted in 200µ1 of 
ddH20. For each sample type lµl of diluted tester cDNA was combined with lµl of 
each primer (G3PDH 3' and G3PDH 5' primers, or G3PDH 3' primer and PCR Primer 
1 used at l0µM each). To this was added 22µ1 of PCR master mix, containing 18.5µ1 
sterile ddH20, 2.5µ1 l0X PCR reaction buffer, 0.5µ1 dNTP mix (l0mM) and 0.5µ150X 
Advantage cDNA Polymerase Mix. Tubes were placed into a thermal cycler (Perkin 
Elmer) and reactions amplified according to the following program: 75cc for 5 minutes, 
94 CC for 30 sec, followed by 25 cycles of: 94 CC for 10 sec, 65CC for 30 sec, 68CC for 2.5 
minutes. Gel electrophoresis was used to compare bands resulting from PCR using 
different pri1ner combinations as described in Section 2.5.2. 
2.7 SUBTRACTIVE HYBRIDISATION AND SUPPRESSIVE PCR. 
Two hybridisations were performed. In the first, an excess of driver was added to tubes 
containing either Tester 1 or Tester 2R cDNA (Fig 2.2). These samples were then heat 
denatured and allowed to anneal. During hybridisation, sequences common to tester and 
driver formed double stranded molecules, leaving differentially expressed sequences as 
single-stranded molecules. In a second hybridisation, products of the two primary 
hybridisations were combined with excess driver cDNA. This resulted in hybridisation 
of the remaining subtracted single-strand tester cDNAs. After filling in ends with DNA 
polymerase, hybrids possessed different adaptors at the 3' and 5' ends, corresponding to 
the sequences of adaptors 1 and 2R. 
Two rounds of suppr_essive PCR amplification were then carried out. The first round 
utilised PCR Primer 1 which annealed to a sequence present in both adaptors. Only 
hybrids generated by subtractive hybridisation possessing different adaptors at each end 
were amplified exponentially ( e; Fig 2.2). Molecules without adaptors were not 
an1plified (a and c; Fig 2.2) and those with adaptors at only one end were amplified 
linearly (c; Fig 2.2). The amplification of molecules with identical adaptors at each end 
(b; Fig 2.2) was suppressed because during the primer annealing step, the hybridisation 
kinetics strongly favoured the fonnation of pan-like structures . These structures formed 
when complin1entary sequences in the identical adaptors annealed, preventing the 
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Figure 2.2. Subtractive hybridisation and suppressive PCR using the PCR-Select 
cDNA Subtraction Kit. Two hybridisation reactions were performed. In the first, excess 
driver cDNA was added to Tester 1 and Tester 2R cDNA. During hybridisation, 
differentially expressed sequences were left as single-s tranded n1olecules (a) . In the 
second hyb1idisation reaction, products of the first hybridisation (a, b, c, d) were combined 
with excess denatured driver cDNA. This resulted in the formation of double-stranded 
hybrids (e) fro1n differentially expressed single-s tranded molecules. Two rounds of 
suppressive PCR were performed. Only double-stranded hybrids possessing different 
adaptors at each end were exponentially a1nplified. This generated amplified subtracted 
cDNA (e) . 
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primer from annealing. This procedure is known as suppressive PCR. The second round 
of PCR used Nested primers 1 and 2R (sequences given in Table 2.6), which annealed 
to sequences specific for Adaptor 1 or 2R and exponentially amplified only those 
sequences with different adaptors at each end. 
2.7.1 Subtractive hybridisation reactions. 
Prior to subtractive hybridisation, the concentration of driver and tester cDNA was 
calculated using UV spectrophotometry and tester cDNA diluted with ddH20 so that 
driver cDNA would be 10-fold more concentrated. For the first hybridisation step, 1.5µ1 
Rsal-digested driver cDNA and 1µ14X Hybridisation buffer were combined in two 
separate tubes. Aliquots of 1.5µ1 of Tester 1 was added to the first tube (hybridisation 
sample 1) and 1.5µ1 of Tester 2R to the second tube (hybridisation sample 2R). Tubes 
were incubated in a thermal cycler (Perkin-Elmer) at 98 QC for 3 minutes, then 68 QC for 
8 hours. Rsal-digested driver cDNA (lµl), 1µ14X Hybridisation buffer and 2µ1 sterile 
ddH20 were then combined in PCR tubes. Excess driver was incubated at 98QC in a 
second thermal cycler (Perkin Elmer) for 3 minutes. During the second hybridisation, 
hybridisation samples 1 and 2R and freshly denatured driver cDNA were combined. 
Hybridisation sample 1 was drawn into a pipette tip followed by a small amount of air. 
Denatured excess driver cDNA (lµl) was then drawn into the pipette tip and the entire 
contents of the tip transferred into hybridisation sample 2R. The reaction was mixed 
briefly by pipetting once, then replaced at 68QC in the thermal cycler overnight for 
approximately 16 hours. To halt the reaction, 200µ1 of dilution buffer (20mM Hepes-
HCl (pH 8.3), 50mM NaCl, 0.2mM EDTA (pH 8.0)) was added and tubes heated in the 
thermal cycler at 68QC for 7 minutes. 
2.7.2 Suppressive PCR amplification of hybridisation products. 
To prepare unsubtracted tester controls for PCR amplification, 1 µl was removed from 
each adaptor-ligated unsubtracted tester (products of Section 2.6.3) and diluted into 1ml 
of sterile ddH20. For the first round of PCR, aliquots of lµl of diluted subtracted cDNA 
and 1µ1 of diluted unsubtracted tester cDNA were placed into separate 0.2ml PCR 
tubes. A premixed PCR master mix was added to each tube containing 19.5µ1 sterile 
ddH20, 2.5µ1 l0X PCR reaction buffer, 0.5µ1 dNTP mix (l0mM), 1.0µ1 PCR primer 1 
(l0µM) and 0.5µ1 SOX Advantage cDNA polymerase mix. Tubes were placed in a 
thermal cycler for an1plification (Perkin Elrner) using the following program: 75 QC for 5 
minutes, 94 QC for 25 sec, followed by 27 cycles of: 94 QC for 10 sec, 66QC for 30 sec and 
72QC for 1.5 minutes. 
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For the second round of PCR, 3µ1 of primary PCR product was diluted in 27µ1 of sterile 
ddH20. An aliquot of 1µ1 of this diluted product was transferred to a PCR tube. To this 
was added 24µ1 of a premixed PCR master mix, containing 18.5µ1 sterile ddH20, 2.5µ1 
lOX PCR reaction buffer, 1µ1 Nested PCR primer 1 (lOµM), 1µ1 Nested PCR primer 
2R (lOµM), 0.5µ1 dNTP mix (lOmM) and 0.5µ1 SOX Advantage cDNA polymerase 
mix. Tubes were placed in a thermal cycler for amplification (Perkin Elmer) using the 
following program: 12 cycles of 94 °C for 10 sec, 68 °C for 30 sec and 72°C for 1.5 
minutes. Products were stored at -20°C. Aliquots of 8µ1 of first round PCR product and 
8µ1 of second round PCR product were analysed by gel electrophoresis. To obtain clear 
visualisation of bands, samples were placed into wide wells of a 2 % agarose gel and run 
at 60V for 2-2.5 hours. 
2.7.3 PCR analysis of subtraction efficiency. 
Subtraction efficiency was monitored by PCR to compare the abundance of the house-
keeping gene G3PDH before and after subtraction. Successful subtraction should result 
in a reduction in G3PDH. Concentrations of the second round PCR products for 
subtracted cDNA and unsubtracted tester cDNA were measured using UV 
spectrophoto1netry. Second round PCR products were diluted approximately 10-fold 
and care was taken to ensure that the concentration of subtracted and unsubtracted PCR 
products was approximately equal. 
A PCR master mix was prepared containing 22.4µ1 sterile ddH20, 1.2µ1 G3PDH 3' 
prin1er (lOµM), 1.2µ1 G3PDH 5' prin1er (lOµM), 3µ1 lOX PCR reaction buffer, 0.6µ1 
dNTP mix (lOmM) and 0.6µ1 SOX Advantage cDNA polymerase mix per reaction tube. 
Aliquots of 29µ1 of master mix and either 1µ1 of diluted subtracted cDNA or 1µ1 of 
unsubtracted tester cDNA were combined in PCR tubes. Samples were amplified in a 
thermal cycler (Perkin Elmer) using the following program: 33 cycles of 94 °C for 30 
sec, 60°C for 30 sec and 68°C for 2 minutes. Aliquots of 5µ1 were removed from the 
PCR mix at 18, 23, 28 and 33 cycles and analysed using gel electrophoresis. The 
intensities of G3PDH bands for subtracted and unsubtracted samples were compared at 
different cycle numbers. 
2.7.4 Use of control RNA to monitor subtraction procedure. 
A control sample was included to ensure that the multistep procedure described in 
Sections 2.5.3 - 2.7.3 worked efficiently. Control human placental total RNA (lµg/µl) 
was supplied by the SMART PCR cDNA Synthesis Kit. It was used in first strand 
cDNA synthesis reactions in a volume of 1µ1 (lµg total RNA). Following purification 
of Rsal-digested human placental cDNA, control tester cDNA was prepared by mixing 
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an aliquot of human placental cDNA with a small amount of HaeIII-digested ¢XI 74 
DNA. To do this, 2µ1 of ¢XI 74/Haelll DNA (3ng/µl) was added to 38µ1 of sterile 
ddH20 (I50ng/ml final). Control tester cDNA was generated by adding Iµl of purified, 
Rsal-digested human placental cDNA (prepared as described in Section 2.6.2) to 5µ1 of 
the diluted ¢XI 74/HaeIII DNA, generating 0.2% Haelll-digested ¢XI 74 DNA. After 
subtraction against human placental driver cDNA, bands produced in the second round 
of PCR should correspond to ¢XI 74/HaeIII control fragments only. To confirm this, a 
successfully subtracted n1ixture of HaeIII-digested ¢XI 74 DNA provided in the PCR 
Select cDNA Synthesis Kit, was included as a positive control in the two rounds of 
suppressive PCR described in Section 2.7.2. 
2.8 GENERATION OF SUBTRACTED cDNA LIBRARIES. 
The subtracted PCR products were cloned using the CloneAmp pAMPIO System for 
rapid nondirectional cloning of amplified products (Life Technologies, Gibco BRL). 
This system utilises Uracil DNA Glycosylase (UDG) to facilitate the nondirectional 
cloning of PCR products. Second round PCR amplification was repeated using the UDG 
primers I and 2R which contain dUMP residues in place of dTMP at their 5' ends (refer 
to Table 2.6 for sequences). After amplification, PCR products contained the dUMP-
containing sequences at their 5' termini. Treatment with UDG rendered the dUMP 
residues abasic and unable to base pair, resulting in 3' protruding termini. This allowed 
insertion into the linearised vector pAMPIO which contains a modified multiple cloning 
site with 3' protruding termini. 
2.8.1 Second round PCR of subtracted cDNA using UDG primers. 
The product of first round PCR on subtracted cDNA (3µ1) was exposed to a second 
round of PCR. The method used was identical to that in Section 2.7.2 except that Iµl of 
UDG primers I and 2R were substituted for the nested primers I and 2R and a post-
cycle incubation at 72°C for 5 minutes was added. The secondary UDG PCR product 
(8µ1) was run on a 2% agarose gel at 60V for 2-2.5 hours to check that the subtracted 
banding pattern corresponded to that produced by Nested primers I and 2R. Two 
hybridisation controls were also subjected to secondary PCR. However, these were 
amplified using nested primers I and 2R, since they were not to be cloned. 
Hybridisation controls included plasmids containing one of two cDNA inserts. These 
cDNAs were not present in the subtracted cDNA libraries and so were appropriate 
negative controls for hybridisation. The cDNA A insert was a 320bp human homologue 
of mouse mRNA for testis-specific protein (GenBank accession #X52I28). The cDNA 
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B insert was a 220bp clone of human semenogelin II mRNA (GenBank accession 
#ANM81652), specific for seminal vesicles. 
2.8.2 Purification of PCR products using the Clontech Nucleospin Extraction Kit. 
PCR products were purified to remove any primer-dimers and excess dNTPs. 
Purification was carried out using the Nucleospin Extraction Kit (Clontech 
Laboratories) according to the manufacturer's instructions. Briefly, a mixture of the 
PCR product and Buffer NT2 was loaded on to a Nucleospin column and centrifuged 
(13,500g, 5 minutes). The column was washed twice with Buffer NT3 and the purified 
PCR product was eluted with 50µ1 of Buffer NE. The yield and quality of purified 
product was assessed using UV spectrophotometry and agarose gel electrophoresis. 
2.8.3 Cloning of subtracted cDNA using the CloneAmp pAMPl0 system. 
Subtracted cDNA was cloned using the CloneAmp pAMPl0 System (Life 
Technologies, Gibco BRL). In order to ligate inserts into the pAMPl0 vector, 3µ1 of 
purified second round PCR product (10-50ng) was combined with 2µ1 of pAMPl0 
vector DNA (25ng/µl), 2µ1 of l0X Boehringer PCR reaction buffer (l00mM Tris-HCl, 
15mM MgC12 , 5001nM KCl, adjust pH 8.3 at 20°C), lµl of UDG (1 U/µl) and 12µ1 of 
sterile ddH20. This mixture was incubated at 37°C for 30 minutes and then placed on 
ice. 
Competent cells (50-100µ1) were thawed on ice followed by addition of 3µ1 of the 
ligation reaction. Cells were kept on ice for 30 minutes, heat shocked at 42°C for 2 
minutes and placed on ice for a further 2 minutes. Cells were placed on a shaker at 37°C 
for 1 hour, following addition of 900µ1 of SOC medium (Appendix B). Cells were then 
centrifuged and resuspended in 200µ1 of Luria Broth (LB)/ampicillin (Appendix B). 
This volume was divided and plated on to each of two large LB/ampicillin plates 
(Appendix B). Plates were inverted and incubated overnight at 37°C. 
2.9 DIFFERENTIAL SCREENING OF SUBTRACTED CLONES. 
A screening step was performed to identify unique cDNA clones and to detect cDNA 
clones comn1on to both tester and driver populations. Subtracted libraries could still 
contain some cDNA clones common to both tester and driver populations. Differential 
screening of clones in subtracted libraries was ca1Tied out using the Clontech PCR-
Select Differential Screening Kit (Clontech Laboratories) according to manufacturer's 
instructions. Reagents supplied in the PCR-Select Differential Screening Kit are listed 
in Table 2.8. This 111ethod involves hybridisation of subtracted clones with 4 different 
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Table 2.8 Reagents supplied in the PCR-Select Differential Screening Kit 
(Clontech Laboratories, Cat# K1808-1). 
Reagent 
Nested Primer 1 
Nested Primer 2R 
cDNAA 
cDNAB 
Rando111 primer mix 
Reaction buffer (-dCTP) 
Klenow enzyme (exo-) 
Stop solution 
Blocking solution 
Components 
lOµM, refer to Table 2.6 for sequence 
lOµM, refer to Table 2.6 for sequence 
5µg/ml, GenBank accession #X52128 
5µg/ml, GenBank accession #ANM81652 
0.9mg/ml random nonamers, 50mM Tris-HCl (pH 
8), lOmM MgCl2, lmM DTT, 50µg/ml BSA 
333mM Tris-HCl (pH 8), 33.3mM MgCl?, lOmM 
2-mercaptoethanol, l 70µM dCTP, l 70µM dGTP, 
170µM dTTP 
2-5U/µl 
O.lM EDTA, 500µg/ml yeast tRNA 
lOmg/ml sheared salmon sperm DNA, 300µg/ml 
oligonucleotides corresponding to nested primers 
and complementary sequences 
probes prepared from 'forward subtracted' , 'reverse subtracted', 'forward unsubtracted ' 
and 'reverse unsubtracted' cDNA. 'Forward' and 'reverse' refers to the direction of 
subtractive hybridisation. Forward probes were made from the same cDNA used to 
generate the subtracted library from which the subtracted clones in question originated. 
Reverse probes originated from subtractive hybridisation performed with the original 
tester cDNA as driver and the driver cDNA as tester. Differentially expressed clones 
within subtracted libraries were selected on the basis of hybridisation with the forward 
and not reverse probes. 
2.9.1 Preparation of cDNA arrays of subtracted clones. 
Subtracted libraries were plated and 480 colonies were randomly picked for each 
subtracted library. Each colony was transfen·ed into 100µ1 of LB/ampicillin (l00µg/ml) 
mediu1n in wells of a Falcon 96-well U bottomed plate (Becton Dickinson Labware). 
Bacteria were grown up by incubating at 37°C for 2 hours with shaking (200 rpm). 
Bacteria were used as the template for PCR amplification of the cloned insert. PCR 
reactions were ca1Tied out in 48-well PCR plates (Robbins Scientific). 1 µl of bacterial 
culture was combined with 2µ1 of l0X Boehringer PCR reaction buffer, 0.6µ1 of Nested 
PCR pri1ner 1 (l0µm), 0.6µ1 of nested PCR primer 2R (l0µM), 0.4µ1 of dNTP mix 
(l0mM), 0.5µ1 of Taq Polymerase (kindly supplied by J. Banyer, JCSMR, ANU) and 
14.9µ1 of sterile ddH20. Plates were placed in a thermal cycler (PTC-200 Peltier 
Thermal Cycler; MJ Research) for amplification of cDNA inserts using the following 
progra1n: precycling 94 °C for 30 sec, then 23 cycles of 95°C for 10 sec and 68°C for 3 
n1inutes. Gel electrophoresis (2% agarose) with 5µ1 of PCR product was carried out to 
ensure that each well contained a single clone and to assess insert size. 
PCR an1plified inserts were dotted out on to nylon membranes in preparation for 
Southern hybridisation dot blotting. An aliquot of 5µ1 of the PCR product was 
con1bined with 5µ1 of 0.6N NaOH in a 96-well plate. Control PCR products from cDNA 
A and cDNA B (Section 2.8.2) were also included. An aliquot of 2µ1 of each mixture 
was transfe1Ted on to a nylon n1embrane (Hybond N+; Amersham) in a 96-dot format. 
Triplicates of each blot were made. Blots were neutralised in 0.5M Tris-HCl (pH 7.5) 
and washed in sterile ddH20. DNA was cross-linked to the membrane using using a UV 
crosslinker (Amersham) at 70ml. 
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2.9.2 Hybridisation of random primer-labelled cDNA probes with subtracted 
cDNA clones. 
Random pri1ner labelling of the probes was can·ied out using reagents supplied in the 
Differential Screening Kit and following 1nanufacturer' s instructions. To label probe, 
80-90ng of forward or reverse subtracted cDNA, or 50-l00ng tester or driver 
unsubtracted cDNA, were combined with sterile ddH20 to make a volume of 9µ1. 
Aliquots of cDNA were denatured by heating for 8 minutes at 95 °C in a thermal cycler 
(Perkin Elmer) and then chilled on ice. To each tube of denatured cDNA, 3µ1 of 
reaction buffer (minus dCTP), 2µ1 of random primer mix, 5µ1 of [a-32P]dCTP (50µCi) 
(A1nersham Pharmacia Biotech) and 1µ1 of Klenow enzyme (exo-), was added. 
Labelling reactions were incubated for 30 minutes in a 37°C heating block. Each 
reaction was terminated by addition of 5µ1 of Stop Solution. 
Probes were purified from unincorporated dNTPs using MicroSpin G-25 Columns 
(Amersham Pharmacia Biotech). Resin within each column was resuspended, then each 
column was pre-spun for 1 minute at 735g in a variable-speed centrifuge (Eppendorf 
Model 5415 C). Each column was placed in a new 1.5ml tube and the sample applied 
slowly to the centre of the resin bed. Colu1nns were centrifuged for 2 minutes at 735g. 
The purified probe was collected at the bottom of the 1.5ml tube. The specific activity 
and percentage incorporation of radionucleotides was determined for each probe. Both 
purified and unpurified ( 1 µl) probe solution was placed in a 1.5ml tube inside a 
scintillation vial. Radiosignal was quantified using the Cherenkov counting program on 
a scintillation counter (Beck1nan LS6500). Percentage incorporation was determined by 
dividing the counts after purification by the number of counts before and multiplying 
this by 100. Probes were used if they emitted> 107 cpm. 
Prehybridisation solution containing 250µ1 of 20X SSC (Appendix B), 250µ1 of 
Blocking solution ( containing sheared sahnon spenn DNA and oligonucleotides 
corresponding to the nested primers and complimentary sequences) and 25ml of 
hybridisation solution (Appendix B) was prepared. Nylon membranes (usually 3-4) 
were arranged between mesh and placed into each hybridisation tube. Prehybridisation 
solution was added and membranes were continuously agitated at 72°C for 3-4 hours. 
Each 32P-labelled probe was diluted into 50µ1 of 20X SSC and 50µ1 of Blocking 
solution. The same nu1nber of cpm was used for each pair of probes. The hybridisation 
n1ixture was denatured for 5 1ninutes at 95 °C in a heating block and chilled on ice. 
Hybridisation mixture was then added into the hybridisation tube, avoiding direct 
addition of probe to the men1brane. Hybridisation was caiTied out overnight at 72°C 
with continuous agitation. 
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Membranes were washed with low-stringency (2X SSC/0.5 % SDS) washing solution at 
68 °C using four washes of 20 minutes. Membranes were then washed twice more with 
high-stringency (0 .2X SSC/0.5 % SDS) washing solution at 68 °C, each wash for 20 
minutes. Washed 1nembranes were placed on filter paper and covered with Saran Wrap. 
They were exposed to 2 layers of autoradiography film (Biomax MR; Kodak) between 
intensifying screens at -70°C. Films were developed at various time points depending on 
strength of signal observed at 24 hours. 
2.10 SEQUENCING AND ANALYSIS OF SELECTED CLONES. 
2.10.1 Miniprep of clones. 
The Proprep Mini prep Kit (Astral Scientific) was used to prepare mini preps of clones 
following manufacturer's instructions. Bacterial clones were grown overnight in 250µ1 
of 2X Tryptone Yeast medium (TY; Appendix B) to early stationary phase. A final cell 
concentration of 2-4x 108cells/ml was confirmed by spectrophotometry, since a 1: 10 
dilution of the culture gave an OD600 of 0.2-0 .4. Cells were concentrated by 
centrifugation at 1200g for 5 minutes. The cell pellet was resuspended in 20µ1 of TEI 
buffer including 1µ1 of RNase cocktail. Alkaline lysis buffer (20µ1) was added and 
incubated for 2 minutes at 20°C. Neutralisation buffer (20µ1) was then added and 
incubated for 3 minutes at 20°C. Procipitate (10µ1) was added with a wide bore pipette 
tip and 1nixed by pipetting, before a 2 minute incubation at 20°C. Samples were 
transfen·ed to the wells of a 96-well filter plate attached to a vacuum manifold and 
receiver plate. Vacuum was applied until no visible liquid was left in the wells. 
To precipitate plasmid DNA, a volume of 100% ice-cold ethanol twice that of sample 
filtrate, was added to the filtrate. Following agitation, this was incubated on ice for 10 
1ninutes. Samples were centrifuged at 13 ,500g for 15 minutes. The DNA pellet was 
washed with 50µ1 70% ice-cold ethanol and centrifuged at 13,500g for 5 minutes. The 
DNA pellet was dissolved in 15µ1 of sterile ddH20. 
2.10.2 Purification of minipreps. 
A purification procedure was required because the resultant plasmid DNA preparation 
was not pure enough to be sequenced directly. Each plasmid DNA sample was run on a 
1.2% agarose gel at 80V and stained with 5µg/ml EtBr. The plasmid band was excised 
under UV light and the DNA purified using the BRESAclean DNA purification kit 
(Geneworks) . Briefly, three volumes of BRESA-Salt was added to samples and the 
agarose dissolved by incubation at 55°C for 5 nunutes. BRESA-Bind (5µ1) was added 
and incubated at room temperature for 5 minutes. The BRESA-Bind/DNA complex was 
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pelleted by centrifugation at 13,500g for 5 sec. The pellet was washed with BRESA-
Wash solution followed by centrifugation at 13,500g for 5 sec. DNA was eluted fron1 
the BRESA-Bind beads by resuspension to 10µ1 of sterile ddH20 followed by 
incubation for 5 minutes at 45-55°C. The sample was centrifuged at 13,500g for 1 
minute and the resultant supernatant containing plasmid DNA was transferred to a fresh 
tube. Plasmid yield was assessed using UV spectrophotometry. 
2.10.3 PCR amplification and purification. 
So1ne clones were prepared for sequencing by PCR amplification directly from bacteria. 
In this case, PCR amplification was carried out as described in Section 2.9.1. PCR 
products were purified using the Nucleospin Extraction Kit as described in Section 
2.8.2. The quality and quantity of PCR product was assessed using agarose gel 
electrophoresis (1.2% agarose) and UV spectrophotometry. 
2.10.4 Sequencing using Big Dye Terminator. 
Subtracted cDNA inserts were sequenced using the Big Dye Terminator Reaction Mix 
(ABI). Sequencing was carried out in 0.2ml PCR tubes containing 5µ1 DNA template 
(150-200ng of double stranded DNA or 45-90ng of PCR product DNA), 1µ1 of Nested 
Primer 1 or Nested Primer 2R and 4µ1 of Big Dye Terminator Ready Reaction Mix. 
Tubes were placed in a thermal cycler (Perkin Elmer) with the following program: 25 
cycles of 96°C for 10 sec, 68 °C for 5 sec and 60°C for 4 minutes. The products of each 
sequencing reaction were precipitated in 70% ice-cold ethanol containing 0.08M 
sodiu1n acetate, followed by shaking and incubation on ice for 10 minutes. Precipitated 
products were pelleted by centrifugation at 13,500g for 30 minutes. The pellet was 
washed twice by addition of ice-cold 70% ethanol and centrifugation at 13,500g for 5 
minutes. Pellets were air-dried for 5-15 1ninutes. 
Sequencing products were electrophoresed on a 5% polyacrylamide gel under 
denaturing conditions (6M urea) in an automated DNA sequencer (ABI model 377) at 
the Biomolecular Resource Facility (JCSMR). Analysis was carried out using ABI 
Sequencing Software Version 3.0. 
2.10.5 Database searches for homologous sequences. 
Sequence results were submitted to various online databases to elucidate the identity of 
clones. Databases were searched using Basic Local Alignment Search Tool (BLAST). 
BLASTn compares nucleotide query sequences with nucleotide reference databases. 
Initially sequences were submitted to the National Center for Biotechnology 
Information (NCBI; NIH) 'nr' database (all non-redundant GenBank CDS translations, 
39 
PDB, SwissProt, PIR and PRF) to find similar known genes and full-length cDNA 
clones. Sequences with no significant similarity were aligned to find duplicates using 
the Mac Vector program (Oxford Molecular Group). Some sequences were then 
submitted to the EST database to find matching known expressed sequence tags (EST). 
To perform domain searches, the nucleotide sequences were translated in 6-frames 
using a translate tool in the Expasy Molecular Biology Server (http://www.expasy.org/). 
These anuno acid query sequences were then used to search the NCBI conserved 
do1nain database (Pfam and Smart) using RPS-BLAST. 
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CHAPTER3 
Non-adherent cells produced in LTC represent two subsets of small and large 
LTC-DC. 
3.1 INTRODUCTION 
While DC are known to arise from BM and HSC (Inaba et al., 1992a; Manz et al., 
2001) their developmental pathway(s) are not well defined. The study of DC 
development and function has been difficult due to the low numbers of these cells in 
vivo (Hart, 1997; Steinman and Cohn, 1973). This problem has been overcome through 
expansion of DC from progenitors by in vitro culture with cytokines. For example, DC 
are co1nmonly generated from peripheral blood monocytes using GM-CSF and IL-4 
(Sallusto and Lanzavecchia, 1994; Schreurs et al., 1999) and from BM or cord blood 
HPC using GM-CSF, SCF and TNF-cx (Caux et al., 1996; Zhang, Y. et al., 1998). 
While these in vitro culture systems have been used effectively to generate large 
numbers of DC for study, there are disadvantages associated with their use. These 
include the limited period of time of DC proliferation and survival and the artificial 
environment of in vitro culture. A number of DC lines have been generated and 
sustained for more than 12 months, but these cells are also dependent upon cytokines 
for survival (Elbe et al. , 1994; Winzler et al., 1997; Xu et al., 1995). 
Within our lab, DC are continuously generated within a spleen-derived LTC system. 
DC can be collected from a single L TC line for experimental use over a period of years 
rather than weeks (O'Neill et al., 1999b). Exogenous growth factors are not added into 
LTC. Instead haen1opoiesis is supported by the presence of a stromal layer comprising 
endothelial cells, fibroblasts and some macrophages which promotes the survival, 
proliferation and differentiation of cells. Non-adherent cells produced in LTC have 
previously been characterised as DC based on morphology , phenotype and antigen 
presenting capacity (Ni and O'Neill, 1999; Ni and O'Neill, 1997; Ni and O'Neill , 1998). 
One can argue that LTC simulate conditions much closer to normal physiological 
conditions than do cultures supplemented with growth factors. 
Study of the Forward Scatter and Side Scatter profile of non-adherent LTC-DC has 
revealed the presence of two major cell subsets, referred to as small LTC-DC and large 
LTC-DC. Initial experiments presented in this chapter investigate the kinetics of cell 
growth within LTC. The replication and turnover of small and large LTC-DC and the 
presence of apoptotic and necrotic cells within subsets is analysed. Information from 
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these experiments has contributed to the optimisation of cell collection and FACS-
sorting procedures to isolate non-adherent LTC-DC subsets. A majority of the non-
adherent cells collected display DC surface marker expression and morphology. 
3.2 RESULTS 
3.2.1 Production of DC in L TC. 
LTC-DC were initiated from whole murine spleen as described in Section 2.1.1. Over a 
period of approximately 8 weeks, culture conditions supported the developn1ent of an 
adherent stromal layer and production of non-adherent DC. During the first 3-4 weeks 
of culture a stromal layer comprising endothelial cells, fibroblasts and some isolated 
macrophages, formed across the floor of the flask. By 3 weeks all lymphocytes and 
erythrocytes had disappeared from culture. Also during this time, cultures began to 
produce small non-adherent cells. Large dendritic-like cells appeared after a further 2 to 
3 weeks. These cells often developed in foci on the stromal surf ace and cells were then 
released into the medium where they were collected for experimentation. Figure 3.1 
shows a focus of developing cells above aggregated stromal cells. 
LTC-DC used during this project were derived from B 1 0.A(2R) mice. Multiple LTC 
lines were generated from a number of different individual mice on separate occasions 
prior to and during this project. Work was initially carried out with cultures established 
during 1997, denoted LTC-1S. During October 1998 a number of new LTC lines were 
established. Cells from one of these, L TC-HJ d, were used in experiments over the next 
3 years. In February 2000, further LTC lines were established. Cells from three of these, 
LTC-2Rl, LTC-2R3 and LTC-2R4, were used in experiments over the next 18 months. 
The productivity of a LTC related to the number of non-adherent DC generated. A 
productive LTC yielded 0.5-1.0xl06 non-adherent DC every 48 hours. By maintaining a 
small number of LTC, cells were available for experimentation on a regular basis. The 
collection of non-adherent DC from LTC flasks was a relatively simple procedure. 
Medium containing cells was pipetted out of the flask and the stroma washed gently 
with fresh medium to collect weakly adherent cells. Fresh replacement medium was 
added back to the flask. The collected cell suspension was filtered through 200G ny Ion 
mesh to remove cell clumps. Due to the homogeneous nature of cells produced in LTC, 
there was no need for further enrichment of cells to obtain DC. 
The longevity of the LTC system was n1aintained by passaging both stromal and non-
adherent cells into new tissue culture flasks. A small section of stroma was scraped 
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Figure 3.1. Non-adherent cells produced in LTC represent two major subpopulations. (A) Cell foci in developing spleen-derived LTC. 
Cells were incubated in sDMEM at 37°C in 5% CO2 in air for 10 weeks . Stromal cells fanned a monolayer over the floor of the flask. In dense 
areas of stron1a, foci of DC developed above the stromal cell layer (x200). (B) The Forward Scatter versus Side Scatter FACS plot shown is 
representative of non-adherent cells fron1 nurnerous B 10.A(2R)-derived LTC. Cellular debris is present in the lower left corner of the plot, while 
mall and large LTC-DC subpopulations are circled. Small LTC-DC represent an average of 14.1 + 0.9 % (mean+ SE, n=39) of the total non-
adherent LTC-DC population. 
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fro1n the donor flask. Medium containing stromal and non-adherent cells was 
transferred to a fresh flask along with fresh medium. New LTC took 3-4 weeks to form 
a stromal layer and become productive. Individual LTC could be maintained for 2-3 
months before passaging was required. This was necessary to prevent fibroblast 
overgrowth in the culture and to maintain progenitors essential for continuity of LTC. 
Non-adherent cells alone seeded into a flask of medium will not survive beyond 
approximately 7 days (Wilson et al., 2000). Passage of the stromal cell layer is essential 
for maintenance of the culture. 
3.2.2 Non-adherent cells produced in LTC represent two major subsets. 
The morphology and size distribution of non-adherent LTC-DC was studied over time 
by FACS analysis. Forward Scatter was used as a reflection of cell size and Side Scatter 
as a measure of cell co1nplexity or granularity. Non-adherent cells collected from LTC 
were shown to maintain a constant Forward Scatter and Side Scatter profile during a 4 
year period of experimentation involving cells collected from multiple LTC at multiple 
time points. By nature, LTC contain a small amount of debris because cultures are long-
term and support cell turnover and death. Debris was diluted out at medium change. It 
can be observed by FACS analysis in the lower left corner of the FACS plot shown in 
Figure 3.1. 
After exclusion of debris, two distinct cell populations were distinguishable by Forward 
Scatter and Side Scatter analysis. These two main populations were termed 'small' 
LTC-DC and 'large' LTC-DC. The large LTC-DC population (high Forward Scatter 
with high Side Scatter) contained cells that morphologically resembled DC. Cells were 
very large with cytoplasmic extensions. Typical morphology of large LTC-DC is 
displayed in Figure 5 .2. Electron and transmission scanning micro graphs showing large 
LTC-DC morphology have been published (Ni and O'Neill, 1997). These cells were 
also found to be very complex as shown by their high Side Scatter profile, reflecting 
extensive surface 1ne1nbrane and the presence of cytoplasmic organelles. The small 
LTC-DC population had a mean Forward Scatter approximately 3-fold lower than the 
large cell population and a mean Side Scatter approximately 8-fold lower. Small LTC-
DC did not possess cytoplasmic extensions. Their morphology following FACS-sorting 
is also shown in Figure 5.2. The size distribution of non-adherent LTC-DC remained 
constant over time and across many cultures. The small LTC-DC population contributed 
an average of 14.1 + 0.9% (mean+ SE, n = 39) of the total non-adherent LTC-DC 
population. 
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3.2.3 Apoptosis and cell death within small and large LTC-DC subsets. 
The number of apoptotic and necrotic cells in the small and large L TC-DC subsets was 
estimated using Annexin-V-FITC and PI staining of cells from well-established LTC (1-
3 years old) as described in Section 2.4.4. Co-staining with PI was used to differentiate 
apoptotic from necrotic cells. To visualise Annexin-V-FITC staining, cells were first 
incubated with CV to quench background autofluorescence (Ni and O'Neill, 2000). 
The small and large LTC-DC subsets were gated to distinguish the nu1nber of live, early 
apoptotic and necrotic cells in each subset. The large L TC-DC subset contained two 
clearly distinct populations. Live cells (Annexin-V-;Pr-) comprised 68.0 + 1.2% and 
necrotic cells (Annexin-V+/Pr+) comprised 26.8 + 0.5% of large LTC-DC (Fig 3.2A). 
Further analysis showed that these populations were spread evenly throughout the large 
gated area (data not shown). The percentage of cells present in viable, early apoptotic 
and necrotic populations are presented in Fig 3.2A. In contrast, small LTC-DC confined 
within the gate in Figure 3.2A comprised subsets of live cells (38.0 + 1.5%), necrotic 
cells (Annexin-V-;PI+ and Annexin-V+/Pr+: 37.8 + 1.4%) and a distinct population of 
early apoptotic cells (Annexin-v+;pr-: 24.2 + 0.5% ). 
The position of the gating area for small LTC-DC was adjusted to test whether the 
percentage of viable small LTC-DC could be increased for cell sorting and analysis. 
Early apoptotic and necrotic small LTC-DC seen in Figure 3.2A were found to occupy 
distinct regions on a Forward Scatter versus Side Scatter plot (data not shown). Using 
this information, the small LTC-DC gate was repositioned so that a majority of early 
apoptotic and necrotic cells could be excluded. Figure 3 .2B shows the new gate which 
gives 64.3 + 3.9% viable small LTC-DC. Exposure to CV (S00µg/ml) can reduce cell 
viability by approximately 10% (Ni, unpublished data (O'Neill lab)). After taking this 
into account, the gating shown in Figure 3.2B allowed analysis of small and large LTC-
DC subsets containing up to 75% and 78% viable cells, respectively. 
The percentages of viable and necrotic cells within small and large LTC-DC subsets did 
not vary significantly between 1 and 3 days post medium change (data not shown). 
However, if cells were ren1oved from LTC and placed into stroma-free culture for 24 
hours, a decrease in the percentage of viable cells was observed. There was an 11 % 
decrease in the number of viable s1nall LTC-DC and a corresponding 11 % increase in 
the nun1ber of early apoptotic cells (Fig 3.2A). When large LTC-DC were incubated in 
stroma-free culture for 24 hours there were 3% and 17% increases in the numbers of 
early apoptotic and necrotic cells, respectively (Fig 3 .2A). Clearly, the presence of 
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Figure 3.2. Delineation of viable, apoptotic and necrotic cells within small and large LTC-DC subsets. Non-adherent cells were collected 
frorn LTC 24 hours post n1edium change and stained with Annexin-V-FITC and PI to detect early apoptotic and necrotic cells, respectively. 
Two-colour FACS analysis of one representative experiment is presented for small and large populations gated on Forward Scatter and Side 
Scatter. Viable cells are distinguished as Annexin-v-;pr-, early apoptotic cells as Annexin-v+;pr- and necrotic cells as Annexin-V+/pI+ or 
Annexin-V-/Pr+. (A) Small LTC-DC were examined using gates that enclosed all small-sized cells and excluded debris. Data in the table 
represents n1ean + SE (n = 3). It also shows the percentage of viable, early apoptotic and necrotic cells within small and large gates for one 
experiment involving cells isolated following 24 hours in stron1a-free culture. (B) Small LTC-DC were examined using gates that omitted a 
majority of apoptotic and necrotic small cells. The table shows the percentage of viable, early apoptotic and necrotic cells contained within these 
gates (n = 3). 
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stroma supports the survival of large LTC-DC and reduces the proportion of small LTC-
DC which become apoptotic. 
3.2.4 Optimisation of conditions for sorting small and large LTC-DC. 
Small and large L TC-DC were sorted and collected for use in various experiments 
including MLR (Section 4.2.4 ), cell subset growth on stromal cell layers (Section 5 .2.1 ), 
colony assays (Section 5.2.2), trans well assays (Section 5.2.3) and preparation of RNA 
for subtracted cDNA library production (Section 6.3.1). Non-adherent LTC cells were 
sorted based on Forward Scatter and Side Scatter analysis using a FACStar Plus (Becton 
Dickinson). Gates used for cell sorting were optimised to include viable cells and to 
reject debris and dead or dying cells as described in Section 3.2.3. This was crucial for 
optimising the yield of viable small LTC-DC for RNA preparation. Gates shown in 
Figure 3.3 are representative of those used for cell sorting small and large LTC-DC in 
preparation for experiments. Medium used for cell preparation and collection was 
selected for capacity to maintain survival of LTC-derived cells during the sorting 
procedure. However, medium containing high levels of proteins or sugars can cause 
blockage of the FACStar. The highest viability of sorted cells was obtained when cells 
were resuspended into HBSS/5% FCS/1 % glutamine for cell sorting and were deposited 
in sDMEM/25 % FCS as the collection medium. Cell viability was found to drop to 50-
60% when cells were sorted in PBS and collected in sDMEM/10% FCS. Under the 
conditions chosen, trypan blue staining after cell sorting gave cell viabilities of 85-90% 
for both small and large LTC-DC subsets. Trypan blue staining also identified 
approxi1nately 80% of cells with low Forward Scatter and high Side Scatter as dead 
cells. These cells were rejected during sorting. 
3.2.5 The rate of cell division within small and large LTC-DC subsets. 
Cell cycle analysis, as described in Section 2.4.6, was performed on non-adherent cells 
produced in L TC to identify the proportion of replicating cells within the small and 
large LTC-DC subsets. At 48 hours post medium change, the DNA content of cells was 
assessed by permeabilising cells and incubating them with PI to determine the 
proportion of cells in various stages of cell cycle. PI intercalates into DNA, allowing the 
three phases of cell cycle - GoG1, S and G2M - to be measured in terms of fluorescent 
levels indicating DNA content. A majority of both small (86.8%) and large cells 
(73.7 %) had diploid content of DNA and existed in the quiescent GoG1 state (Fig 3.4). 
This represented a higher percentage of resting cells than was determined previously for 
ex vivo thymocytes (58.7 %) and BM cells (67.7 %) (Wilson et al., 2000). While most 
cells were resting, both subsets contained a population of replicating cells. However, the 
large cell subset contained double the nun1ber of cells in S and G2M phases in 
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Figure 3.3. Gates used to sort non-adherent LTC-DC into small and large subsets. 
Non-adherent cells were sorted in HBSS/5 % FCS/1 % glutamine and collected in 
sDMEM/25 % FCS. The gates shown were chosen for sorting the highest number of 
viable s111all and large LTC-DC. 
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Figure 3.4. Cell cycle analysis of s1nall and large LTC-DC. Non-adherent cells were collected at 48 hours post 1nediun1 change and fixed in 
thanol before staining with Pl. Fluorescence due to PI incorporation was 111easured by FACS analysis as an indication of DNA content. ModFit 
LT software was used to n1odel the distribution of cells within the GoG1 , S and G2M phases of cell cycle. (A) Fluorescence histograins of the 
DNA content of small and large LTC-DC are shown for one representative flask of LTC-DC. (B) Percentage of small and large LTC-DC in cycle 
determined fron1 fluorescence hi stogran1s is shown by 111ean + SE (n = 9). 
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comparison with the small cell subset. The large L TC-DC population had more 
replicating cells at 48 hours post medium change than the small LTC-DC subset. 
The rate of turnover of small and large L TC-DC was examined by following the 
kinetics of BrdU labelling under conditions of continuous exposure, as described in 
Section 2.4.5. The DNA precursor BrdU was added to culture medium on a daily basis. 
Incorporation of BrdU into cellular DNA was detected at various times up to 4 days 
using an FITC-conjugated anti-BrdU monoclonal antibody. Growth kinetics was 
monitored for 4 days following co1nplete medium change when cells were normally 
removed from LTC for experimentation. Neither small nor large LTC-DC showed any 
lag in BrdU labelling (Fig 3.5A). A lag would be expected if one non-replicating subset 
was the direct product of another replicating subset. This was consistent with cell cycle 
data which indicated that both small and large subsets in LTC-DC contained actively 
di vi ding cells. 
Incorporation of BrdU into both the small and large LTC-DC subsets occun·ed rapidly 
within the first 2 days of the assay (Fig 3.5A) indicating that most cell proliferation 
occu1Ted in the first 48 hours following medium change. However, even after 4 days not 
all cells had divided and incorporated BrdU. Only subsets of cells (52.3% of large LTC-
DC and 40.5% of small LTC-DC) had replicated over this time period. Since the 
percentage of BrdU+ small L TC-DC reached a plateau by 3 to 4 days, these cells 
appeared to have a turnover time of approximately 3 days. BrdU incorporation by large 
LTC-DC slowed after 2 days. However, a second slight increase in BrdU+ large LTC-
DC was observed at 4 days. This could represent the transition of small LTC-DC into 
large LTC-DC in culture, with the small LTC-DC increasing in size so as to be included 
in the larger gate. This would be consistent with a model whereby the small population 
contains precursors of the large cell population. 
Cell cycle analysis indicated that approximately 85% of small LTC-DC and 75% of 
large LTC-DC were not dividing. BrdU labelling showed that up to approximately 50% 
of small and large LTC-DC were capable of dividing. The cell cycle data represents a 
'snap shot' at approximately 48 hours post medium change and measures the number of 
cells in cycle at that particular instance. In contrast, the BrdU assay measures the 
cumulative number of cells that are dividing and that have divided during the assay, 
since exposure to BrdU is continuous. 
Following a pulse with BrdU for 1 hour, 7.6% of small LTC-DC were found to 
incorporate BrdU after 2 days (Fig 3.5B). This percentage did not increase after 2 days 
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Figure 3.5. Cell turnover and replication 1neasured by BrdU incorporation into DNA. Cells were cultured continuously in the presence of 
BrdU (12.5µg/n1l) (A), or pulsed with BrdU (30µg/ml) for 1 hour (B). After 1, 2, 3 and 4 days of culture an aliquot of cells was collected, 
penneabilised and stained with an FITC-conjugated anti-BrdU antibody. BrdU incorporation was analysed by FACS following post-acquisitional 
gating into sn1all and large LTC-DC subsets on the basis of Forward Scatter and Side Scatter. Percentages were determined fron1 fluorescence 
histogra111s of BrdU+ cells after the subtraction of background fluorescence. (A) Data shown reflects 1nean + SE of 2 separate experiments. Each 
experin1ent used cells pooled from 4 or 5 separate LTC flasks. (B) Data shown reflects values fro1n 1 experiment. This experiment used cells 
pooled fron1 6 separate L TC flasks. 
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post-pulse, instead it decreased so that only 5.5 % of small LTC-DC were BrdU+ by 4 
days. In contrast, the percentage of large BrdU+ cells increased until 3 days post-pulse 
when a maximum of 21.6% of cells were BrdU+. The mean fluorescence of these cells 
more then halved between 1 and 2 days post-pulse, suggesting that the rapid replication 
observed between 1 and 2 days was due to the same cells replicating more than once. 
The slight decrease in the proportion of BrdU+ small L TC-DC and the increase in BrdU+ 
large LTC-DC between 2 and 3 days post-pulse may represent small LTC-DC 
increasing in size to be analysed within the large gate. 
3.2.6 Expression of DC markers on viable small and large cell subsets. 
The expression of DC markers on small and large LTC-DC subsets was examined to 
confirm that the viable cells defined by the gates described in Section 3.2.4 were DC. A 
more detailed analysis of LTC-DC surface marker expression is presented in Chapter 4. 
Two-colour staining using monoclonal antibodies specific for the DC markers CDl lc, 
MHC Class II, CD86, CD205 and CD 11 b was performed using FACS analysis, as 
described in Sections 2.2.4 and 2.2.6. Marker expression was examined using CDl lc as 
the distinguishing DC marker, because it is strongly expressed by murine DC and 
particularly by splenic DC (Metlay et al., 1990). High CDl lc expression is commonly 
used as a criterion to isolate DC from spleen (Crowley et al., 1990; Pulendran et al., 
1997; Vremec et al., 2000). DC have also been identified on the basis of high surface 
expression of MHC Class II, although surf ace levels of this marker are dependent upon 
stage of DC maturation (Coates et al., 1996; Pierre et al., 1997). Mature DC are also 
characterised by high expression of the costimulatory molecule CD86 (Inaba et al., 
1994). CD205 is considered a DC marker since it is expressed on DC at much higher 
levels than on other leukocytes (Inaba et al., 1995; Jiang et al., 1995). The expression of 
different levels of CD205 and CD 11 b on DC is thought to reflect the presence of 
different subsets of DC in murine spleen (Crowley et al., 1989; Leenen et al., 1998; 
Pulendran et al., 1997; Vremec et al., 2000). 
Large L TC-DC were found to be homogeneous in their expression of DC markers (Fig 
3.6). Quadrants were placed to enclose negative cells based on FITC- or PE-labelled 
conjugate in the absence of prin1ary antibody. For some markers, such as CD86 and 
CD205, this resulted in grid lines being placed through the middle of the large stained 
population. This indicated a lower level of expression of the marker on the entire 
population, rather than the presence of positive and negative subpopulations. A majority 
of large LTC-DC expressed high levels of CDl le on their surface (65-80%; Fig. 3.6). In 
addition, a majority of these large CDl le+ cells uniformly expressed CDl lb (67.4%) 
and showed uniform but lower expression of CD86 (48.8 %) and CD205 (38.1 %). Most 
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Figure 3.6. Expression of DC markers on the surface of small and large LTC-DC. Cells were labelled with antibodies specific for DC 
markers using an indirect, 2-colour staining technique. Cells were separated into s1nall and large LTC-DC subsets using post-acquisitional gating. 
Quadrants distinguishing positively and negatively staining cells were placed on the basis of background staining of labelled conjugate only. 
Data are representative of many separate experiments. Primary antibodies used for FACS analysis included affinity purified 1nonoclonal 
antibodies specific for CDllb (Ml/70), CDllc (HL3), CD86 (GLl), CD205 (NLDC-145) and MHC Class II (AF6-120.1). Large LTC-DC 
staining strongly for MHC Class II are gated. 
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large LTC-DC were negative or only weakly positive for MHC Class II. A small 
subpopulation (2 .5 %) were MHCII+CDI le+. 
The small LTC-DC subset showed lower levels of DC marker expression (Fig. 3.6). 
Cells had low expression or were negative for CD 11 c and CD205. As with large L TC-
DC, quadrant lines did not delineate clear subpopulations. Approximately 60% of small 
LTC-DC expressed high levels of CDI lb and half of these were CDI lc+CDI lb+ 
(28.3 %.) A minority of small LTC-DC expressed low levels of CD205 (11.9%) and 
again, a majority of these were CD1 lc+CD205+ (7.9% ). There was no coordinate 
expression of CDI lc and MHC Class II. However, cells expressing low levels of 
CDI lc or MHC Class II were distinguishable in the small LTC-DC subset. CD86 was 
not expressed by a majority of small LTC-DC. Unlike large LTC-DC, small LTC-DC 
were either negative or showed weak expression of DC markers. 
3.3 DISCUSSION 
LTC have been successfully generated from whole murine spleen and maintained for a 
period of 4 years. The method used is highly reproducible, since multiple LTC with 
similar characteristics have been generated independently using the same approach. A 
stromal layer comprising endothelial cells, fibroblasts and some macrophages forms 
within 4 weeks. Foci of large dendritic-like cells develop on the stromal surface and are 
then released into the medium where they are collected for experimentation. Further 
purification of cells is not required. The non-adherent population of L TC contains two 
major cell subsets that differ in their Forward Scatter and Side Scatter profile. The size 
of each subset has remained constant over time and between individual LTC. The 
constant presence of these two subsets within LTC suggests that they are integral to the 
structure and continuation of the LTC system. The observation that stable, productive 
cultures are associated with maintenance of small numbers of small-sized cells above 
the stromal cell layer indicates that small LTC-DC in particular are important for the 
continuous generation of DC. 
Large LTC-DC are large-sized cells that possess dendrites. They exhibit high Side 
Scatter, reflective of an extensive surface membrane and the presence of cytoplasmic 
organelles. Small LTC-DC have undifferentiated morphology, being small, rounded 
cells that lack dendrites. S1nall and large LTC-DC subsets both contain necrotic cells. 
However, only the small cell subset contains a distinct population of early apoptotic 
cells. This raises the question of what triggers apoptosis in small but not large LTC-DC. 
It may be that the non-adherent small LTC-DC are not receiving the necessary signals 
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for survival, implying that they have different requirements for survival in comparison 
with large LTC-DC. 
Both small and large LTC-DC subsets contain subpopulations of replicating cells. Cell 
cycle analysis shows that at 48 hours post medium change n1ost small and large cells are 
resting. However, 13.2% of small LTC-DC and 24.3% of large LTC-DC are in cell 
cycle. BrdU incorporation studies indicate that L TC cells have a turnover time of 
approximately 3 days and that over 4 days post medium change, 40.5% of small LTC-
DC and 52.3% of large LTC-DC are able to divide. BrdU pulse data indicates that the 
52.3% population of BrdU+ large LTC-DC must include cells that have replicated more 
than once. The percentage of BrdU+ small LTC-DC did not increase significantly when 
cultured following a pulse with BrdU. If small LTC-DC are precursors of large LTC-
DC, this suggests that many s1nall LTC-DC may differentiate directly into large L TC-
DC or divide only once and then differentiate into large LTC-DC. Some large LTC-DC 
are then able ·to divide multiple times. The possibility cannot be excluded that small and 
large LTC-DC represent two unrelated partially transformed cell types. Mature or end-
stage DC do not divide (Bowers and Berkowitz, 1986), so the capacity of both small 
and large LTC-DC to proliferate suggests that they are either immature cells or that they 
are partially transformed. However, since LTC-DC do not grow in vitro independently 
of stroma, there is no evidence to date which supports transformation. 
The LTC system sustains replication and production of DC for at least 3 days following 
1nedium change, allowing convenient collection of high numbers of cells for analysis. 
Annexin-V and BrdU incorporation experiments have been used to optimise cell 
collection and gates for F ACS-sorting of cells into viable small and large L TC-DC 
subsets. Cells can be collected from LTC flasks at 48 hours post medium change to 
obtain (1) a high yield, since most proliferation occurs during the first 2 days after 
medium change, (2) viable cells, because cells show a similar Annexin-V /PI profile 
over the first 3 days after medium change, and (3) maximum small LTC-DC yield. The 
collection of the purest population of viable cells following FA CS-sorting has been 
achieved by optinusing medium and FACS gating. This is particularly important for the 
sn1all LTC-DC subset which contains distinct populations of early apoptotic and 
necrotic cells resulting in low viable cell yield. Forward Scatter and Side Scatter gates 
have been defined for sorting small LTC-DC to exclude early apoptotic and most 
necrotic small cells. These gates have also been used for FACS analysis of surface 
marker expression, endocytic capacity and BrdU incorporation. 
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The coexpression of CD 11 c with other DC surface markers has been examined on 
subsets of L TC-DC. Large LTC-DC showed uniform expression of CD 11 c and co-
expression of CDI lb, CD86 with lower levels of CD205. A majority of CDl lc+ cells 
were also weakly MHC Class Ir+. Non-adherent LTC cells have previously been shown 
to contain many cells representing DC (Ni and O'Neill, 1997; Ni and O'Neill, 1998; 
O'Neill et al., 1999b). The homogeneous expression of DC markers, in combination 
with dendritic morphology now indicates that large LTC-DC clearly resemble DC. 
Small LTC-DC display lower and more heterogeneous expression of DC markers. 
S1nall L TC-DC do not resemble typical DC, although, they may represent an earlier 
stage in DC development. It is hypothesised that small LTC-DC represent precursors of 
large LTC-DC. 
so 
CHAPTER4 
Large LTC-DC represent immature CDllc+CDllb+MHCII1°CD8cx- DC. 
4.1 INTRODUCTION 
The wide range of functional roles attributed to DC relates to their ability to modify 
their phenotype and functional capacity in response to stimuli. It also reflects the 
existence of different DC subsets or classes. A number of properties distinguish DC as 
either immature or mature/activated and as either CD8cx- or CD8cx+ DC. 
Murine DC can be divided into a number of subsets on the basis of cell surface marker 
expression (Henri et al., 2001; Pulendran et al., 1997; Vremec et al., 2000). These do 
not delineate DC of a particular origin or lineage, but they do distinguish DC of distinct 
functional state (Hochrein et al., 2001; Maldonado-Lopez et al., 1999b; Pooley et al., 
2001). Recently, mouse spleen DC were divided into three separate subsets primarily on 
the basis of CD4 and CD8cx expression (Vremec et al., 2000). DC expressing high 
levels of CD8cx, CD205 and heat stable antigen (HSA) but lacking CD4, CD 11 b, 33D 1 
and F4/80 resemble lymphoid-like thymic DC (Ardavin, 1997). It has been reported that 
they are responsible for the stimulation of CDS+ T cells (Pooley et al., 2001) and Thl 
type immune responses (Hochrein et al., 2001; Maldonado-Lopez et al., 1999a). In 
contrast, DC displaying a myeloid-like phenotype, CD8cx-cD205-
CDl lb+33Dl +p4;go+cD4-1+, are potent stimulators of CD4+ T cells (Pooley et al., 2001) 
and they may direct Th2 type immune responses (Maldonado-Lopez et al., 1999a). 
Before becoming functional antigen presenting cells, DC progress through distinct 
maturational stages. Immature DC monitor the environment through the uptake of 
particulate and soluble products. They are highly endocytic and possess receptors such 
as CD 16/32 (FcyR) (Sallusto and Lanzavecchia, 1994) and CD205 (Jiang et al., 1995; 
Mahnke et al., 2000) that mediate endocytosis. Immature DC express low levels of 
surface MHC Class II, but abundant intracellular MHC Class II is present within 
specialised endocytic compartments as part of an efficient antigen processing system 
(Pierre et al., 1997; Turley et al., 2000). Maturing DC lose their capacity for antigen 
capture and processing and acquire capacity to activate T cells as they migrate to 
secondary lymphoid organs. They possess long cytoplasmic processes for cell 
interaction (Nijman et al., 1995), upregulated surface expression of MHC Class II for 
peptide presentation (Nijn1an et al., 1995; Pierre et al. , 1997) and increased expression 
of co-stimulatory molecules including CD40, CD80 and CD86 (Banchereau and 
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Steinman, 1998; Inaba et al., 1994; Sallusto et al., 1995). DC activation can be induced 
by a number of different types of stimuli. Inflammatory stimuli including necrotic cells, 
cytokines like TNF-a and IFN-a, microbial products like LPS and T cell mediators like 
CD40L all trigger DC activation (Cella et al., 1996; Gallucci et al., 1999; Verhasselt et 
al., 1997). However, even physical disruption of cells has been shown to induce DC 
activation (Gallucci et al., 1999). 
Large and small L TC-DC differ in terms of morphology and DC marker expression 
(Section 3.2.2 and 3.2.6). LTC cells have now been analysed using surface marker 
expression and functional capacity to determine whether they show characteristics 
reflecting DC of a particular lineage, subset or stage of maturation. 
4.2 RESULTS 
4.2.1 S1nall and large LTC-DC display a myeloid-like cell surface phenotype. 
Staining of cells with specific antibodies has been used extensively to define DC 
subsets. This has been important for detecting DC of different lineage and/or functional 
capacity. Two-colour staining using specific monoclonal antibodies ( described in 
Section 2.2.4) was undertaken to determine whether cells expressing markers 
representative of particular DC subsets could be identified amongst the non-adherent 
L TC-DC population and between small and large LTC-DC. 
CDllb, a marker of CD8a- myeloid-like DC already shown to be strongly expressed by 
both small and large LTC-DC (Section 3.2.6), was used to examine coexpression of 
other known DC subset markers. This is shown in Figure 4.1 where the level of 
background staining with fluorescein labelled-conjugate is indicated by the placement 
of quadrants. A majority of cells in the large LTC-DC subset had a myeloid-like 
phenotype, coexpressing the markers 33Dl (70.1 %), F4/80 (67.3%) and CDllb (Fig. 
4.1). Again, the large LTC-DC subset was found to be homogeneous in terms of these 
markers. Lower levels of CD205 were expressed on large LTC-DC and only 4.9% of 
cells expressed low levels of CD8a. Low expression of CD8a and CD205 is also 
consistent with a myeloid-like phenotype. A majority of small LTC-DC were clearly 
CDl lb+. A proportion of CDl lb+ cells expressed CD205 (14.2%), 33Dl (36.5%), 
F4/80 (13.6%) and CD8a (5.3%) (Fig 4.1). While not as clear, the surface marker 
expression of small LTC-DC also n1ore closely rese1nbles that of myeloid-like DC. 
Neither small nor large LTC-DC expressed CD4 or HSA (data not shown), providing 
further evidence that they do not represent CD4+CD8a- or CD4-CD8a+ DC, 
respectively. Both small and large LTC-DC most closely resemble CD4-CD8a-
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myeloid-like DC. Marker expression related to particular DC subsets cannot be used to 
divide LTC-DC into separate subsets. 
4.2.2 Small and large LTC-DC differ in their expression of maturation markers. 
Particular cell surface markers have been linked to DC maturation/activation. The 
maturation/activation status of the small and large LTC-DC subsets was assessed using 
specific antibodies and FACS analysis, as described in Sections 2.2.3 and 2.2.6. To 
detect mature or immunostimulatory DC, cells were stained with antibodies specific for 
MHC Class II, CD86, CD80 and CD40 (Banchereau and Steinman, 1998; Inaba et al., 
1994; Pierre et al., 1997; Sallusto and Lanzavecchia, 1994). To detect immature DC, 
cells were stained with antibodies specific for CD 16/CD32 and CD 117. CD 117 is a 
marker of early haemopoietic cells (Doi et al., 1997), including precursors in the 
thymus, BM (Wu et al., 1995; Zhang, Y. et al., 1998) and liver (Zhang et al., 2000) that 
can develop into DC. CD 117 expression has also been noted previously on splenic DC 
(Vremec and Shortman, 1997). MHC Class I and CD44 expression were also included 
in this analysis. MHC Class I is expressed ubiquitously on most cell types. However, it 
has been shown to be highly expressed by DC (Vremec et al., 1992) and to be 
upregulated upon activation (Kukutsch et al., 2000; von Stebut et al., 1998). CD44, a 
receptor important in cell homing, is expressed at high levels on both immature and 
mature leukocytes, but in lower levels on intermediate stage cells (Lewinsohn et al., 
1990). In addition, upregulaton of certain CD44 isoforms on DC has been associated 
with 1nigration and adhesion following DC activation (Weiss et al., 1997). These two 
markers may give information on the maturation stage of small and large LTC-DC. 
Both small and large LTC-DC were found to express CDl 17, CD16/CD32, MHC Class 
I and CD44 (Fig 4.2). The expression of markers associated with DC activation varied 
between small and large LTC-DC. Both subsets expressed high levels of CD80 and 
lacked CD40. However, while most small LTC-DC were negative for MHC Class II and 
CD86, large LTC-DC uniformly expressed moderate levels of CD86 and low levels of 
MHC Class II (Fig 4.2). A small percentage (2.5%) of large LTC-DC expressed very 
high levels of MHC Class II (Fig 3.7 and 4.2). The maturational state of large LTC-DC 
is not clear since they appear to express markers of both immature and activated DC. 
However, their expression of moderate and low levels of CD86 and MHC Class II, 
respectively, suggests that they are more mature than small LTC-DC. Small LTC-DC 
appear to resemble immature cells, a hypothesis further supported by their low surface 
expression of CDl lc. CDl lc- DC in human blood have previously been described as 
functionally immature (O'Doherty et al., 1994). The high levels of CD80 on small LTC-
DC may be a useful marker to identify these cells in vivo . 
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Figure 4.2. Expression of maturation n1arkers on the surface of s1nall and large LTC-DC. Cells were incubated with specific antibody 
followed by FITC- or PE-conjugated second-s tage reagent ( or FITC-conjugated antibody specific for MHC Class II). Control cells were 
incubated with second-s tage conjugate alone (grey area). Cells were separated into sn1all and large LTC-DC subsets using post-acqui sitional 
ga tin g. The plots shown are representative of n1any separate experiments. Prin1ary antibodies used for FACS analysis included affinity purified 
nal antibodies specific for CD16/32 (2.4G2), CD40 (3/23), CD80 (lGl0), CD86 (GLl), CD117 (2B8) and MHC Class II (AF6-120.l). 
ulture supernatant of hybridon1a cells was used as a source of antibody specific for CD44 (IM-7.8.1) and MHC Class I (TIB126). 
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4.2.3 Small and large L TC-DC subsets maintain consistent cell surface marker 
. 
expression . 
Table 4.1 displays a summary of the surface marker analysis carried out on small and 
large LTC-DC. This represents results generated by multiple single-colour monoclonal 
antibody stainings can·ied out on cells collected fro1n different L TC over a period of 3 
years. Control populations of spleen, thymus and/or BM were used to validate the 
activity of the antibody preparations (data not shown). The median fluorescence ratio, 
reflecting the shift in fluorescence after staining, gives an indication of the quantity of 
marker present on the surface of cells relative to background. For example, large LTC-
DC show very high expression of CDI lb (median fluorescence ratio of 66.3), high 
expression of 33D 1 (median fluorescence ratio of 15.1), moderate expression of CD86 
(median fluorescence ratio of 5.3) and low or no expression of CD40 (median 
fluorescence ratio of 1.5). Table 4.1 shows that surface marker expression on both small 
and large L TC-DC was stable over the 3 years of experimentation. This is important as 
it demonstrates that the non-adherent cells produced within LTC maintain a consistent 
phenotype. Small L TC-DC showed lower expression of markers in comparison to large 
LTC-DC, but are characterised by expression of CD 11 b, CD80, CD44, CD 16/CD32 and 
MHC Class I. In contrast, large L TC-DC expressed most of the markers examined with 
the exception of CD8a and CD40. In particular, large LTC-DC showed high CDl lc, 
CD 11 b, CD80, F4/80, 33D 1, CD44, CD 16/CD32 and MHC Class I expression. 
4.2.4 Small and large L TC-DC differ in their endocytic and iinmunostimulatory 
capacity. 
Immature DC demonstrate a superior capacity to capture antigen by phagocytosis, 
endocytosis and n1acropinocytosis (Nijman et al., 1995; Sall us to et al., 1995; Winzler et 
al., 1997). Upon exposure to inflammatory stimuli, DC undergo a process of maturation 
characterised by downregulation of capacity to engulf antigen and upregulation of 
antigen presentation and T cell stimulatory capacity (Sallusto et al., 1995; Winzler et 
al., 1997). The endocytic capacity and antigen presenting capacity of small and large 
LTC-DC was compared to investigate the developmental stage of cells in each subset. 
Antigen uptake was measured by pulsing cells with OV-FITC for various lengths of 
time up to 24 hours followed by FACS analysis as described in Sections 2.3.1 and 2.2.6. 
The large L TC-DC subset represented a homogeneous population of cells with high 
endocytic capacity. Approximately 85% of cells had engulfed OV-FITC by 6 hours 
(Fig . 4.3A). In addition, the fluorescence intensity of FITC+ large cells was greater than 
that of the few ( ~ 16%) FITC+ cells of the small subset, indicating that large LTC-DC 
were able to endocytose more of the labelled protein than small L TC-DC. The number 
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Table 4.1 Marker expression on small and large subsets of cells produced in L TC. 
Small LTC-DC 1 Large LTC-DC 
Surface marker Experiments % positive cells2 Median fluorescence % positive cells Median fluorescence 
ratio 3 ratio 
CDllc 9 26.8 + 4.24 5.1 + 0.7 66.5 + 3.9 11.0 + 1.5 
CDllb 8 51.7 + 0.6 17.7+2.2 91.9 + 1.4 66.3 + 9.7 
MHC Class II 7 11.0 + 2.2 3.4+0.1 20.7 + 1.6 4.1 + 0.3 
CD80 5 58.7 + 4.5 20.1 +4.9 81.3 + 5.9 15.2 + 3.9 
CD86 4 10.6 + 1.4 2.4 + 0.2 46.6 + 0.6 5.3 + 0.2 
CD205 4 16.9 + 2.9 3.5 + 0.2 37.1+4.4 7.5 + 2.3 
CD40 4 5.8 + 2.0 1.5 + 0.1 6.7 + 1.9 1.5+0.1 
CDJ 17 (c-kjt) 4 33.4 + 4.5 3.5 + 0.6 54.7 + 4.8 5.5 + 0.6 
CD8a 4 2.8 + 1.6 1.0 + 0.0 2.7 + 1.6 1.9 + 0.9 
F4/80 4 15.6 + 3.4 5.8 + 0.4 69.0 + 2.8 10.7 + 0.3 
CD44 3 72.2 + 5.5 4.7 + 0.7 94.9 + 0.5 12.8 + 7.8 
CD16/32 (FcyR) 2 54.8+ 9.6 8.6 + 3.9 71.2 + 18.6 14.9 + 7.9 
33Dl 2 44.9 + 5.3 11.8+1.1 74.0 + 0.7 15.1 + 0.3 
MI-IC C1ass I 2 51.7+8.5 5.1 + 1.5 88.1 + 0.4 13.1 + 0.2 
1 Srnal I and large LTC-DC were de] ineated using post-acqui si tional gating. 
2 The percentage of pos itive staining cell s was calcu lated by subtracti ng background from specific antibody staining. Background was obtained by replacement of primary 
antibody with rnediurn . 
:i Shift in rnedi an nuorescence intensity of positive ce ll s relative to background (s ignal-to-noise ratio). Thi s was calcul ated to allow for variation in voltage arnplification used 
over the course of rnany ex perirnents. 
4 Data represent rnean ± SE across rnultiple ex perirnents. 
Figure 4.3. Large LTC-DC are highly endocytic. Endocytic capacity was measured by 
exposing cells to OV-FITC. (A) Fluorescence histograms represent FITC+ small and large 
LTC-DC after 6 hours incubation with OV-FITC. At 6 hours, 15.8 + 3.7% (mean+ SE) 
(n = 3) of small cells were FITC+, whereas 84.8 + 5.0% (n = 3) of large cells were FITC+. 
Percentages were calculated by subtracting background values for control cells incubated 
with OV-FITC on ice (dotted line) from cells incubated with OV-FITC at 37°C (solid 
line). (B) Data points represent the percentage of FITC+ cells after incubation at 37°C in 
the presence of OV-FITC. Data fro1n three replicate experin1ents are shown. Percentages 
were calculated by subtracting background values for control cells incubated with OV-
FITC on ice fron1 cells incubated with OV-FITC at 37°C. Open symbols represent small 
LTC-DC; closed sy1nbols represent large LTC-DC. 
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of OV-FITC+ large cells increased rapidly in the first 3 hours and reached a peak at 12 
hours with an average of 91.6 + 3.4% OV-FITC+ cells over 3 experiments (Fig. 4.3B). 
Large cells retained OV-FITC in their cytoplasm for at least 24 hours. The percentage 
of FITC+ small LTC-DC peaked at 3 hours with an average of 18.6 + 4.4% over 3 
experiments. Uptake of OV-FITC by the small cell population appeared to relate to the 
presence of a minor subset of endocytic cells rather than a lower endocytic capacity 
across the whole population (Fig 4.3A). 
The antigen presenting capacity of small and large LTC-DC was compared in both 
syngeneic and allogeneic MLR as described in Section 2.3.3. MLR were established 
with irradiated small or large LTC-DC as stimulators and splenocytes as responders. 
Proliferation of responder cells was detected by incorporation of 3HT over the final 6 
hours of a 72 hour incubation. Bl0.A(2R) splenocytes were compared with LTC-DC as 
syngeneic control stimulators. Both small and large LTC-DC were effective as antigen 
presenting cells in allogeneic and syngeneic MLR while control B 1 0.A(2R) splenocytes 
induced negligible proliferation under the conditions of these experiments (Fig. 4.4 ). 
The proliferation of both allogeneic and syngeneic responders was dose-dependent, with 
as few as 30 large LTC-DC and 100 small LTC-DC per well sufficient to induce a 
proliferative response significantly greater than background (p<0.05). There was also a 
significant difference in the stimulatory capacity of small and large L TC-DC across the 
range of 30 to 1000 stimulators per well (p<0.05). Three to 10-fold more small LTC-DC 
than large LTC-DC were required to induce the same proliferative response in spleen 
responder cells (Fig. 4.4). This suggests that the large LTC-DC population has 3-10 fold 
greater antigen presenting capacity than the small L TC-DC population. This could 
relate to either the number of cells with antigen presenting capacity or the stimulation 
capacity of individual cells. 
4.2.5 Both small and large LTC-DC become activated in response to LPS. 
The effect of LPS on the function of small and large L TC-DC was tested to determine 
whether LTC-DC were responsive to activation as demonstrated for other immature DC 
or DC precursors (De Smedt et al., 1996; Gallucci et al., 1999; Granucci et al., 1999; 
Verhasselt et al., 1997). Non-adherent LTC-DC were incubated with l0µg/ml LPS for 
24 hours and then analysed for cell surface marker expression, endocytic and antigen 
presenting capacity and apoptotic cell numbers. A 24 hour incubation period was 
selected since it has been reported that the immature D 1 DC line takes at least 18 hours 
to display mature DC characteristics following LPS exposure (Granucci et al., 1999). 
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Figure 4.4. Large LTC-DC have greater antigen presentation capacity in an MLR than small LTC-DC. FACS-sorted small and large LTC-
DC were i1Tadiated and used as stimulators across the concentration range of 3 to 1000 cells/well. In-adiated syngeneic B 1 0.A(2R) splenocytes 
were used as control stimulators across a range of 30 to lxl05 cells/well. Stimulator cells were incubated with lxl04 (A) syngeneic, or (B) 
allogeneic responder cells per well for 72 hours. Proliferation of responder cells was detected by 3HT incorporation over the period from 66 to 72 
hours of culture. The plots shown are representative of three separate experiments. 
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Cell surface marker expression on non-adherent LTC-DC was compared following 
isolation directly from LTC (untreated), after stroma-free culture for 24 hours, or after 
stro1na-free culture for 24 hours in the presence of LPS (l0µg/ml). Cells were stained 
with antibodies specific for a variety of markers including the maturation markers MHC 
Class I/II, CD86, CD80, CD40, CD44 and CD16/CD32 and the DC markers CDl lc, 
CD205 and CD 11 b. The expression of these markers on small and large LTC-DC was 
analysed using post-acquisitional gating. Clear upregulation of CD86, MHC Class I and 
CD44 expression on large LTC-DC was obtained after overnight culture with LPS. 
Large LTC-DC cultured overnight without LPS showed only a small increase in MHC 
Class I and CD44 expression in comparison with untreated cells (Fig 4.5). Small LTC-
DC exhibited an increase in CD86 and MHC Class I but not CD44 expression upon 
culture with LPS. In contrast, for both small and large LTC-DC, only a slight shift in 
fluorescence was noted for CD80, MHC Class II and CD40 following culture and LPS 
treatment (Fig 4.5). There was no change in expression of CD16/CD32, CDl lc, CD205 
and CDl lb (data not shown). This suggests that both small and large LTC-DC are 
activated in response to LPS. However, small and large LTC-DC respond in different 
ways since only large LTC-DC upregulated CD44 expression upon exposure to LPS. 
Exposure to LPS can induce DC apoptosis and death (De Smedt et al., 1998). The effect 
of LPS on the viability of small and large L TC-DC was therefore tested using Annexin-
V-FITC and PI staining of cells. Non-adherent LTC-DC were cultured for 1, 2 and 3 
days without stroma, in the presence and absence of LPS (l0µg/ml). Cells isolated 
directly from LTC (day 0) as untreated LTC-DC were used as controls. All cells were 
stained with Annexin-V and PI to detect apoptotic and necrotic cells, respectively. After 
overnight stroma-free culture, regardless of the presence of LPS, there was a decrease in 
the viability of both small (20%) and large (30%) LTC-DC (Fig 4.6A). This is 
consistent with the fact that LTC-DC are dependent on the presence of stroma and/or 
stroma-deri ved factors for optimal survival and proliferation (Wilson et al., 2000). The 
increased proportion of viable cells at days 2 and 3 of culture noted in Figure 4.6A 
could be the result of phagocytosis of necrotic cells by functional DC. The percentage 
of viable cells in cultures with and without LPS was similar. LPS addition did not 
reduce the viability of small or large L TC-DC over 3 days of culture in the absence of 
stroma (Fig 4.6A). In addition, the ratio of early apoptotic to necrotic cells did not vary 
between treated and untreated cultures , indicating that LPS did not induce higher levels 
of apoptosis in LTC-DC (data not shown). 
Antigen uptake was also compared in non-adherent LTC-DC isolated from stroma-free 
culture for 24 hours in the presence and absence of LPS (l0µg/ml ). Cells isolated 
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Figure 4.5. LPS up regulates the expression of cell surface markers on L TC-DC. 
Non-adherent LTC-DC were collected directly from LTC (untreated) and from 24 hour 
strorna-free cultures of LTC-DC in the presence and absence of LPS (lOµghnl) . Cells 
were incubated with specific antibody followed by FITC- or PE-conjugated second-stage 
reagents, except in the case of antibody specific for MHC Class II which is directly 
conjugated with FITC. The solid line represents the staining of cultured LPS-treated cells 
and the dotted line represents cells cultured without LPS. The broken line represents 
untreated cells and is shown only when different to that of control cells isolated from 
stroma-free culture in the absence of LPS (MHC Class I and CD44). Background 
staining of cells incubated with second-stage conjugate alone is shown as the grey area. 
Background staining for all treatments was identical and so is represented by a single 
peak. Cells were separated into small and large LTC-DC subsets using post-acquisitional 
gating. Plots shown are representative of two separate experiments. 
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Figure 4.6. Activation of LTC-DC with LPS. (A) Viability of cells treated with LPS . 
Cells were collected directly from LTC (day 0), or from stroma-free culture in the presence 
and absence of LPS ( 1 0µg/ml) at 1, 2 and 3 days post 1nedium change. Cells were stained 
with both Annexin-V-FITC and PI to distinguish early apoptotic and non-viable cells, 
respectively. Two-colour FACS analysis was carried out on small and large gated 
populations. Data represent the percentage of viable cells (Annexin-v-Pr-) in small and 
large LTC-DC subsets. (B) Endocytic capacity of cells exposed to LPS. LTC-DC were 
isolated from 24 hour stro1na-free cultures in the presence or absence of LPS (l0µg/ml). 
Freshly collected LTC-DC were used as untreated controls. Endocytic capacity was 
n1easured by uptake of OV-FITC. Data points represent the percentage of FITC+ cells 
after 3, 6 and 24 hours incubation at 37°C in the presence of OV-FITC. Percentages were 
calculated after subtracting background for control cells incubated with OV-FITC on ice 
(data not shown). (C) Antigen presenting capacity of cells treated with LPS. LTC-DC 
were isolated from 24 hour stroma-free culture in the presence and absence of LPS 
( l0µghnl ) then used as stimulators (3x l0 1-3xl03 cells/well) in an allogeneic MLR. 
Responder cells ( 1x104) were added and proliferation detected by 3HT incorporation over 
the final 6 hours of a 72 hour incubation. 
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directly from LTC as 'untreated' LTC-DC were compared as controls. All cells were 
exposed to OV-FITC for 3, 6 and 24 hours , followed by FACS analysis. Over all 
treatments, large L TC-DC displayed higher endocytic capacity than small LTC-DC (Fig 
4.6B). At 3 and 6 hours a lower percentage of LPS-treated large LTC-DC were FITC+. 
However, more than 75% of all cells were still capable of endocytosis at all time points. 
There was a small increase in the number of endocytic small L TC-DC following LPS 
treatment in comparison to untreated and 24 hour cultured cells at 3 hours (10% and 
5%, respectively). The percentage of endocytic cells amongst the small subset decreased 
over 3 to 24 hours. This experiment showed that LPS treatment did not have a 
significant effect on the endocytic capacity of either small or large L TC-DC. Large 
LTC-DC remained highly endocytic. 
Changes in antigen presenting capacity of L TC-DC after LPS treatment was assessed in 
an allogeneic MLR using C57BL/6J splenocytes as responders. It was not possible to 
compare stimulatory capacity of small and large L TC-DC in this assay due to 
difficulties in isolating enough small L TC-DC for experimentation. Stimulators were 
total non-adherent L TC-DC cultured in the absence of stroma for 24 hours, with or 
without LPS (l0µg/ml). An enhanced proliferative response amongst spleen responders 
was observed with LTC-DC stimulators that had been cultured with LPS for 24 hours. 
A significant increase in proliferation was evident when 103 and 3xl03 stimulators were 
added to the reaction (p<0.05; Fig 4.6C). LTC cells respond to LPS by increasing their 
stimulatory capacity for lymphocytes. Increased stimulatory capacity is consistent with 
upregulation of MHC Class I and CD86 expression on both small and large LTC-DC. 
4.3 DISCUSSION 
LTC cells have been analysed to determine whether small and large LTC-DC represent 
known subsets of DC. A combination of marker expression, endocytic capacity, 
stimulatory capacity and responsiveness to LPS have been used to characterise the two 
subsets. Both small and large LTC-DC resemble CD8cx- myeloid-like DC. Most express 
CD 11 b, F4/80 and 33D 1 and lack CD4 and CD8cx. They also lack CD8cx expression at 
the mRNA level (O'Neill, manuscript in preparation). Surface CD8cx expression is 
absent in most cultured DC populations including DC derived from 'lymphoid' 
progenitors like the 'CD4 low' thymic precursors (Saunders et al. , 1996) and the CLP 
of BM (Manz et al., 2001). While it is possible that an in vivo counterpart of LTC-DC 
could express CD8cx, the strong expression of the myeloid markers CD 11 b, F4/80 and 
33Dl on LTC-DC foreshadows CD8cx- myeloid-like DC. 
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In comparison with LTC-DC, ex vivo CD8cx- myeloid-like DC lack expression of 
CD205 (Vremec et al., 2000). The low levels of CD205 observed on LTC-DC may not 
reflect lymphoid-like DC and could be a result of in vitro culture since CD205 has been 
shown to be upregulated on ex vivo splenic DC following a period of in vitro culture 
(Leenen et al., 1998; Vremec and Shortman, 1997). Alternatively, LTC-DC could 
represent a distinct subset or class of splenic DC that expresses CD205 but not CD8cx. It 
is known that murine LN contains a subset of CD205+ DC that stains negatively to low 
for CD8cx (Henri et al., 2001). While LTC-DC appear to be myeloid-like they also 
differ from other myeloid-like CD8cx- DC since they are produced independently of 
GM-CSF. This factor is not detectable in conditioned medium from LTC (Ni and 
O'Neill, 1997) and the cells generated do not depend on GM-CSF for colony growth in 
agar (Wilson et al., 2000). LTC producing DC can also be successfully generated from 
GM-esp-I- mice (Ni and O'Neill, 2001). 
Small and large LTC-DC are readily distinguishable by their cell surface phenotype and 
function. Small L TC-DC appear to represent an earlier stage in DC development in 
comparison to large L TC-DC. They are a heterogeneous population, but display 
undifferentiated morphology, weaker cell surface marker expression and weaker 
functional capacity. A majority of small LTC-DC express CDl lb, CD80, CD16/32, 
CD44 and MHC Class I but lack CDl lc, CD40, CD86 and MHC Class II. Only a 
subpopulation of small L TC-DC are endocytic and 3 to 10 fold more small than large 
L TC-DC are required to achieve the same response in an MLR. Small L TC-DC can 
respond to LPS by upregulating surface expression of CD86 and MHC Class I and may 
also increase stimulatory capacity following exposure to LPS for 24 hours. 
Large LTC-DC represent fully differentiated DC since they show dendritic morphology, 
express DC markers and have high stimulatory capacity. Large LTC-DC can clearly be 
described as CDl lc+CDl lb+MHCII1°CD8cx- DC. By comparison with small LTC-DC, 
they show stronger expression of the DC markers CD 11 c and CD205 and express 
higher levels of CD86 and MHC Class II. The small population of large LTC-DC that 
expresses very high levels of MHC Class II, could represent a small number of 
terminally mature DC within LTC. Large LTC-DC do not represent activated DC since 
they retain many properties of immature DC including highly endocytic capacity, short 
dendritic projections, low levels of MHC Class II and absence of CD40 surface 
expression. 
The responsiveness of large LTC-DC to LPS further supports the hypothesis that large 
LTC-DC are not activated, end-stage cells. Large LTC-DC respond to LPS by 
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upregulating surface levels of CD86, MHC Class I and CD44. This makes LPS-
acti vated large LTC-DC better able to present antigen in the context of MHC Class I 
and to provide co-stimulatory signals through CD86. This is reflected by increased 
stimulatory capacity. Large LTC-DC respond differently to LPS in comparison to small 
LTC-DC by showing enhanced surface CD44 expression. Particular CD44 isoforms are 
known to be upregulated following activation of human DC and their expression is 
associated with adoption of migration and adhesion capacity (Haegel-Kronenberger et 
al., 1998; Weiss et al., 1997). At this stage, CD44 expression on LTC-DC has only been 
studied with an antibody recognising all isoforms. Further investigation will require the 
use of antibodies specific for different CD44 isoforms. A small number of LTC-DC 
have been shown previously to migrate to the spleen in vivo (O'Neill et al., 1999a). 
However, the migratory capacity of small and large LTC-DC has not been compared, 
nor has the migratory capacity of LPS-treated LTC-DC been measured. 
The combination of properties displayed by large L TC-DC does not allow them to be 
categorised strictly as immature or mature DC. These labels have been defined for cells 
cultured in vitro with cytokines and may not reflect the stages in DC development 
identified in L TC. It has also been shown that maturing DC can maintain some 
endocytic capacity (Coates et al., 1996; Nijman et al., 1995) and that immature DC 
exposed to antigen can present that antigen more effectively than mature DC (Nijman et 
al., 1995). The partially activated phenotype of LTC-DC may be a result of long-term in 
vitro culture. Consistent with this is evidence that physical disruption and exposure to 
necrotic cells can activate DC (Gallucci et al., 1999; Sauter et al., 2000) and in vitro 
culture can alter the expression of some cell surface markers (Leenen et al., 1998; 
Schuler and Steinman, 1985; Vremec and Shortman, 1997). Large LTC-DC are 
considered to be immature DC since they retain many immature DC characteristics. 
This is consistent with definition of cytokine-dependent cell lines that display immature 
DC function and n1oderate expression of mature DC markers like CD86 as immature 
·Dc (Winzler et al., 1997). 
Isolation procedures have been noted to activate DC and even gentle disruption of cell-
to-cell contact can induce activation of cultured DC (Gallucci et al., 1999). Non-
adherent DC are handled with care in order to reduce activation. However, some 
experiments require centrifugation steps , FACS-sorting and overnight culture of cells 
without stroma. The collection and subsequent culture of large LTC-DC without stroma 
for 24 hours has been shown to result in only small changes in the phenotype of large 
L TC-DC. A small shift in the CD44 and MHC Class I fluorescence peaks were 
observed in comparison with freshly isolated large LTC-DC. A far greater effect was 
59 
observed in response to LPS confirming that activation during collection and overnight 
culture of LTC-DC is minimal. 
Large LTC-DC cannot be fully activated by LPS stimulation alone since they maintain 
high endocytic capacity and upregulate only a limited range of cell surface markers. 
Surface levels of MHC Class II, CD80 and CD40 do not increase significantly in 
response to LPS. By comparison with other studies, it is unclear why LPS induces only 
a partially activated state in large LTC-DC. It has been suggested that different types of 
stimuli can induce different states of maturation in DC, and so induce varied types of 
immune response (Mellman and Steinman, 2001). The upregulation in MHC Class I and 
CD86 observed for LTC-DC is consistent with LPS enhancement of Thl type immune 
responses (De Smedt et al., 1996; Mellman and Steinman, 2001; Verhasselt et al., 
1997). Alternatively, it has recently been shown that the receptor for LPS, TLR-4, is 
differentially expressed on human DC subsets (Kadowaki et al., 2001). LTC-DC may 
be unable to respond fully to LPS if they express insufficient levels of TLR-4. The 
possibility that large LTC-DC could also require signals other than LPS to induce 
activation and upreguation of marker expression must be considered. 
L TC-DC may also represent a different type or subset of DC that retains a stable 
phenotype in response to immune stimuli such as LPS. L TC-DC have been shown to 
exhibit some unique properties. They resemble CD8cc DC but express low levels of 
CD205. While they have been shown to have stimulatory capacity for T cells (Ni and 
O'Neill, 1997; O'Neill et al., 1999a; O'Neill et al., 1999b), recent work in this lab has 
demonstrated that LTC-DC show even greater capacity to stimulate B cells (Quah and 
O'Neill, manuscript in preparation). These properties, in combination with their low 
MHC Class II expression suggest that L TC-DC could represent a distinct subset in vivo. 
This subset may have been missed in previous analyses since ex vivo splenic DC are 
often selected on the basis of high MHC Class II expression (Vremec et al., 2000; 
Vremec and Shortman, 1997). 
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CHAPTERS 
Small LTC-DC represent committed precursors of large LTC-DC. 
5.1 INTRODUCTION 
A DC-committed precursor population was recently isolated from murine blood. This 
population comprises CDl lc+MHC IfB220+CD19- cells which generate all known 
subsets of DC but not lymphocytes, macrophages or granulocytes ( del Hoyo et al., 
2002). However, a resident DC precursor population has not yet been identified in 
spleen and this investigation needs to be done. It has been shown that DC can develop 
in vitro fron1 proliferating MHC Class If splenic progenitors (Lu et al., 1995). 
However, most work on splenic DC has been conducted on mature, end-stage DC. A 
majority of in vitro culture systems that support DC growth and proliferation depend on 
cytokines which drive progenitors to become mature DC (Brasel et al., 2000; Saunders 
et al., 1996; Schreurs et al., 1999), preventing the study of intermediate precursor stages 
in their development. Haemopoiesis in LTC occurs independently of exogenous 
cytokines. The consistent turnover of cells in LTC over an extended period of time 
indicates the presence of a self-renewing population of cells within LTC. A previous 
study indicated that HSC were not present within the non-adherent cell population 
produced by LTC (Wilson et al. , 2000). However, based on characterisation of small 
and large LTC-DC subsets it is now hypothesised that small L TC-DC represent 
precursors of large LTC-DC. This model is consistent with observations that small 
LTC-DC are less mature than large L TC-DC and need to be maintained at culture 
passage for continuous DC production. 
Experiments herein examine the developmental capacity of isolated small versus large 
LTC-DC after culture separately on a ST-X3 spleen stromal monolayer. ST-X3 has 
been derived fron1 a non-producing LTC and is comprised of endothelial cells , 
fibroblasts and some n1acrophages (Ni and O'Neill, unpublished data). ST-X3 stromal 
monolayers can be in·adiated to prevent any endogenous cell production in line with 
previous use of stromal cell irradiation (20 Gy) (Kee et al. , 1994; Verfaillie et al. , 
1990). ST-X3 acts as a support matrix for the growth of transferred LTC-DC subsets. 
Experiments have confirn1ed that the small L TC-DC subset contains precursors of large 
LTC-DC and that these require cell-to-cell contact with stroma for optimum 
proliferation and differentiation. 
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5.2 RESULTS 
5.2.1 The small LTC-DC population contains precursors of large LTC-DC. 
Non-adherent LTC-DC were collected and sorted into small and large LTC-DC subsets 
using flow cyto1netry. Sorted small or large cell populations were then transfe1Ted in 
fresh medium on to irradiated ST-X3 stromal monolayers as described in Section 2.4.4. 
The proliferation and differentiation of transferred cell subsets was then monitored over 
time using photomicroscopy and FACS analysis. 
During the first 4-5 days following transfer of small LTC-DC, few changes were 
observed in the number of small LTC-DC present on stromal layers. After 1 week, 
several colonies of cells were observed to form on the stroma. The development of one 
of these colonies was photographed over a period of 18 days, from day 8 to day 26 of 
culture (Fig 5.la-e). By day 8, some small cells in the colony had adopted a size 
equivalent to that of large cells. An increase in the number of cells within colonies over 
time indicated that cells were proliferating. Some cells had also developed dendritic 
extensions and cytoplasmic granularity. By 19 days, there was a dramatic increase in the 
nun1ber of cells produced in culture. This was associated with a more even distribution 
of dendritic-like cells over the entire stroma, rather than localisation of cells in separate 
clusters as noted initially. An increase in cell number at day 19, also coincided with 
release of non-adherent cells into supernatant. The same developmental progression was 
observed in a repeat experiment, although cells were produced at a slightly faster rate, 
with confluent DC growth occu1Ting at 14 days after establishment. Throughout 
experi1nentation no cell growth was detected in control flasks replenished with sDMEM 
only (Fig. 5. lf). However, after 3-4 weeks, some stromal cell death caused by 
irradiation was observed in all flasks and affected overall yield of non-adherent cells. 
When non-adherent large LTC-DC were transferred on to irradiated stroma they also 
proliferated. An example result is shown in Figure 5.6 as part of another experiment. 
There was confluent growth of large L TC-DC across the stroma of transferred flasks by 
day 9 in contrast to day 14-19 for small LTC-DC. This is consistent with cell cycle and 
BrdU incorporation data which suggests that the large LTC-DC subset contains more 
replicating cells (Section 3.2.5). Overall, large LTC-DC did not increase in size 
dran1aticall y during culture on the stromal layer. Instead, an increase in large L TC-DC 
size was found to be associated with dying large cells. After 3-4 weeks, Forward Scatter 
and Side Scatter profiles indicated that cell death was occurring. This may be caused by 
death of stro1nal cells following radiation, although low level apoptosis and cell death 
has been associated with cells developing within LTC (Section 3.2.3). 
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Figure 5.1. Transfer of small LTC-DC on to an irradiated spleen strornal cell line (ST-X3) results in proliferation and differentiation into 
large LTC-DC. FACS-sorted small LTC-DC were transferred on to an irradiated ST-X3 stro1nal monolayer. One cluster of dividing cells 
derived fron1 transferred small LTC-DC was selected and photographed at 8 days (a), 13 days (b), 16 days (c), 19 days (d) and 26 days (e) after 
establishment of culture (x200). By 19 days (f), no cell growth had occurred on a stromal monolayer of the control flask supplemented with 
medium only (x200). 
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The morphology of small and large L TC-DC at days 0 and 16 of culture is shown in 
Figure 5.2. At the time of transfer, large LTC-DC were approximately 3 times larger in 
diameter than small LTC-DC and possessed dendrites. Small LTC-DC could be 
distinguished by the absence of dendrites. After 16 days of culture on the stromal 
monolayer, flasks established from small and large L TC-DC each contained cells of 
comparable size. Cells in both flasks displayed clear dendritic projections (Fig 5 .2 C 
and D). These experiments demonstrated that small LTC-DC can proliferate and 
develop morphology resembling that of large LTC-DC after culture on the ST-X3 
spleen stromal cell line. Similarity in cell size was confirmed in Forward Scatter versus 
Side Scatter plots shown in Figure 5.3. By day 19, most non-adherent cells in the 
culture established from small LTC-DC had increased in size to fall within the large 
LTC-DC gate. Upon comparison of the number of cells within the small gate to that in 
the large gate, only 7.0% of cells fell within the large gate at day 0, 71.5% by day 12, 
and 94.5% by day 19 of culture. The distinct small cell starting population diminished 
with tin1e by 19 days of culture. This indicated that small L TC-DC were not maintained 
as a population of 'small-sized' cells following transfer on to in·adiated stroma. 
Transferred large L TC-DC maintained consistent size over 19 days of culture. 
Approximately 5% of cells fell within the small gate and approximately 95% of cells 
were present in the large gate after each of 0, 12 and 19 days of culture (Fig 5.3). No 
distinct population of small cells developed within these cultures indicating no 
production of small LTC-DC from FACS-sorted large LTC-DC. 
Cell surface expression of CD 11 c and CD86 was also studied on cells produced 
following transfer on to ST-X3, as described in Section 2.2.5. At the establishment of 
culture sorted small LTC-DC expressed low levels of CDl le and lacked CD86 
expression as described in Section 3.2.6 (data not shown) . After 19 days of culture small 
LTC-DC had increased in size to produce large cells expressing high levels of both 
CDl le and CD86 (Fig 5.3). Cells produced in cultures established with sorted large 
LTC-DC either n1aintained or increased expression of CDl le and CD86. Marker 
expression on cells collected from cultures established with small or large LTC-DC was 
identical after 19 days of culture. This suggests that, over time, not only do small cells 
increase in size and develop dendrites, they also upregulate marker expression to 
resemble large L TC-DC. 
5.2.2 Small LTC-DC show limited proliferative capacity in colony assays. 
Colony assays were carried out, as described in Section 2.4.5, in an attempt to quantitate 
the number of cells within the small and large LTC-DC subsets capable of dividing 
numerous times to form clusters or colonies in agar. Clusters of cells contain 4 or more 
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cells, while colonies consist of 50 or more cells (Reid et al., 1992; Wilson et al. , 2000). 
Microscopy was used to examine the morphology of cells within clusters and colonies. 
FACS-sorted small and large LTC-DC were cultured at low density (5xl04 cells/ml 
final) in agar plates with LTC-CSN and a layer of stromal cells on the floor of the plate. 
Stromal cells from the ST-X3 line were seeded in plates 5-7 days previously to produce 
a single layer of confluency. At 7 and 19 days after plating, agar cultures were 
examined for cluster/colony number and type. At day 19, plates were stained in situ 
with Wright-Giemsa stain to enhance cell morphology for microscopy. 
As previously shown (Wilson et al., 2000), only two main types of clusters were 
generated by LTC cells in colony assays. The first comprised differentiated cells 
displaying dendritic cell morphology with either long or short dendritic extensions (Fig 
5.4 a & b). The second type comprised undifferentiated cells which were rounded with 
no dendrites (Fig 5.4c). Clusters did not develop in plates with medium added in place 
of cells (Fig 5.4d). Agar cultures initiated from both small and large LTC-DC generated 
very few undifferentiated clusters. A maximum of 4.0 + 2.0 (mean+ SE, n = 3) and 7.3 
+ 1.8 (n = 3) was seen for small and large LTC-DC, respectively (Fig 5.4d). Greater 
numbers of differentiated clusters, consisting of 4-10 cells, were observed in cultures 
from both small and large cells. The number of these increased over time (Fig 5.4d). 
There was a significant difference in the number of differentiated clusters produced in 
plates seeded with small versus large LTC-DC (p<0.05). By day 19, small LTC-DC had 
generated an average of 12.0 + 3.8 (mean+ SE, n = 3) clusters while the same number 
of large LTC-DC had produced 416.7 + 76.6 (n = 3) clusters. 
Previous experiments indicated that the large L TC-DC subset contains more replicating 
cells than the small LTC-DC subset (Section 3.2.5). However, the difference in number 
of clusters generated by small and large LTC-DC in colony assays does not relate to the 
2-fold difference in number of replicating cells observed in cell cycle assays. In 
addition, confluent small LTC-DC growth was observed by 19 days after transfer on to 
an irradiated stromal 1nonolayer (Section 5.1). This suggested that some aspect of the 
colony assay environment was limiting for small LTC-DC. Non-adherent cells seeded 
into a colony assay are suspended in agar medium above the stro1nal monolayer. These 
cells receive stromal-derived factors by diffusion and from LTC-CSN, without cell 
contact with the stromal monolayer. Non-adherent cells transferred directly on to 
irradiated stromal monolayers were seen to remain adhered to this layer for several days 
after transfer (Section 5 .1). This suggests that cell-to-cell interaction involving small 
cells may be very important in the development of LTC-DC. 
64 
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5.2.3 Cell-to-cell contact with the stromal cell layer is required for small LTC-DC 
development. 
Experiments were conducted to test whether small and large LTC-DC require cell-to-
cell contact with the stroma for optimum development and survival. FACS-sorted non-
adherent LTC-DC were added either directly on to an irradiated stromal monolayer or 
into transwells suspended over in·adiated stroma for comparison of growth potential, as 
described in Section 2.4.6. Transwells are inserts for wells of tissue culture plates with a 
porous membrane forming the base of the trans well. Cells within the transwell can 
adhere to and grow over the membrane surface. They are exposed to factors secreted 
from the stromal 1nonolayer in the tissue culture plate in the absence of cell-to-cell 
contact with the stroma. The growth of small and large LTC-DC was compared in 
contact with stroma and in transwells where no cell contact occurs. As a control for 
endogenous DC production from the irradiated stroma, medium was added to control 
culture plates in place of cells. The morphology and nu1nber of cells were observed over 
35 days. 
Small LTC-DC cultured directly on the stromal cell layer proliferated and differentiated 
as described in Section 5 .2.1. Clusters of cells were observed by 8 days of culture and 
by 12 days individual cells were visible which morphologically resembled large DC 
generated in L TC. Confluent cell growth was observed above the stroma by 17 days of 
culture (Fig 5.5A). In contrast, mostly single cells were detected when small LTC-DC 
were transferred into a transwell above the stromal layer (Fig 5.5B). Only a small 
number of clusters were observed in the transwell. They formed at a very slow rate and 
were not observed until after 20 days of culture. In addition, they remained as individual 
clusters of 4-10 cells. There was no confluent growth of cells across the floor of the 
transwell. Small LTC-DC transferred into the transwell also displayed limited 
differentiative capacity. Some cells increased in size. However, they did not develop 
dendrites and did not appear to contain intracellular bodies. These observations suggest 
that small LTC-DC require cell-to-cell contact with the stromal monolayer in order to 
proliferate and differentiate. 
Large LTC-DC proliferated efficiently when transfe1Ted directly on to stroma, 
producing confluent growth of cells across the stromal monolayer by 9 days of culture 
(Fig 5.6A). These cells did not increase in size significantly and maintained expression 
of dendrites. Similarly, large LTC-DC transferred into transwells proliferated efficiently 
and generated a confluent growth of cells across the floor of the transwell by 9 days of 
culture (Fig 5.6B). This indicates that many large LTC-DC can proliferate 
independently of cell-to-cell contact with the stro111al monolayer. By 20 days, however, 
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Figure 5.5. Small LTC-DC require cell-to-cell contact with stroma for optimal development. Sorted small LTC-DC ( l xl05 cells) were 
added directly on to an i1Tadiated ST-X3 stromal monolayer (A) or into a transwell suspended over an i1Tadiated ST-X3 stromal monolayer (B). 
No cell growth was observed above irradiated stromal monolayers into which no cells were added (C) . Cells were photographed 30 days after the 
establishment of cultures (xl00). 
(A) Small L TC-DC on 
stromal layer 
(B) Small L TC-DC in 
transwell 
(C) Stromal layer 
Figure 5.6. Large LTC-DC proliferate without stromal contact. FACS-sorted large LTC-DC were transferred directly on to an irradiated ST-
X3 stronial monolayer (A) or into a transwell suspended over an irradiated ST-X3 stromal monolayer (B). Cells were photographed at 2, 4, 9 and 
20 days after establishment of cultures (xl00). No cell growth occu1Ted on the stromal monolayer of the control flask supple1nented with medium 
only (data shown in Fig S.SC). 
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many large LTC-DC within the transwell showed morphology consistent with cell 
death. They increased in size and granularity. This suggested that a viable stromal layer 
was important for supporting the survival of large LTC-DC over long periods of time. It 
should be noted that this cell death could also be a result of over-crowding of large 
LTC-DC inside the transwell or medium toxicity induced by breakdown of the stromal 
layer. 
5.3 DISCUSSION 
Data presented here provides direct evidence that the small LTC-DC subset contains 
precursors of large LTC-DC. When transferred on to the ST-X3 stromal monolayer, 
small L TC-DC proliferate, increase in size, develop dendrites and upregulate surface 
expression of CDl lc and CD86. Morphologically and phenotypically they resemble a 
homogeneous population of large LTC-DC. Following 19 days of culture on ST-X3 
stroma, 88.5% of transfe1Ted small LTC-DC had developed into large-sized cells. Small 
LTC-DC were not 1naintained as a distinct population of small-sized cells and so do not 
have capacity for long-term self-renewal as would be expected of HSC (Harrison and 
Zhong, 1992; Morrison and Weissman, 1994; Osawa et al., 1996). This suggests that 
small L TC-DC may represent a transient stage in DC development, perhaps already 
committed to forming large L TC-DC. They do not appear to resemble recently 
identified murine blood-derived CDl lc+MHC IfB220+CD19- committed DC precursors 
( del Hoyo et al., 2002) since they do not express B220 or generate multiple DC subsets. 
This could relate to their being a distinct and different precursor type, representing a 
later stage in DC developn1ent, or a result of the selective nature of LTC-DC stroma. 
Development within LTC is unidirectional. At no stage have small LTC-DC been 
shown to form following the transfer of large L TC-DC on to a ST-X3 stroma. Large 
LTC-DC proliferate efficiently when transferred on to a ST-X3 stromal monolayer and 
show small increases in size and expression of CDl lc and CD86. The high expression 
of CDl lc and CD86 on large-sized cells, derived from both small and large LTC-DC, 
could reflect activation of cells as a result of experimental procedures and the extended 
time in culture. This could be an example of how physical disruption and in vitro 
culture of DC causes changes in cell surface phenotype consistent with activation 
(Gallucci et al., 1999). 
The limited growth of small L TC-DC in transwell and colony assays confirms that DC 
development is dependent on cell-to-cell contact with stromal cells. Most small LTC-
DC cultured within a transwell remain as single cells, although a small number replicate 
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slowly, forming clusters of up to 10 cells. In addition, while these cells increase in size 
they do not develop dendrites or intracellular bodies. Factors or signals responsible for 
interaction between small LTC-DC and stromal cells need to be elucidated. The 
possibility that a limiting factor exists that remains associated with the stroma or that 
signalling mediated by cell surface receptors is involved must be considered. 
Both transwell and colony assays have confirmed that large LTC-DC are not dependent 
on cell contact for proliferation but their survival is enhanced by cell-to-cell contact 
with the stroma. Large LTC-DC proliferate successfully in colony assays and inside 
transwells. Large LTC-DC probably require a soluble stroma-derived factor(s) for their 
survival since it has also been shown that LTC-CSN support LTC proliferation in 
colony assays (Wilson et al., 2000). At present, the exact nature of this soluble factor(s) 
is unknown. Splenic stromal layers are known to secrete a range of cytokines, including 
TGF-~, M-CSF, IL-6 and neuroleukin (Gimble et al., 1989). Other studies have shown 
that together endothelial cells, fibroblasts and macrophages can produce GM-CSF, G-
CSF, TNF-a, TGF-~, IL-1 and IL-6 (Broudy et al., 1987; Fries et al., 1994; Guba et al., 
1992; Sieff et al., 1987; Sunderkotter et al., 1991). The LTC stroma has the potential to 
secrete a wide range of cytokines that may support LTC-DC development and survival. 
However, at this stage, only IL-3 and IL-6 have been detected within LTC (Ni and 
O'Neill, 1997) and these cytokines alone are unable to stimulate large L TC-DC 
proliferation. Combinations of GM-CSF, TNF-a, IL-1, IL-3, IL-6, IL-7, SCF and Flt3L 
are also unable to stimulate large L TC-DC proliferation in colony assays (Wilson et al., 
2000). 
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CHAPTER6 
Generation of small and large LTC-DC subtracted cDNA libraries. 
6.1 INTRODUCTION 
Small LTC-DC have been defined as precursors of large, highly endocytic, CD8a-
myeloid-like LTC-DC. Further examination of small and large LTC-DC has involved 
the isolation of differentially expressed genes from both subsets. It is hypothesised that 
this will identify a range of known and novel genes related to L TC-DC development 
and function. The LTC is an ideal system in which to undertake this kind of analysis. In 
particular, the large LTC-DC subset represents a homogeneous population of cells. The 
small LTC-DC subset shows greater cell heterogeneity. However, transfer of these cells 
on to irradiated stroma and into colony assays has shown that they generate a 
homogeneous population of cells resembling large L TC-DC (Section 5 .2.1). On all 
accounts, large L TC-DC are the product of a single developmental pathway for DC. 
Collection of cells from L TC and F ACS-sorting procedures, have been optimised to 
isolate pure small and large LTC-DC starting populations (Section 3 .2.4 ). A comparison 
of gene expression in the two populations should delineate genes that relate specifically 
to cell differentiation and function and not to other background cell functions, or to 
differences in the sources or culture conditions of cells. 
A subtractive hybridisation procedure has been used to generate subtracted cDNA 
libraries for isolation of cDN A copies of genes expressed in the small L TC-DC 
population and not the large L TC-DC population, and vice versa. This chapter outlines 
the procedure and successful production of small and large LTC-DC subtracted cDNA 
libraries. 
6.2 PROCEDURE 
An overview of the experimental procedures used to generate subtracted libraries and to 
identify differentially expressed sequences is presented in Figure 6.1. More detailed 
descriptions of cDNA synthesis , subtractive hybridisation and suppressive PCR are 
presented in Sections 2.5 .1 -2.8.3 and in Figures 2.1 and 2.2. The difficulty of isolating 
enough small LTC-DC cDNA was a limiting step in the generation of a subtracted 
cDNA library of small LTC-DC. To overcome this, the SMART PCR cDNA Synthesis 
Kit was used to synthesise and amplify cDNA. By this procedure, cDNA was 
synthesised directly from small amounts of total RNA (0.05-1.00µ g) and then amplified 
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Figure 6.1. Overview of the experimental procedure used to generate subtracted 
libraries and to identify differentially expressed sequences. The experimental 
procedures are shown in red text and the outcornes are shown in black text. The generation 
of large subtracted cDNA involved the subtraction of srnall d1iver cDNA from large tester 
cDNA. The same procedure was used to generate differentially expressed sequences in 
small LTC-DC. 
FAGS-sorted large cells (tester) 
Total RNA extraction l 
Large total RNA 
cDNA synthesis and 
amplification l 
Amplified large cDNA 
Rsal digestion l 
Large Rsal digested cDNA 
✓ Adaptor ligation ~ 
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✓ ~ 
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~ + ✓ 
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PCR amplification l 
Amplified large subtracted cDNA 
Cloning and transformation l 
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Differential screening l 
Differentially expressed large clones 
Sequencing l 
Differentially expressed large sequences 
+ 
to produce sufficient material for the subtraction procedure. Synthesis of cDNA created 
full-length single-stranded product that contained SMART PCR primer and RsaI 
digestion sites at both ends. Full-length cDNA was then amplified by PCR using the 
SMART PCR primer. Amplified cDNA was digested using the endonuclease RsaI to 
generate fragments that were blunt-ended for adaptor ligation, and short for optimal 
subtractive hybridisation. Long cDNA molecules form complex networks that prevent 
the hybridisation of complementary sequences. Furthermore, cutting cDNA into a 
number of fragments provides better representation of individual genes (Diatchenko et 
al., 1996). 
Henceforth, cDNA sequences unique to the population of interest are referred to as 
'tester' and the reference cDNA as 'driver' . Following Rsal-digestion, only tester 
cDNA was ligated with either adaptor 1 or adaptor 2R. Both adaptors contain sequences 
that allow annealing of PCR primer 1. However, they differ in that they contain 
sequences for binding either Nester primer 1 or Nested primer 2R. 
Two rounds of subtractive hybridisation were then undertaken. The first round 
combined either denatured tester 1 (tester cDNA ligated to adaptor 1) or tester 2R 
(tester cDNA ligated to adaptor 2R) with excess driver cDNA, generating hybridisation 
samples 1 and 2R, respectively. During hybridisation, sequences common to tester and 
driver formed double-stranded molecules, leaving differentially expressed sequences as 
single stranded molecules. At the same time, the concentration of high and low 
abundance single-stranded tester cDNA was equalised due to the second order kinetics 
of hybridisation (Diatchenko et al., 1996). The second round of hybridisation combined 
hybridisation sample 1 and hybridisation sample 2R in the presence of additional 
denatured driver cDNA. This resulted in the hybridisation of the remaining equalised 
and subtracted single-stranded tester cDNAs. These hybrids possessed different 
adaptors at the 5' and 3' ends, corresponding to the sequences of adaptors 1 and 2R. 
Two rounds of suppressive PCR were used to amplify the double-stranded hybrid 
products of subtractive hybridisation. During the first round using PCR primer 1, only 
double stranded cDNAs with different adaptors at each end were exponentially 
amplified due to the nature of suppressive PCR (described in detail in Section 2.7.2). A 
second round of PCR amplification using the adaptor-specific nested primers, Nested 
primer 1 and Nested primer 2R, was used to enrich for differentially expressed 
sequences and to further reduce background. In order to create subtracted cDNA 
libraries, subtracted PCR products were cloned using the CLONEAMP System which 
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uses UDG to facilitate the nondirectional cloning of PCR products. Vector/inserts were 
transformed into bacteria and plated to grow individual colonies. 
The subtractive hybridisation procedure was carried out in both directions in order to 
analyse differential gene expression in both small and large LTC-DC. Large LTC-DC 
driver cDNA was subtracted from small LTC-DC tester cDNA to generate subtracted 
cDNA containing sequences differentially expressed in small LTC-DC. This was 
termed 'small subtracted cDNA'. 'Large subtracted cDNA' was generated by 
subtracting small LTC-DC driver cDNA from large LTC-DC tester cDNA. Small and 
large subtracted cDNA libraries were then generated. 
6.3 RESULTS 
Successful production of subtracted libraries required tests at each stage of the 
procedure. Results of these tests are shown below. 
6.3.1 Extraction of total RNA from F ACS-sorted small and large LTC-DC. 
Non-adherent LTC-DC were sorted into small and large cell subsets using the 
conditions and gates defined in Section 3 .2.4. The collection of pure populations of 
viable small and large L TC-DC was critical since contamination with non-viable cells 
or cells of incorrect size could invalidate the subtraction procedure. For example, if 
large L TC-DC were collected as contaminants within the small LTC-DC subset, large 
cDNA would be seen as common when small driver cDNA was subtracted from large 
tester cDN A, thus removing sequences specific to the large L TC-DC subset. Special 
care was taken when setting gates to collect small L TC-DC, so that non-viable cells and 
large cells were excluded. Gates used to sort small and large LTC-DC are shown in 
Figure 3 .4. Small L TC-DC were present in low numbers in the non-adherent population 
of LTC, contributing approximately 14% of non-adherent cells (Section 3.2.2). As a 
result, numerous cell sorts were performed and sorted cells stored prior to preparation of 
total RNA. Total RNA extraction of small LTC-DC required cells collected from ten 
separate sorts. For storage, collected cells were washed with PBS, before the cell pellet 
was frozen in liquid nitrogen (Sections 2.3.2 and 2.5.1). 
Total RNA was isolated from sorted small and large LTC-DC using the TRizol Reagent 
as described in Section 2.5.1. Total RNA was isolated from 1.8xl06 small LTC-DC and 
5.0x106 large LTC-DC. RNA quality was assessed by agarose gel electrophoresis and 
by measuring the optical density at 260nm and 280nm. The extraction of high quality 
RNA was demonstrated by the presence of clear 18S and 28S ribosomal RNA bands 
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and the absence of genomic DNA in ethidium bromide stained gels. Figure 6.2A shows 
total RNA isolated from large LTC-DC. Two distinct RNA bands are visible. Similar 
results were obtained for total RNA isolated from small LTC-DC (data not shown). In 
addition, the A260/ A280 ratios generated for small and large LTC-DC total RNA were 1.8 
and 1.9, respectively. This confirmed the presence of high quality total RNA. 
6.3.2 Amplification of cDNA as starting material for subtractive hybridisation. 
The SMART PCR cDNA Synthesis Kit was used to generate sufficient starting material 
for the subtraction procedure. cDNA was synthesised and amplified as described in 
Section 2.5.3. Full length single-stranded cDNA containing SMART PCR primer and 
Rsal sites at its ends, was synthesised using a modified oligo(dT) primer (CDS primer) 
and the SMART II Oligonucleotide. The optimum number of PCR cycles used for 
cDNA amplification was assessed by testing aliquots at 15, 18, 21 and 24 cycles. 
Selection of the optimum number of cycles ensured that the cDNA remained in the 
exponential phase of amplification and was not overcycled. This would result in a poor 
template for subtraction (SMART PCR cDNA Synthesis Kit User Manual, Clontech 
Laboratories). The optimum number of cycles was chosen to be one cycle less than the 
number needed to reach a plateau. Figure 6.2B shows the smear produced by agarose 
gel electrophoresis of large LTC-DC cDNA after 15, 18, 21 and 24 cycles of PCR (Fig 
6.2B, lanes 1-4). The optimum number of cycles for large LTC-DC was 17. Similar 
smears were observed in the electrophoresis gels of PCR amplified small L TC-DC 
cDNA, except that small LTC-DC cDNA required 20 cycles of PCR for optimal 
amplification ( data not shown). On the basis of this assessment, samples were returned 
to the thermal cycler and subjected to additional cycles until the optimum number was 
reached. 
Chroma-Spin 1000 columns were used to purify PCR amplified cDNA from 
contaminants such as salts, solvents, nucleotides, enzymes and proteins (Section 2.5 .3). 
These columns remove DNA fragments of up to l000bp and retain larger fragments 
useful for library construction. Fractions were collected from the column and aliquots of 
these subjected to agarose gel electrophoresis for assessment of their content of large-
sized DNA fragments. Figure 6.2C shows electrophoresis of four fractions of purified 
large LTC-DC cDNA isolated from the Chroma-Spin 1000 column in comparison to 
unpurified large LTC-DC cDNA. Fractions Band C of purified large LTC-DC cDNA 
were retained (Fig 6.2C, lanes 3 and 4 ). Fraction B was enriched for large-sized 
fragments between l000bp and l0000bp (lane 3). Fraction C still contained a high 
concentration of cDNA and was enriched for fragments between 500bp and 1500bp 
(lane 4 ). Fractions A and D were discarded. Similar results were obtained for small 
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Figure 6.2. Preparation of large LTC-DC cDNA for subtractive hybridisation. Through all experiments Lane M represents the 1kb DNA 
ladder size n1arker. (A) Assessn1ent of quality of total RNA (20µ1) prepared from large LTC-DC (5xl06 cells) by electrophoresis on a 1.2% 
agarose ge l. Lane l contains lµl of total RNA product. (B) First strand cDNA amplification by PCR using the SMART PCR primer. Cycle 
nun1ber was optin1ised by ren1oving 5µ1 aliquots of PCR product at various cycles and running the1n on a 1.2% agarose gel. Lane 1 contains 
cDNA removed after 15 cycles; Lane 2, 18 cycles; Lane 3, 21 cycles; Lane 4, 24 cycles. (C) Purification of large LTC-DC PCR products using 
colurnn chron1atography. An equal proportion by volume of each column fraction was run on a 1.2% agarose gel to check for product presence 
and size. Lane 1 contains unpurified cDNA (6µ1), Lane 2 contains fraction A cDNA (10µ1), Lane 3 contains fraction B cDNA (10µ1), Lane 4 
contains fraction C cDNA (3µ1) and Lane 5 contains fraction D cDNA (2µ1). (D) Purified large cDNA digested with the endonuclease Rsal. To 
confinn that digestion was successful, equal proportions of uncut and digested cDNA were run on a 1.2% agarose gel. Lane 1 contains uncut 
large cDNA, Lane 2 contains Rsal digested large cDNA and Lane 3 contains Rsal digested cDNA following Nucleotrap PCR purification. (E) 
Ligation efficiency analysis confirms that tester cDNA has adaptors at both ends following adaptor ligation. PCR products of different reactions 
were run on a 2.0% agarose gel. Lane 1: Adaptor 1 ligated cDNA was used as te1nplate for the G3PDH3' primer and PCR primer 1. Lane 2: 
Adaptor 1 ligated cDNA as ternplate for the G3PDH 3' and 5 ' primers. Lane 3: Adaptor 2R ligated cDNA as template for the G3PDH 3' primer 
and PCR prin1er 1. Lane 4: Adaptor 2R ligated cDNA as ten1plate for the G3PDH 3' and 5' primers. 
( A )  
( B )  
( C )  
( D )  
( E )  
M  1  
M  1  2  3  4  
M  1  2  3  4  5  
M  1  2  3  
1  2  3  4  M  
1 0 0 0 0  
u  
1 , ,  , , ,  
1 0 0 0 0 -
3 0 0 0  
, ,  I f  
, ? f ~ .  
, , . . : , , · . ;  W  3 0 0 0  
1  0 0 0 0  , , ,  . : , .: . ,  
I  ' 1  1  
: , , , , . ,  ~
' ' I ,  
'  . . . .  , ,  ," f ' l i g ,  .  , ; : , ,,  
•  •  1 "  
~ . .  '  
3 0 0 0 - = '  
_  ,
, _ , , , . . . , . . , . , ~ _ . _ . . . . . , _ . . _ . ,  _ _ _ _ _  . _ , . - , . , . , n , . - , . , , . , _ . _ . . . . . _  _ _ _ _ _ _  
1 5 0 0  
I ~  ; • ' ' . ? 1 '  ' \ \  
m _ r  . . .  , , . - a ~ t 9 t m  
3 0 0 0  
3 0 0 0  
- ·  · · c • · l l l ' J ' ' { l ' - t < B " , ' i t i 9 1 1 l l l l l r J , _ I T • ' ·  : : • • W . t , , f r ;  
,  ! l f f ' l ' I I  
- ~ a - _' l N f f • ! a l . . ! ' \ . ' \ l t , l l l " r i / ' - U l f ~  . .  - , r . 1 1 I t U l l 1 J H - • f A l l l ' 1 A l l 1 - - - l - -
1 5 0 0 -
'  ~. ' i ~: ;  I J } (  
~ ; ~ ~ 1 0 0 0  
1 5 0 0 - · , , : . , f i  '·  
7 5 0  
1 5 0 0  
.  .  ~l xl  I  
'  . ,  · ,  i t B ~ ! I !
1
t  I '  
• ~ : . 3 l ~ M  ~ « f f  
7 5 0  
'  t i , .  , c , : 1 , ) , ' , ,  . .  ,  ' \  
(  
: t , 8 1 .  { ; ~ ~  · /  ' \  (  ;  
7 5 0  
,y , : ~ v  ·  i } f ~  \ : - . ,  : - ,  . , ,  
7  5 0  ~ :  '  § - : ' : ~ ~ ~ R f f l i !  
7 5 0  
•  
, !  
, .  
, . , .  
5 0 0  
1 - •  _ , , .  ·  .  : f , ~ •  ,  I  1 • · •  j  · .  ·  . '  •  
1 . 1  , 1 · . J / ; _ ,  . .  . ; i \ i t ,  ; , • w . & > < . - ! '  ' . -
1
, t : ' <  ' J d  L i  
' , .  J  
2 5 0  
LTC-DC cDNA (data not shown). Fractions Band C of purified small LTC-DC cDNA 
were also retained and combined. 
6.3.3 Endonuclease restriction digest of cDNA generates short, blunt-ended 
molecules. 
An endonuclease restriction digest using Rsal was carried out to generate shorter, blunt-
ended cJ?NA fragments, necessary for both adaptor ligation and subtraction. Small and 
large LTC-DC cDNA was digested with Rsal as described in Section 2.6.1. To confirm 
that digestion was complete, aliquots of cDNA taken before and after incubation with 
Rsal were subjected to agarose gel electrophoresis. Prior to digestion with Rsal, large 
LTC-DC cDNA fragments ranged in size from 500bp to 7000bp (lane 1; Figure 6.2D). 
After digestion, the majority of fragments were <1500bp in size (lane 2; Figure 6.2D), 
indicating successful Rsal digestion. Similar results were obtained when small L TC-DC 
cDNA was digested with Rsal (data not shown) . 
Digested cDNA was purified using the Nucleotrap PCR Kit. Purified cDNA was 
ethanol precipitated to concentrate cDNA fragments in preparation for ligation of 
adaptors and subtractive hybridisation (Section 2.6.2). Again, the yield of cDNA was 
assessed by agarose gel electrophoresis and UV spectrophotometry. Figure 6.2D shows 
the purified and precipitated large LTC-DC cDNA as a faint smear across the range 
500bp to 1500bp (lane 3). It is composed of cDNA fragments in the size range of 
unpurified digested large LTC-DC cDNA (lane 2). While some cDNA was lost during 
the purification procedure, the faintness of the smear in lane 3 is also a result of loading 
a smaller percentage of the total sample into the agarose gel than in lane 2. The 
concentration of purified large LTC-DC cDNA was estimated from A260 to be 
1.520µg/µl (5.5µ1 total volume). This was sufficient cDNA to proceed to the next step. 
The appearance of purified and precipitated small LTC-DC cDNA on an agarose gel 
was similar to that of the large LTC-DC cDNA, with the exception that the smear was 
fainter (data not shown). The concentration of sn1all LTC-DC cDNA was estimated as 
0.220µg/µl (5.5µ1 total volume). This was also sufficient cDNA to proceed to the next 
step. 
6.3.4 Ligation of adaptor 1 and adaptor 2R to the ends of tester cDNA. 
The adaptors 1 and 2R were ligated to the ends of tester cDNA as described in Section 
2.6.3. This involved setting aside a portion of the purified cDNA as driver, then 
dividing the tester portion into two separate tubes for ligation with either adaptor 1 or 
adaptor 2R. The efficiency of adaptor ligation was assessed using PCR. For each 
adaptor ligation reaction, two PCR reactions were carried out. The first used two gene-
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specific primers to amplify the G3PDH house-keeping gene. The second PCR reaction 
amplified a sequence of cDNA using one gene-specific primer for G3PDH and PCR 
primer 1 which is specific for sequence common to both adaptors 1 and 2R. This second 
amplification reaction will only produce a product if an adaptor has been successfully 
ligated on to the G3PDH fragment. This allowed comparison of the number of G3PDH 
sequences with adaptors, to the total number of G3PDH sequences in the cDNA 
population. Ligation was judged successful if at least 25% of cDNA had adaptors at 
each end. 
Figure 6.2E shows an electrophoresis gel of PCR products from reactions using large 
LTC-DC tester cDNA after ligation of adaptor 1 (lanes 1 and 2) or adaptor 2R (lanes 3 
and 4) as template. Lanes 2 and 4 show the strong G3PDH band produced using two 
gene-specific primers. Lanes 1 and 3 show multiple bands produced using one G3PDH-
specific primer and PCR primer 1. A PCR product of approximately l 200bp was 
expected when using these primers to amplify mouse cDNA, since mouse G3PDH 
cDNA lacks the Rsal restriction site. The appearance of a second strong band (at 
approximately 800bp) and a number of smaller, weaker bands could be explained by the 
possibility that the G3PDH-specific prirner is cross-reactive with an unrelated gene or is 
amplifying G3PDH cDNA of different lengths. 
The intensity of bands generated by PCR using one gene-specific primer and PCR 
primer 1 suggested that a high portion of the large LTC-DC cDNA had adaptors 
successfully ligated to the ends. Similar results were obtained upon agarose gel 
electrophoresis of small LTC-DC PCR products. The same banding pattern of two 
strong bands (approximately 1200bp and 800bp) and three smaller, weaker bands was 
observed ( data not shown). Again the intensity of bands suggested that a high 
proportion of small LTC-DC cDNAs had adaptors ligated to the ends. Adaptor-ligated 
small and large LTC-DC cDNA was used in the next step, subtractive hybridisation. 
6.3.5 Generation of subtracted cDNA using a combination of subtractive 
hybridisation and suppressive PCR. 
Prior to subtractive hybridisation, the concentration of driver and tester cDNA was 
calculated using UV spectrophotometry since it was necessary that driver cDNA be ten-
fold more concentrated then tester cDNA in the subtractive hybridisation reactions. 
Table 6.1 shows the concentrations of tester and driver used in the various subtractions. 
Two rounds of subtractive hybridisation were carried out as described in Section 2.7 .1. 
Two critical steps were involved in the subtraction procedure. The first of these was the 
use of tester and driver cDNA at con·ect concentrations. The 10-fold excess of driver 
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Table 6.1 Concentration of cDNA used in subtractive hybridisation. 
Tester 1 Tester 2R Driver 
(µg/µl) (µg/µl) (µg/µl) 
Control a 
Human placental total RNA 0.110 0.100 1.095 
Samples 
Small minus large L TC-DC b 0.078 0.078 0.760 
Large minus s1nall LTC-DC 0.028 0.028 0.220 
a Human placental tester 1 and tester 2R contained a small amount (0.02%) of HaeIII-
digested bacte1iophage ¢XI 74 DNA. 
b In the Small minus large LTC-DC subtraction, large driver cDNA was subtracted from 
small tester cDNA. 
cDNA over tester cDNA during hybridisation ensures that driver competes effectively 
for hybridisation with common tester sequences allowing maximum enrichment of 
single-stranded differentially expressed sequences. The second critical step involved the 
combination of hybridisation samples 1 and 2R during the second round of 
hybridisation (Section 2.7.1). To maintain the temperature of samples it was necessary 
to carry out this step as quickly as possible. Any decrease in the temperature would 
allow reannealing of excess driver before combination with hybridisation samples 1 and 
2R. This would impede the hybridisation of differentially expressed single-strand 
molecules generated during the first round of hybridisation and lead to reduced 
subtraction efficiency. 
Two rounds of suppressive PCR were can·ied out to amplify the double-stranded hybrid 
products of subtractive hybridisation. This is described in Section 2.7.2. Figure 6.3A 
shows PCR products of subtracted and unsubtracted, small and large LTC-DC cDNA 
following two rounds of amplification. The amount of cDNA in subtracted samples 
(lanes 1 and 3) was reduced with comparison to unsubtracted samples (lanes 2 and 3). 
The same volume of all samples was loaded on to gels. This indicated that the 
subtraction process had successfully removed common sequences through hybridisation 
with driver, resulting in less cDNA being available as the starting material for 
arnplification. Subtracted cDNA was composed of distinct bands rather than the smear 
present in lanes containing unsubtracted cDNA (Fig 6.3A). This was expected as only 
differentially expressed sequences possessing different adaptors would be exponentially 
amplified in subtracted samples. In contrast, unsubtracted cDNA had both adaptors 1 
and 2R ligated to its ends. Thus it possessed different adaptors without undergoing 
subtractive hybridisation and so generated a smear following PCR as a random selection 
of sequences were amplified. Figure 6.3B shows small and large LTC-DC subtracted 
cDNA side by side. As in Figure 6.3A, these are the PCR products of two rounds of 
amplification. Small subtracted cDNA (lane 1) comprised bands ranging in size from 
250bp to 1400bp, while a n1ajority of large subtracted cDNA (lane 3) bands were 
between 500bp and 1700bp. The variation in banding pattern suggests that different sets 
of genes were transcribed in the subtracted cDNA populations. 
The different banding patterns of small and large LTC-DC subtracted cDNA was 
consistent with the expectation that the two cell subsets have different gene expression. 
However, it was necessary to quantify the efficiency of subtraction. This was done by 
comparing the abundance of the house-keeping gene G3PDH before and after 
subtraction. Successful subtraction should result in reduction of G3PDH. PCR reactions 
using two G3PDH-specific primers were carried out as described in Section 2.7.3. 
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Figure 6.3. Electrophoresis of secondary PCR products of subtracted and unsubtracted small and large cDNA. Following second round 
PCR, 5µ 1 of product was run on a 2.0% agarose gel. To obtain clear resolution of fine bands the gel was run at 80V. DNA size 1narkers (bp) are 
indicated for the 1kb DNA ladder in Lane M. (A) Lane 1 contains s1nall subtracted cDNA, Lane 2 contains small unsubtracted cDNA, Lane 3 
ontains large subtracted cDNA and Lane 4 contains large unsubtracted cDNA. (B) Lane 1 contains sn1all subtracted cDNA and Lane 2 contains 
ubtracted large cDNA. 
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Subtracted and unsubtracted second round PCR products of equal concentration were 
used as starting material. Figure 6.4 shows the reduction of G3PDH in both small (A) 
and large (B) LTC-DC subtracted cDNA. A G3PDH product is visible in the 
unsubtracted cDNA reaction after 18 cycles of PCR. However, in both subtracted 
samples only a relatively faint band becomes visible at 28 cycles. A product becomes 
visible 10 cycles later in small and large L TC-DC subtracted samples in comparison 
with unsubtracted samples. A difference of 5 cycles corresponds to approximately a 20-
fold cDNA enrichment (Clontech PCR-Select cDNA Subtraction Kit User Manual). 
Small and large LTC-DC subtracted cDNA were enriched for differentially expressed 
sequences by at least 640-f old. This confirms that the subtraction procedure was 
successful. 
6.3.6 Confirmation of subtraction procedure using control cDNA. 
Control human placental total RNA supplied by the SMART PCR cDNA Synthesis Kit 
was run through the subtraction process in parallel with small and large LTC-DC 
samples to ensure that the multi-step procedure worked efficiently. As with the small 
and large LTC-DC samples, cDNA was synthesised and amplified from control human 
placental total RNA. This cDNA was then digested with Rsal. To prepare tester cDNA, 
a small amount of HaeIII-digested cpXl 74 DNA was added to an aliquot of human 
placental cDNA (0.02% of the total cDNA). Human placental tester cDNA was then 
divided into two portions and ligated to adaptors 1 or 2R. The two rounds of subtractive 
hybridisation involved human placental/<j)Xl 74 cDNA with adaptor 1 as tester 1, hun1an 
placental/<j)Xl 74 cDNA with adaptor 2R as tester 2R, and human placental cDNA as 
driver. Two rounds of PCR were carried out to amplify differentially expressed 
sequences. 
Figure 6.5A shows subtracted control cDNA following the first (lane 1) and second 
(lane 2) rounds of PCR in comparison with unsubtracted control cDNA after the first 
(lane 3) and second (lane 4) rounds of PCR. Instead of the smear observed in 
unsubtracted samples, there are clear bands present in the subtracted lanes. These bands 
correspond to fragments of the cpXl 74/HaeIII digest. The bands of lanes 1 and 2 
correspond to those of positive PCR controls in lanes 5 and 6. PCR controls comprised 
a successfully subtracted 1nixture of HaeIII-digested cpXl 74 DNA after the first (lane 5) 
and second (lane 6) rounds of PCR. 
To assess the efficiency of subtraction, PCR was carried out to compare the prevalence 
of G3PDH in subtracted and unsubtracted cDNA as described in Section 2.7.3. In 
Figure 6.5B, a G3PDH product is visible after 18 cycles in unsubtracted human 
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Figure 6.4. PCR analysis of subtraction efficiency. The efficiency of subtraction was 
judged by cornpaiing the prevalence of the house-keeping gene G3PDH before and after 
subtraction. Following 18, 23, 28 or 33 cycles of PCR using G3PDH 3' and 5' primers, 
5µ1 of PCR product was run on a 2.0% agarose gel along with the 1kb DNA ladder size 
n1arker. (A) Compa1ison of small subtracted and unsubtracted cDNA. (B) Comparison of 
large subtracted and unsubtracted cDNA. 
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Figure 6.5. Use of the control human placental cDNA to confirm successful 
subtraction. Human placental cDNA was subtracted from a mix of human placental 
cDNA containing a small amount (0.02%) of HaeIII-digested ¢Xl 74 DNA. (A) PCR 
products of subtracted and unsubtracted human placental cDNA. Following primary and 
secondary PCR, 5µ1 of product was run on a 2.0% agarose gel with 1kb DNA ladder size 
marker (lane M). To obtain clear resolution of fine bands the gel was run at 80V. The gel 
displays subtracted human placental cDNA following primary (Lane 1) and secondary 
(Lane 2) rounds of PCR, unsubtracted hun1an placental cDNA following primary (Lane 3) 
and secondary (Lane 4) rounds of PCR and the positive PCR control cDNA following 
primary (Lane 5) and secondary (Lane 6) rounds of PCR. (B) PCR analysis of 
subtraction efficiency. The efficiency of subtraction was judged by comparing the 
prevalence of the house-keeping gene G3PDH before and after subtraction. Following 18, 
23, 28 or 33 cycles of PCR using G3PDH 3' and 5' primers, 5µ1 of PCR product was 
run on a 2.0% agarose gel with 1kb DNA ladder size marker. 
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placental cDNA. However, in subtracted samples a very faint product is not visible until 
28 cycles. This reduction in G3PDH following subtraction, confirms the power of 
subtractive hybridisation for enrichment of differentially expressed sequences. 
6.3.7 Second round PCR of subtracted cDNA using UDG primers and subsequent 
cloning into pAMPl0. 
Second round PCR was performed using the UDG primers 1 and 2R and first round 
small and large subtracted PCR products as template. This procedure has been described 
in Section 2.8.1. Second round UDG-primed PCR products were run on an agarose 
electrophoresis gel alongside second round PCR products amplified using Nested 
primers 1 and 2R. This was performed to check that PCR products exhibited similar 
banding patterns, as an indication that the two primer sets had amplified the same range 
of cDNA sequences. Figure 6.6 demonstrates that the products of PCR using UDG 
primers and Nested primers had a similar size range, with small subtracted cDNA 
ranging from 250bp to 1400bp and large subtracted cDNA from 500bp to 1700bp. 
Distinct bands present in subtracted cDNA amplified with Nested primers 1 and 2R 
were also visible in subtracted cDNA amplified using UDG primers 1 and 2R (Fig 6.6). 
The bands of UDG-primed cDNA were less intense than those of cDNA produced by 
Nested prin1ers, suggesting that less product was generated by PCR amplification using 
UDG primers, although this was sufficient for cloning into pAMPl0. 
PCR products were purified using the Nucleospin Extraction Kit to remove any primer-
dimers and excess dNTPs, as described in Section 2.8.2. Purified subtracted cDNA was 
then cloned into the pAMPl0 vector as described in Section 2.8.3. Transformed bacteria 
were plated to grow up individual colonies, each of which contained a single insert. The 
transformation efficiency ,vas 1.6xl06 cfu/µg DNA for small subtracted cDNA and 
1.4xl06 cfu/µg DNA for large subtracted cDNA. CloneAmp control insert DNA should 
yield at least 1.0xl05 cfu/µg DNA when using the pAMPl0 System. Thus the 
transformations performed with small and large subtracted cDNA resulted in acceptable 
cloning efficiencies. 
6.4 DISCUSSION 
A number of methods have been developed to investigate altered gene expression 
between different cell types or under different conditions. These include subtractive 
cloning, differential display and representational difference analysis. Subtracted cDNA 
cloning uses repeated hybridisation of target cDNA with biotinylated reference cDNA, 
followed by removal of comn1on sequences using streptavidin and phenol extraction or 
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Figure 6.6. Preparation of subtracted cDNA for cloning into pAMPlO. Second 
round PCR products generated using Nested primers 1 and 2R or UDG primers 1 and 2R 
were compared. Five µl of product was run on a 2.0% agarose gel. To obtain clear 
resolution of fine bands the gel was run at 80V. DNA size 1narkers (bp) are indicated for 
the 1kb DNA ladder in Lane M. Lane 1 contains s1nall subtracted cDNA arnplified using 
Nested prin1ers 1 and 2R. Lane 2 contains small subtracted cDNA an1plified with UDG 
pri1ners 1 and 2R. Lane 3 contains large subtracted cDNA a1nplified with Nested primers 
1 and 2R. Lane 4 contains large subtracted cDNA amplified with UDG pri1ners 1 and 2R. 
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streptavidin-magnetic beads (Sagerstrom et al., 1997). Differential display amplifies the 
3' termini of cDNA fragments that can then be separated on a gel. Altered gene 
expression is detected by comparing the banding patterns of two populations (Liang et 
al., 1993; Liang and Pardee, 1992). Representational difference analysis is similar to the 
subtractive hybridisation procedure described in this study. It differs in that tester 
molecules have the same adaptor ligated to each end. Following hybridisation with 
driver, cDNA specifically expressed in the tester population hybridises to itself 
generating double-stranded target sequences that can be PCR amplified using primers 
specific to the adaptors. The hybridisation and PCR steps must be performed at least 3 
times to enrich for differentially expressed molecules that can be visualised on an 
agarose gel (Hubank and Schatz, 1994). 
The procedure described in this study uses a combination of subtractive hybridisation 
and suppressive PCR. It was selected for use since it is a relatively fast method in 
comparison to techniques such as subtractive cloning. It is a sensitive method, capable 
of isolating rare genes and requiring relatively little starting material (1-2 µg poly(At 
RNA). Total RNA can be used as starting material. Since the amount of total RNA 
obtainable from small L TC-DC is limiting, this method also allows the amplification of 
starting material before subtraction. It can also isolate genes present in different levels 
within samples (Diatchenko et al., 1996). Furthermore, subtraction occurs by selective 
amplification of differentially expressed genes, which is more reliable than the physical 
separation that occurs during subtractive cloning. This procedure also targets the 
complete set of RNA, unlike differential display that can favour 3' untranslated regions 
and not open reading frames. 
Powerful gene expression techniques involving spotted cDNA microarrays or 
Affymetrix genechips were not available at the time this study was initiated. Affymetrix 
genechips can be used to assay expression of around 12,000 genes represented on the 
chip by a set of oligonucleotides. Chips can be labelled with fluorescent cRNA probe 
generated fron1 the target cell population and laser scanning can be used to detect the 
pattern of hybridisation with oligonucleotides on the chip (http://jcsmr.anu.edu.au/brf). 
This type of technique could be used to produce gene expression profiles for each of the 
small and large LTC-DC populations. Differences in gene expression level could be 
obtained by comparison of hybridisation results obtained with different cell populations. 
However, in addition to detecting expression of known genes relating to L TC-DC 
development and function during this study, one important aim is to isolate novel genes. 
The subtractive hybridisation and differential screening procedure directly isolates 
differentially expressed novel sequences, whereas microarrays can only detect known 
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genes and ESTs and so might miss important, as yet unidentified sequences. One further 
limitation with screening Affymetrix gene chips is the amount of RNA needed for probe 
preparation and the need to use unamplified material for quantitative analysis of gene 
expression. 
Using subtractive hybridisation and suppressive PCR, sn1all and large subtracted cDNA 
libraries have been successfully generated in order to isolate genes differentially 
expressed in the small and large LTC-DC populations. Analyses performed during the 
preparation of subtracted cDNA have ensured the success of each step. Small and large 
subtracted cDNA demonstrate different banding patterns when run on an agarose 
electrophoresis gel and show lower abundance of the house-keeping gene G3PDH. 
Results indicate that both small and large subtracted cDNA are enriched at least 640-
fold for differentially expressed genes. Control human placenta total RNA run through 
the subtraction process in parallel with small and large LTC-DC samples confirms that 
the combination of subtractive hybridisation and suppressive PCR is a powerful 
technique for the enrichment of differentially expressed genes. 
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CHAPTER 7 
Identification of differentially expressed genes in small and large LTC-DC subsets. 
7.1 INTRODUCTION 
The small and large subtracted libraries generated in Chapter 6 could be used to identify 
unique gene expression in both small and large LTC-DC populations. The small and 
large LTC-DC would be expected to contain few differentially expressed transcripts 
since they represent precursor and progeny cell subsets and both subsets are generated 
within the same L TC system. It is also expected that the small and large subtracted 
cDNA libraries would contain some cDNA clones common to both small and large 
populations and that the number would depend on the efficiency of the subtraction 
process and the quality of starting RNA. However, it has also been shown that common 
clones are often isolated when few differentially expressed mRNA transcripts exist 
between two cell populations (PCR Select Differential Screening Kit User Manual, 
Clontech Laboratories). 
With a view to isolating unique genes expressed in either small or large LTC-DC, 
differential screening of clones in subtracted libraries was performed using the Clontech 
PCR-Select Differential Screening Kit. The method involved hybridisation of subtracted 
clones with 4 different probes prepared from each of small subtracted cDNA, large 
subtracted cDNA, small unsubtracted cDNA and large unsubtracted cDNA. 'Forward' 
and 'reverse' has been used to refer to the direction of subtractive hybridisation. 
Forward probes were made from the same cDNA used to generate the subtracted 
library, from which the subtracted clones in question originate. For example, small 
subtracted clones would be hybridised with small subtracted cDNA and small 
unsubtracted cDNA as forward probes. Reverse probes were made from a subtractive 
hybridisation performed in the opposite direction with the original tester cDNA as 
driver and the driver cDNA as tester. Differentially expressed clones within subtracted 
libraries were selected on the basis of hybridisation with the forward and not reverse 
probes. Subtracted probes were used since they should be highly sensitive for clones in 
the subtracted library. Use of unsubtracted probes should allow confirmation or 
elimination of ambiguous results obtained with subtracted probes. 
Selected differentially expressed clones have been sequenced and these sequences 
submitted to NCBI databases to test for homology with known genes. It was anticipated 
that a number of different types of genes would be isolated. Identification of known 
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genes will help delineate the developmental stage and lineage of small and large LTC-
DC. In addition, identification and analysis of novel genes should uncover novel 
proteins involved in DC development and function. For the purpose of this study, a 
small profile of gene expression was prepared. This involved selection and screening of 
several hundred colonies from each library. 
7.2 RESULTS 
7.2.1 Differential screening of subtracted clones. 
Individual colonies were randomly picked to give a total of 480 clones from both the 
small and large subtracted libraries. Transformed bacterial colonies were grown up and 
used as template for PCR amplification of cloned inserts as described in Section 2.9 .1. 
PCR products were run on an agarose electrophoresis gel to ensure purity of each 
bacterial clone and to assess insert size. Figure 7. IA represents one of 27 gels run for 
small subtracted clones. All of the small subtracted cDNA inserts shown in the gel 
represent a single clone. Inserts ranged in size from approximately 250bp (clone 4/E3) 
to 1 l00bp (clone 4/G2). This corresponds to the range of small subtracted cDNA bands 
observed in Figure 6.5. One of 27 gels of PCR-amplified large subtracted cDNA inserts 
is also shown in Figure 7. IB. All of the large subtracted cDNA inserts represent a single 
clone. Inserts ranged in size fron1 approximately 600bp to 1300bp, consistent with the 
higher average size of large subtracted cDNA over small subtracted cDNA shown in 
Figure 6.5. 
PCR amplified inserts of single subtracted clones were dotted on to duplicate nylon 
membranes as described in Section 2.9 .1. Membranes were then hybridised with four 
different random primer-labelled cDNA probes as described in Section 2.9.2. For 
example, to screen small subtracted cDNA clones, duplicate membranes dotted with 
clones were hybridised separately with either small subtracted cDNA probe or large 
subtracted cDNA probe. Following exposure to x-ray film, membranes were stripped 
and the process repeated with either small unsubtracted cDNA probe or large 
unsubtracted cDNA probe. Membranes dotted with large subtracted cDNA clones were 
treated in the same way. Figure 7 .2 shows results of hybridisation of small subtracted 
cDNA clones with the four different cDNA probes. This result represents one of a total 
of five 1nembrane sets that were dotted with small subtracted cDNA clones. Negative 
hybridisation controls, cDNA A and cDNA B, were used to assess the degree of non-
specific binding occu1Ting during hybridisation. High background can be caused by 
high complexity in cDNA probes and the presence of adaptor sequences in both the 
a1Tayed clones and cDNA probes (PCR-Select Differential Screening Kit User Manual, 
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Figure 7.1. PCR amplification of inserts in randomly selected small (A) and large 
(B) subtracted clones. Amplification was carried out using transformed bacteria as 
template and Nested pri111ers 1 and 2R. Following PCR amplification, 5µ1 of product was 
run on a 2.0% agarose gel. DNA size markers (bp) are indicated for the 1kb DNA ladder 
in Lane M. All other lanes are labelled with the clone name. 
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Figure 7.2. Differential screening of small subtracted clones using Southern dot blots. Small subtracted clones were dotted on to nylon 
men1brane and hybridised with 32P-labelled (A) sn1all subtracted cDNA probe, (B) large subtracted cDNA probe, (C) small unsubtracted cDNA 
probe or (D) large unsubtracted cDNA probe. 32P-labelling was detected by exposure to x-ray film for 72 hours. (E) Hybridisation controls. Lane 
1 contains a representative differentially expressed small subtracted clone and Lane 2 contains a representative small subtracted clone that is 
co111monly expressed in small and large LTC-DC. Lane 3 contains cDNA A and Lane 4 contains cDNA B as negative hybridisation controls. 
Row A was hybridised with small subtracted cDNA probe, Row B with large subtracted cDNA probe, Row C with small unsubtracted cDNA 
probe and Row D with large unsubtracted cDNA probe. 
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Clontech Laboratories). Both controls provided in the kit, did not hybridise to any of the 
cDNA probes (Fig 7 .2E). 
7 .2.2 Interpretation of screening results. 
Criteria used for interpretation of differential screening results are summarised in Table 
7 .1. Clones have been ranked into groups A through F on the basis of pattern of 
hybridisation with different probes. Clones were selected for sequencing if they fulfilled 
the requirements described for rankings of A, B or C. These are best described by 
applying them to the results shown in Figure 7 .2. Small clones with an A ranking 
hybridised to small subtracted and small unsubtracted cDNA probes, but not to large 
subtracted and unsubtracted probes. Clone Cl is an example of this. Clones of rank A 
are almost always (>95 % probability) differentially expressed genes (PCR-Select 
Differential Screening Kit User Manual, Clontech Laboratories). To receive a B 
ranking, small clones hybridised only to the small subtracted cDNA probe. These 
clones, such as clone B9, are usually low-abundance transcripts that are enriched during 
subtraction and are strong candidates for differential expression (PCR-Select 
Differential Screening Kit User Manual, Clontech Laboratories). To receive a C 
ranking, small clones hybridised to both small and large subtracted cDNA probes, but 
with different intensities. When the intensity of hybridisation between the small clone 
and small subtracted cDNA probes was 5-fold greater than the intensity of hybridisation 
between the small clone and large subtracted cDNA probe, the clone was considered to 
be a differentially expressed gene (PCR-Select Differential Screening Kit User Manual, 
Clontech Laboratories). Results of hybridisation with unsubtracted probes were used to 
co1Toborate or disprove subtracted probe results. Clone D8 represents a small subtracted 
cDNA clone of this type. Subtracted clones that fulfilled the requirements described for 
a ranking of D, E or F (Table 7 .1) were not selected for further investigation. 
Guidelines were created to distinguish negative clones from those weakly positive. 
Clones were scored as positive if a solid black spot was visualised on the x-ray film, 
such as clones A2, B9 and E6 (Fig. 7 .2A). Dots of inconsistent intensity were scored as 
negative since these were found to vary between replicates ( data not shown). Examples 
of negative clones include Al, C7 and G 11 (Fig 7.2A). These guidelines were followed 
stringently for analysis of clones hybridised with subtracted probes. However, lower 
intensity dots could be scored positive when hybridised with unsubtracted probes. For 
example, the clone shown in Row 1 of Figure 7 .2E was ranked A. 
A total of 71 small subtracted clones, or 14.8% of small clones, were selected for 
sequencing. These are listed in Table 7 .2 under hybridisation ranks A, B and C. In 
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Table 7.1 Criteria for interpretation of differential screening results3 • 
Ranking 
A 
B 
C 
D 
E 
F 
Forward 
subtracted 
+ c 
+ 
++ 
+ 
+ 
Type of probe 
Reverse 
subtracted 
+ 
+ 
Unsub.b 
tester 
+ 
+ 
+ 
+ 
Unsub. 
driver 
-/+ 
+ 
+ 
Interpretation 
Clones that hybridise to the forward-subtracted and unsubtracted tester probes, but not the reverse-
subtracted or unsubtracted d1iver probes almost always (95% probability) correspond to differentially 
expressed genes (eg. clone Cl ct). 
Clones that hybridise only to the forward-subtracted probe are strong candidates for differential 
expression (eg. clone B9). These clones typically conespond to low-abundance transcripts enriched 
during subtraction, although occasionally they can be an a11efact. 
Clones that hybridise to both subtracted probes, but with different intensities. When the difference in 
signal intensity is >5-fold (eg. clone D8), a clone probably conesponds to a differentially expressed 
gene. Generally, the results with unsubtracted probes can be used to conoborate or disprove the 
subtracted probe results. 
Clones that hybridise to the forward-subtracted probe and both unsubtracted probes but not the 
reverse-subtracted probe can be difficult to interpret (eg. clone A 7). Many of these cDNAs are only 
artefactually em-iched. These may be checked with Northern analysis. 
Clones that hybridi se equally to both subtracted probes and to both un subtracted probes are almost 
never differentially expressed (eg. clone ClO). 
Clones that do not have detectable hybridisation signal for either of the subtracted probes usually 
represent non-differentially expressed cDNAs (eg. Clone A3). 
a adapted from Clontech PCR-Select Differential Screening Kit User Manual 
b Unsub. = Unsubtracted 
c +, signal observed; ++, strong signal; -, no signal observed 
d examples of clones taken from Figure 7 .2. 
Table 7 .2 Clones selected for sequencing by ranking differential screening results. 
Ranking Number of clones 
Small subtracted clones 
A 24 
B 34 
C 15 
Large subtracted clones 
A 24 
B 28 
C 10 
Clone names 
1/A9, 1/Al0, 1/B12, 1/C7, 1/Dl, 1/E2, 1/El0, 1/Fl0, 
2/A7, 2/B3, 2/C2, 2/Cl0, 2/D6, 2/D7, 2/E6, 2/El0, 
2/Ell, 2/E12, 2/G9, 3/Al, 3/Hl, 4/B8, 4/D9, 5/E12. 
1/B2, l/F3, 1/G2, l/G8, 1/H2, 1/Hl 1, 2/Fl 1, 3/Cl, 
3/C4, 3/C7, 3/E4, 3/E6, 3/E7, 3/E12, 3/F3, 3/Fl 1, 
3/GS, 3/G9, 3/G 11, 4/C9, 4/Fl2, 4/H6, 4/Hl0, SIAS, 
5/B9, 5/Bll, SIDS, 5/H3, 5/H7, 11/A3, 11/E5, 
11/F5, 11/G3, 11/Hl. 
1/C8, l/C12, 2/A9, 2/Al0, 2/B9, 2/El, 2/H4, 3/Bl, 
3/Dl,3/H12,4/H6,5/A9,5/D6,5/D9,5/Dl0. 
6/C9, 6/E8, 7/A3, 7/B9, 7/E7, 7/E9, 7/F4, 7/H9, 
8/Al0, 8/B3, 8/B7, 8/C5, 8/C6, 8/D6, 8/H2, 9/A9, 
9/All, 9/Cll, 9/FS, 9/Gll, 9/H8, 9/H9, 10/Al0, 
10/C4. 
6/H8, 7/B8, 7/Ell, 7/F9, 7/G6, 7/Gll, 7/G12, 7/H5, 
8/B4, 8/Dl, 8/D4, 8/E4, 8/G5, 8/H7, 9/B7, 9/E7, 
10/All, 10/A12, 10/Bl0, 10/El, 10/E2, 10/F2, 
10/Hl, 10/Hll, 11/Bl0, 11/B12, ll/C7, 11/Fl0. 
7/D6, 7/H7, 9/Bll, 10/A3, 10/A5, 10/B12, 10/Cl, 
IO/CS, 10/C8, 10/D7. 
general, large subtracted clones showed lower intensities following hybridisation with 
subtracted and unsubtracted probes (Fig 7.3). Hybridisation results shown are from one 
of five membranes dotted with large subtracted cDNA clones. Most large subtracted 
clones selected for sequencing were given a ranking of either A (eg. C4) or B (eg. Hl2). 
A total of 61 large subtracted clones or 12.7% of screened large clones, were selected 
for sequencing (Table 7.2). 
7 .2.3 Analysis of differentially expressed sequences. 
Selected small and large subtracted clones were sequenced as described in Section 
2.12.4. All attempts were successful except for three large subtracted clones and one 
small subtracted clone. Subtracted sequences were analysed to determine whether they 
represented known or potentially novel genes. They were submitted to several online 
databases to locate homologous sequences, as described in Section 2.12.5. It was 
expected that a majority of subtracted clones would show homology with known genes 
and/or other cDNA clones within databases. The strategy employed for analysing 
sequences was as follows. Sequences were first submitted to the NCBI nr database to 
search for similarities with known genes and full-length cDNA clones. Distinct 
sequences with no significant homology were then submitted to the NCBI EST database 
to search for homology with known ESTs and other unidentified clones. Domain 
searches were then performed on translated clone sequences to identify any domains 
that could identify the type of protein encoded by the sequence . . 
The annotation of cloned sequences of interest was based on guidelines outlined by the 
RIKEN Genome Exploitation Research Group Phase II and the Fantom Consortium 
(Kawai et al., 2001). The RIKEN group has contributed to the collection, sequencing 
and functional annotation of full-length mouse cDNAs. Annotation of clones with 
significant similarity to known sequences was guided by descriptors of the database 
sequence most similar to the subtracted clone. Priority was given to database sequence 
descriptors from which functional information could be inferred, even if sequences with 
less informative descriptions were more similar. For example, subtracted clones were 
given descriptions of known genes, even if they showed slightly higher similarity with a 
cDNA clone. 
Subtracted sequences were considered an identical match to database sequences if there 
was >90% of base pairs n1atching over the entire length of the subtracted sequence, so 
giving an E-value of <e-100. Most subtracted sequences contained a few unidentified 
('N') bases and so 100% identical matches were not always possible. Mouse genes 
identical to subtracted clones were the first choice for annotation. For subtracted clones 
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Figure 7.3. Differential screening of large subtracted clones using Southern dot blots. Large subtracted clones were dotted on to nylon 
membranes and hybridised with 32P-labelled (A) large subtracted cDNA probe, (B) small subtracted cDNA probe, (C) large unsubtracted cDNA 
probe or (D) sn1all unsubtracted cDNA probe. 32P-labelling of 1ne1nbranes was detected by exposure to x-ray film for 72 hours. 
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with non-identical similarity to known genes, annotation involved the use of prefix 
terms. These included 'similar to', 'homologue to' or 'related to', to indicate that 
sequence description was derived from non-identical mouse, non-mouse mammal, or 
non-mammal genes, respectively. Subtracted sequences with no significant similarity to 
known sequences, but with matches to ESTs were refen·ed to as 'unclassifiable 
transcript'. Clones with no EST matches were named 'unclassifiable' (Kawai et al., 
2001). 
7 .2.4 Identity of differentially expressed genes in small L TC-DC. 
Small subtracted clones were found to match 18 known genes and 3 RIKEN full-length 
clones that appear to be homologues of known rat genes (Table 7 .3 ). Information on 
these genes has been summarised for reference in Table 7 .4. In Table 7 .3, thymosin ~-4 
is identified as the most common transcript found in the small subtracted clone set. Ten 
clones were found to match this sequence. Multiple biological effects have been 
associated with thymosin ~-4. However, it is best documented for its role in the 
organisation of the cytoskeleton (Huff et al., 2001). It prevents the polymerisation of 
actin filaments but supplies a pool of actin monomers when the cell needs filaments 
(Safer et al., 1990). It plays an important role in cell morphological change and 
migration. 
Small L TC-DC were found to express a number of genes related to the organisation of 
the cytoskeleton. Transcripts for the cytoskeletal proteins ~-actin and M-cx-2-tubulin 
were isolated. M-cx-2-tubulin is most highly expressed in the spleen, thymus and 
immature brain (Lewis et al., 1985). The balancing of monomeric, dimeric and 
polymeric forms of actin and tubulin have been found to underly changes in dendrite 
shape in neurons (van Rossum and Hanisch, 1999). Actin is associated with the 
formation of dendritic processes in Langerhans cells (Ross et al., 1998) and follicular 
DC have been found to express both actin and tubulin (Tsunoda et al., 1990). In 
addition to thymosin ~-4, two other transcripts were isolated that encode proteins 
capable of altering the cytoskeletal proteins of small LTC-DC. Firstly, Cste chaperonin 
containing TCP (CTT) is known to have broad recognition capabilities but appears to 
be involved chiefly in the folding of actin and tubulin (Gao et al., 1992; Gao et al., 
1993; Kubota et al., 1995). Secondly, heat shock protein 90 (Hsp90) is a molecular 
chaperone that assists the conformational n1aturation of many specific targets (Buchner, 
1999). It interacts with cytoskeletal proteins like tubulin and can inhibit polymerisation 
like thymosin ~-4 (Garnier et al., 1998). Eplin is a novel cytoskeletal protein that 
localises to filamentous actin and suppresses cell proliferation when over-expressed 
(Maul and Chang, 1999). The expression of cytoskeletal proteins and proteins capable 
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Table 7 .3 Differentially expressed genes in small L TC-DC. 
Clone frequency Descri~tio n Access ion numbera % identityb E -va lu ec 
10 thymosin S-4 Xl6053 .l 96 0.0 
5 homologue to human glycoprotein hormone a-subunit }00152.1 98 e-101 
4 homologue to human pregnancy-specific S-1-glycoprotein 1 M93705 .l 98 0 .0 
3 Atp6f, lysosomal ATPase H+ transporter AB060655 .1 98 e-153 
2 fen-jtin light chain }04716.1 97 0.0 
2 homologue to human pregnancy-specific S-1-glycoprotein 4 M94891.l 99 0.0 
2 epithelial protein lost in neoplasm-a (Eplin) AF307844.l 100 e-162 
2 peroxisomal acyl-CoA oxidase AF006688.l 89, 96 e-158 
2 ribosomal protein S 12 Xl5962. l 98 e-128 
2 cytochrome C oxidase subunit II AF378830.l 95 0.0 
1 lysosomal membrane protein (LAMP-I) M25244.l 95 0.0 
1 cystatin C (Cst3) M59470.l 99 e-174 
1 M-a-2-tu bulin M28727.l 99 e-166 
1 S-actin X03672.l 95 e-63 
1 Cste chaperonin containing TCP (CTT) £ subunit Z3155.1 98 0.0 
l PCTAIRE-3 X69026.1 100 e-101 
1 thioredoxin interacting factor (Vdupl) AF282826 . l 99 0 .0 
1 homologue to human heat shock protein 90 (Hsp90) D87666.1 97 0.0 
Table 7.3 Differentially expressed genes in small LTC-DC (continued). 
Clone frequency 
2 
1 
1 
2 
1 
1 
1 
1 
7 
3 
Description 
RIK.EN clone 2700056El9, homologue to rat Fl-ATPase E subunit 
RIKEN clone 2700049122, homologue to rat ribosomal phosphoprotein 2 
RIK.EN clone 1810040M08, homologue to rat ATP synthase subunit c, P2 
precursor 
similar to ribosomal protein LS 
homologue to human putative zinc finger protein (C5orD) 
similar to fibroblast growth factor-2 interacting factor (FIF or FTl) 
similar to IMP dehydrogenase 
similar to RIK.EN clone 2410015Al5 
unclassifiable tran sc1ipt 
unclassifiable 
Accession number 
AK012444.l 
AK012402.l 
NM026468.l 
BC005790.l 
XM033575.l 
Z67963.l 
M33934.1 
AK010484.l 
a Database identification code for gene entry, assigned by each database, eg. Genbank, EMEL, DDBJ or PDB. 
b Percent identity is the extent to which two nucleotide sequences are invariant. Percentage is calculated by BLAST. 
% identity 
99 
99 
98 
85 
89 
81 
90 
98 
E-value 
0.0 
e-178 
0.0 
e-59 
3e-81 
4e-10 
9e-48 
e-151 
c Expectation (E)-value represents the number of different alignments with scores equivalent to or better than the alignment in question, and which would be expected to occur 
in the database by chance alone. E-value is generated by BLAST and is a convenient way to create a significance threshold for reporting results. The lower the E-value, the 
more significant the match . 
Table 7 .4 Summary description of gene products encoded by selected small L TC-DC clones. 
Gene product 
Secreted 
glycoprotein hormone ex-subunit 
Cytoplasmic 
thymosin 0-4 
pregnancy-specific 0-1-glycoprotei n 1 
Atp6f 
Ferritin, light chain 
pregnancy-specific 0-glycoprotein 4 
epithelial protein lost in neoplasm 
peroxisomal acyl-CoA oxidase 
ribosomal protein S 12 
cytochrome C oxidase subunit II 
lysosomal membrane protein (LAMP-1) 
cystatin C 
M-ex-2-tubulin 
0-actin 
Cste chaperonin containing TCP-1 (CTT), 
E subunit 
Description 
Common ex-subunit of the 4 glycoprotein hormones (chorionic gonadotropin, luteinizing hormone, follicle stimulating 
hormone, thyroid stimulating hormone) . A free ex-subunit is also produced by a variety of tumours and tumour-derived cell lines. 
Main intracellular G-actin sequestering peptide. Prevents polymerisation of actin filaments (F-actin) but supplies a pool of actin 
monomers when the cell needs filaments. Involved in cell morphological change. 
Glycoprotein that has been reported as an immunomodulator of the innate immune system. Can induce secretion of IL-10, IL-6 
and TGF-0 in monocytes. Expressed in haemopoietic cells (Wu et al., 1993)3. 
Proteolipid localised to early endosomes. Acidifies the organellar lumen by transporting protons across the membrane. 
Metalloprotein comprised of heavy and light subunits. Major binder of non-heme iron in the cytoplasm and so keeps unused 
intracellular iron in a soluble and relatively safe form. 
One of 11 closely related pregnancy-specific glycoproteins. Expressed in haemopoietic cells (Wu et al., 1993) . 
Novel cytoskeletal protein of two isoforms ( ex and 0). Localises to filamentous actin and suppresses cell proliferation when over-
expressed. 
First enzyme of the fatty acid 0-oxidation pathway in peroxisomes. Involved in lipid metabolism (Nohammer et al., 2000). 
Associated with mitochondria. Involved in some aspect of protein chain elongation (Zengel et al ., 1977). 
One subunit of cytochrome C oxidase that catalyses the reduction of molecular oxygen to water and uses the free energy change from this reaction to pump protons across the membrane (Iwata, 1998, Abramson et al., 2001). 
Colocalises with MHC Class II compartments. 
Endogenous inhibitor of cathepsin S. Upregulation of cystatin C leads to inefficient Ii chain cleavage and transport of MHC II:Ii 
chain complexes to lysosomes for degradation. 
Cytoskeletal protein. The balancing of monomeric, dimeric and polymeric forms of tubulin may underly changes in dendrite 
shape in neurons. 
. Cytoskeletal protein. Actin is associated with the formation of dendritic processes in Langerhans cells. 
Chaperonin composed of 8 subunit species. Has broad recognition capabilities but appears to be involved chiefly in the folding 
of actin and tubulin. 
Table 7.4 Summary description of gene products encoded by selected small LTC-DC clones (continued). 
Gene product 
Cytoplasmic (continued) 
PCTAIRE-3 
thioredoxin interacting factor (Vdupl) 
heat shock protein 90 (Hsp90) 
ribosomal phosphoprotein 2 
ATP synthase subunit c, P2 
Fl-ATPase, £ subunit 
ribosomal protein LS 
IMP dehydrogenase 
Nuclear 
Description 
Putative serine/threonine-specific protein kinase. Member of a novel subfamily of cdc2/CDC28-related protein kinases that 
function during cell division and differentiation (Okuda et al., 1992). 
Vitamin D3 up-regulated protein 1 (Vdupl) is a regulatory protein of thioredoxin. Vdupl functions as an oxidative stress 
mediator by inhibiting thioredoxin activity (Junn et al., 2000). 
Molecular chaperone that assists the conformational maturation of specific targets including several protein kinases, 
transcriptional regulators and polymerases. Can also interact with cytoskeletal proteins, it binds tubulin and inhibits 
polymerisation. Also plays a role in the transport of antigenic peptides. 
Role in protein synthesis. Interaction between the phophorylated protein and eukaryotic elongation factor 2 (V ard et al., 1997). 
F 1F0-ATP synthase is the main source of cellular ATP. Subunit c is part of the F0-ATPase which is involved in proton 
translocation (Rastogi and Girvin, 1999). Subunit c encoded by genes Pl and P2, only P2 is expressed constitutively (Andersson 
et al., 1997). 
£ subunit is positioned in the stem region connecting F 1 to F0 and possibly functions in the regulation of the ATP synthase (Gabellieri et al., 1997, Solaini et al., 1997). 
Part of the 60S ribosomal subunit. Binds specifically to and transports SS rRNA. Involved in de nova ribosome synthesis and 
may be involved in other nucleocytoplasmic trafficking (Allison et al., 1991; Rosorius et al., 2000). 
Enzyme that catalyses the NAD-dependent conversion of iosine monophosphate (IMP) to xanthosine monophosphate (XMP) as 
the first committed step in GMP biosynthesis de nova (Tiedeman and Smith, 1991 , Senda et al., 1995). 
fibroblast growth factor-2 interacting factor Nuclear putative anti-apoptotic factor that interacts with fibroblast growth factor 2 (Van den Berghe et al., 2000). 
a References for gene function not cited in the main body of text are cited within the table. 
of changing their form in small LTC-DC suggests that small cells are in a phase of 
morphological change. This is consistent with experiments involving small cell 
develop1nent in transfer assays on to stroma where small LTC-DC increase in size and 
develop dendrites as they develop into large LTC-DC (Section 5.2.1). 
Recently it has been suggested that Hsp90 is also involved with the chaperoning of 
antigenic peptides to MHC Class I and to the cell surface where they can be taken up by 
su1Tounding antigen presenting cells (Li et al., 2002). Small LTC-DC express a number 
of transcripts encoding proteins that are integral to DC antigen processing and 
presenting function. In addition to Hsp90, small LTC-DC produce transcripts for 
LAMP-1, which colocalises with lysosomes (Chen et al., 1985) and MHC Class II 
compartments (Calafat et al., 1994; Kleijmeer et al., 1995; Sallusto et al., 1995) as well 
as Atp6f, a proteolipid that acidifies early endosomes (Sun-Wada et al., 2001). Small 
LTC-DC also specifically express transcripts for cystatin C, an inhibitor of cathepsin S. 
The upregulation of cystatin C leads to inefficient Ii chain cleavage resulting in 
transport of MHC Class II:Ii chain complexes to lysosomes rather than the plasma 
membrane (Pierre and Mellman, 1998). This may contribute to the lack of MHC Class 
II seen on the surface of small LTC-DC (Section 4.2.2). 
Another transcript of immunological significance encodes a homologue to human 
pregnancy-specific ~-1-glycoprotein 1. Four clones were found to be homologous to 
this gene which encodes a protein implicated as an immunomodulator of the innate 
immune system. It can induce secretion of IL-10, IL-6 and TGF-~ in monocytes 
(Snyder et al., 2001). Five clones were also identified which matched human 
glycoprotein hormone a-subunit. This protein is the common a-subunit of the 4 
glycoprotein hormones, chorionic gonadotropin, luteinizing hormone, follicle 
stimulating hormone and thyroid stimulating hormone (Fiddes and Goodman, 1981). 
However, a free a-subunit is also produced by a variety of tumours and tumour-derived 
cell lines. This may be the case in small LTC-DC, since none of the ~-subunit 
transcripts were isolated. A role for this protein in small LTC-DC function is unknown. 
A nu1nber of ribosomal proteins were represented amongst clones unique to small L TC-
DC. Clones were found to match ribosomal phosphoprotein 2 and to be similar to 
ribosomal protein LS. The transcription of genes producing ribosomal proteins 
indicates high level protein synthesis in small L TC-DC, perhaps in preparation for 
differentiation into large L TC-DC. Two clones were also found to match rat ribosomal 
protein S12 associated with mitochondria. A number of mitochondrial transcripts were 
isolated from sn1all LTC-DC. These included cytochrome C oxidase subunit II, a 
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homologue to rat ATP synthase subunit c P2 and a homologue to rat Fl-ATPase £-
subunit. These proteins are involved in the generation of ATP within mitochondria 
(Boyer, 1997; Taanman, 1997). Specific expression of these transcripts in small LTC-
DC could indicate the high energy needs of differentiating cells. Some of these 
transcripts are derived from mitochondrial genes and encode mitochondrial proteins, so 
should remain associated with the mitochondria (Lodish et al., 1995). These transcripts 
were isolated when the guanidine isothiocyanate and phenol dissolved cellular 
components during RNA isolation (Section 2.5.1), allowing mitochondrial sequences to 
escape. A small percentage of mitochondrial genomic DNA was also extracted and has 
been treated as a contaminant. Similar isolation of a small number of genomic and 
mitochondrial sequences has been noted in studies performed by others (Lian et al., 
2001). These sequences have been eliminated from the analysis and are not included in 
Tables 7.3 and 7.4. Most of these mitochondrial sequences were given a Cranking, 
indicating that lower levels were isolated from large L TC-DC. One transcript was also 
identified amongst the large LTC-DC subtracted clones. 
Other differentially expressed transcripts isolated from small LTC-DC encode ferritin 
light chain, peroxisomal acyl-CoA oxidase, PCTAIRE-3, thioredoxin interacting 
factor (Vdupl) and a homologue to human pregnancy specific ~-1-glycoprotein 4. 
Seven different small subtracted clones represent unclassifiable transcripts. They 
showed no similarity with known sequences, but are homologous to known ESTs. Upon 
translation, none of these sequences were found to contain identifiable peptide domains. 
A further 3 clones showed no similarity with known genes or ESTs (Table 7 .3). 
Sequence and domain searches have not identified these transcripts. They may represent 
novel proteins important in the development of small L TC-DC to large L TC-DC. 
7 .2.5 Identity of differentially expressed genes in large L TC-DC. 
Large subtracted clones matched 12 known genes and 5 RIKEN full-length clones. In 
addition, 4 large subtracted clones were found to show similarity to sequences in the 
database. These are listed in Table 7 .5. A summary description of gene products 
differentially expressed by large LTC-DC is presented in Table 7.6. Large LTC-DC 
express a number of transcripts of immunological significance, including the secreted 
proteins lysozyme and osteopontin. Six clones matched lysozyme, an enzyme that 
degrades the cell wall of bacteria (Biggar and Sturgess, 1977; Janeway and Travers, 
1997). Two clones 1natched osteopontin, a phosphoprotein existing in different forms 
that can enhance Thl responses, stimulate B cells and induce chemotaxis in T cells and 
macrophages (Ashkar et al., 2000; Lampe et al., 1991; O'Regan et al., 2000). Alternate 
splicing and post-translational modification (phosphorylation and glycosylation) 
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Table 7.5 Differentially expressed genes in large LTC-DC. 
Clone frequency Descrietion Accession numbera % identityb E- va luec 
6 lysozyme BC002069.1 99 0.0 
2 osteopontin 104806.1 95 0.0 
1 CD86 U39392.1 93 e-137 
1 MIP-lcx receptor U28404.1 97 0.0 
1 gp49B U05265.l 95 0.0 
1 lymphoid enhancer binding factor D16503.1 97 0.0 
1 transcription factor S-II M18209.1 97 0.0 
1 transgolgi network protein 2 (TGN38B) D50032.l 96 0.0 
1 cysteine/gl utamate transporter xCT AB022345.1 96 0.0 
1 complement protein H M12660.1 96 0.0 
1 TGF-B-inducible protein (TSC-36) M91380.1 96 0.0 
1 regulator of G-protein signaling 18 (Rgs 18) AF302685.l 92 e-145 
4 clone IMAGE:3484424, similar to cytochrome b-245 , B polypeptide BC003910.1 98 0.0 
2 clone MGC:7708 IMAGE:3497769, similar to calnexin BC12408.1 95 0.0 
1 RIKEN clone: 1110005L02 AK003474.1 96 0.0 
1 RIKEN clone 4432405K22 AK014477.1 96 e- 119 
1 RIKEN clone 6720435121 AK020121.1 98 0.0 
Table 7.5 Differentially expressed genes in large LTC-DC (continued). 
Clone frequency 
1 
1 
1 
1 
25 
] 
Description 
homologue to rat unr protein 
similar to mou se chromosome lq21-23 clone 
similar to clone MGC:7590 IMAGE:2493738, similar to RIK.EN cDNA 
4930579Al 1 gene 
similar to sequences contai ning bromodomain eg. chromatin remodelling 
factor WCRFl 80 
unclassifiable transcript (16 different) 
unclassifiable 
a, b, c; see legend to Table 7.3. 
Accession number 
X52311.1 
AC008 100.71 
BC00401 3.1 
% identity 
81 
91 
88 
81-88 
E-value 
6e-63 
0.0 
7e-28 
e-36 
Table 7.6 Summary description of gene products encoded by selected large LTC-DC clones. 
Gene product 
Secreted 
Osteopontin 
Cell Surface 
CD86 
MIP-1 a receptor 
gp49B 
Cystine/glutamate transporter xCT 
Complement protein H 
TGF-B-inducible protein 
Cytoplasmic 
Lysozyme 
Transgolgi nework protein 2 (TGN38B) 
Cytochrome b-245, B polypeptide 
Calnexin 
Regulator of G-protein signalling 18 (Rgsl8) 
Description 
Secreted phosphoprotein that exists in functionally distinct forms. Can enhance Th 1 responses, enhance generation of Ig or 
proliferation of B cells and induces cellular chemotaxis of T cells and macrophages. 
Cell surface costimulatory molecule. 
Cell surface receptor. It's ligand MIP-la is an inflammatory chemokine that is chemotactic for many haemopoietic cell types. 
Transmembrane glycoprotein containing a cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM). Functions as 
inhibitory molecule, with possible regulatory role in innate immune system. 
Transmembrane protein. One of two proteins that form xc-, a transport system found in the plasma membrane of cultured 
mammalian cells that is an exchange agency for anionic amino acids. Has high specificity for transp011ing cystine in exhange 
for glutamate. 
High affinity for C3b molecules deposited on self and so protects self against activation of the alternative complement 
pathway (Jokiranta et al., 2000t. 
Extracellular glycoprotein that may be secreted. Upregulated by TGF-B and down-regulated in tumour cells. Suggests that it 
has an antiproliferative function and may inhibit some growth factor-like molecule. 
Enzyme that degrades the cell wall of some Gram-positive bacteria. 
Type I integral membrane protein localised to the trans-golgi network (TGN), though it constitutively cycles between the 
TGN and plasma membrane. Required for the budding of exocytic transp011 vesicles from the TGN (Ladinsky and Howell, 
1992; Ghosh et al., 1998; Kasai et al., 1995). 
Glycoprotein that plays a fundamental role in the NADPH-dependent generation of superoxide. 
Membrane bound chaperone protein that retains MHC class I in a partially folded state in the endoplasmic reticulum. Also 
associates with partially folded MHC class II, TCR and Ig and so also has a central role in assembly of these molecules . 
Enhances GTPase activity of Gal and attenuates signals from Gq-coupled receptors, regulating G-protein signaling. 
Table 7.6 Summary description of gene products encoded by selected large LTC-DC clones (continued). 
Gene product 
Nuclear 
Lymphoid enhancer binding factor 
Transcription factor S-II 
Unr protein 
Description 
Nuclear protein that binds a specific nucleotide sequence of the TCR a enhancer and bends the DNA helix. Required for 
TCR a enhancer function, participating in lymphocyte gene expression and differentiation. 
Transcription factor of RNA polymerase II, important in nuclear RNA synthesis. 
Consists of multiple repeats homologous to the Cold Shock Domain, a motif common to some nucleic acid binding proteins. 
High affinity for single-stranded RNA and DNA without regard for nucleic acid sequence. Could be involved in some aspect of 
mRN A metabolism. 
a References for gene function not cited in the main body of text are cited within the table. 
generate functionally distinct fonns of osteopontin. The sequence of clones gave no 
indication of the form of osteopontin represented in large LTC-DC. This would require 
the isolation and analysis of a full-length clone. 
Large LTC-DC express transcripts encoding a number of immunologically important 
cell surface proteips. One clone matched the costimulatory molecule CD86, supporting 
F ACS data showing that most large L TC-DC express higher levels of this marker in 
comparison with small LTC-DC (Section 4.2.2). A clone encoding macrophage 
inflammatory protein (MIP)-lcx receptor was also isolated. The ligand for this 
receptor is MIP-1 ex, an inflammatory chemokine, chemotactic for many haemopoietic 
cell types including immature monocyte-derived DC (Caux et al., 2000; Sato, K. et al., 
1999). There are also reports that MIP-lcx receptor can specifically regulate the 
interaction of T cells and DC (Sato, K. et al., 1999). Large L TC-DC also showed 
specific expression of gp49B, a transmembrane glycoprotein, which contains an 
immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic region (Katz et al., 
1996) and functions as an inhibitory molecule. It has been suggested that gp49B plays a 
regulatory role in innate immunity. For example, co-ligation of FcsRI and gp49B on the 
surface of mast cells inhibits granule release (Katz et al., 1996), and co-cross-linking of 
gp49B and NKl .1 receptor leads to dose-dependent downregulation of GM-CSP and 
IFN-y in NK cells (Wang et al., 2000). 
Large LTC-DC also express transcripts that show similarity to immunologically 
significant cellular proteins. Four clones matched the IMAGE:3484424 clone which is 
similar to cytochrome b-245 ~-polypeptide and two of these isolated clones were 
found to contain an aldo/keto reductase domain. Cytochrome b-245 is a major 
component of the NADPH-dependent super-oxide generating system (Bellavite et al., 
1986). Generation of an oxidative burst is one way that phagocytic cells, including 
neutrophils, eosinophils and macrophages, can kill microorganisms (Thrasher et al., 
1994). Two clones matched the MGC:7708 IMAGE:347769 clone, which is similar to 
calnexin. Calnexin is a chaperone protein that retains MHC Class I in a partially folded 
state in the endoplasmic reticulum, contributing to the protection and assembly of MHC 
Class I and preventing the transportation of incomplete MHC Class I complexes to the 
cell membrane (Degen and Williams, 1991; Diedrich et al., 2001; Jackson et al., 1994). 
Calnexin can also associate with partially folded MHC class II molecules and TCR, and 
has a central role in the assembly of these molecules (Anderson and Cresswell, 1994; 
Gardner et al., 2000). 
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Large LTC-DC express transcripts for regulatory molecules such as TGF-~-inducible 
protein (TSC-36) which has anti-proliferative function (Sumitomo et al., 2000) and 
Rgs18 which is a novel regulator of G-protein signalling (Park et al., 2001). They also 
express a number of transcripts encoding proteins which interact with DNA to regulate 
transcription. These include lymphoid enhancer binding factor (Giese et al., 1995; 
Travis et al., 1991), transcription factor S-11 (Reines et al., 1989; Ueno et al., 1979) 
and an unclassified transcript that shows similarity to proteins containing a 
bromodomain (Table 7 .6). These domains characterise proteins involved in chromatin-
dependent regulation of transcription (J eanmougin et al., 1997). Other differentially 
expressed transcripts in large L TC-DC encode transgolgi network protein 2, 
comple1nent protein Hand cystine/glutamate transporter xCT. Cystine/glutamate 
transporters generate intracellular cysteine and are found in the plasma membrane of 
cultured mammalian cells (Sato, H. et al., 1999), including cultured monocyte-derived 
DC (Angelini et al., 2002). Once activated by LPS and TNF-cx, monocyte-derived DC 
have been shown to secrete cysteine and contribute to the generation of a reducing 
microenvironment required for T cell activation (Angelini et al., 2002). 
Twenty-five large subtracted clones represented sixteen different unclassifiable 
transcripts that could encode novel proteins. These sequences showed no similarity to 
known sequences. However they did share homology with known ESTs. Upon 
translation, one of these sequences was found to contain an ATP synthase (C/ AC39) 
subunit domain. It also matched an EST clone that showed si1nilarity to mouse vacuolar 
ATP synthase subunit AC39. Four other identical clones were found to show some 
similarity with a RIKEN EST clone that was similar to vacuolar ATP synthase subunit 
D (V-ATPase AC39 subunit). However, these did not contain the ATP synthase 
domain. It is possible that these clones represent different fragments of the same gene. 
No additional information on the identity or function of other unclassifiable transcripts 
could be collected through domain searches. One additional transcript was referred to as 
unclassifiable since it showed no similarity to known sequences or ESTs. 
7.3 DISCUSSION 
Small and large subtracted cDNA libraries were screened to isolate unique cDNA 
clones and to identify genes specifically expressed in L TC-DC subsets. It was 
anticipated that this would identify genes related to LTC-DC function and development. 
The subtractive procedure successfully enriched for differentially expressed sequences. 
Sequencing of isolated clones revealed no overlap in the populations of genes isolated 
from differentially screened small and large subtracted libraries. Together with 
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demonstration of successful subtractive hybridisation in Chapter 6, sequence data 
obtained here confirms subtractive hybridisation and suppressive PCR combined with 
differential screening, can produce sets of genes uniquely expressed in either small or 
large LTC-DC. 
Differential screening yielded a total of 71 (14.8%) small and 61 (12.7%) large 
differentially expressed sequences from each of 480 randomly selected subtracted 
clones. The combined subtraction and screening procedures were lengthy and several 
operations required optimisation. Given the low number of differentially expressed 
genes isolated, it would appear that this technique is fairly inefficient. However, the 
level of common sequences remaining after subtraction is dependent on how closely 
related the tester and driver populations are (PCR Select Differential Screening Kit User 
Manual, Clontech Laboratories). It is known that there can be relatively more 
background gene expression detected in cases where few mRNA transcripts are 
differentially expressed between tester and driver. At least 85% of subtracted clones 
were not judged to be differentially expressed. This would be consistent with the close 
developmental relationship between small and large LTC-DC. However, while analysis 
of distantly related cell populations can lead to identification of more differentially 
expressed clones, fewer of these may relate to the specific functional differences of 
interest. 
The close relationship of s1nall and large LTC-DC is also supported by the limited range 
of known genes represented by subtracted clones. Many genes and full-length clones are 
represented more than once amongst selected clones. Overall, a total of 47 known genes 
and full-length clones match or are similar to small and large subtracted clones. Sixteen 
of these genes are represented more than once, and by 52 subtracted clones. This trend 
is again reflected amongst the large subtracted clones that are 'unclassifiable', where 16 
different sequences were represented amongst 25 clones. The frequency with which 
clones n1atch a particular gene is not an accurate reflection of gene expression levels 
within the tester population. This is due to the nature of the subtractive procedure, the 
equalisation of high and low abundance of single-stranded molecules during 
hybridisation (Section 2.7 .1) and the PCR amplification of cDNA (Section 2.5.3) and 
subtracted cDNA (Section 2.7 .2). However, certain genes occur 5 to 10 times in 
comparison with others that occur just once. These genes may be strongly represented 
in the subtracted library and probably commonly expressed in the subset of interest. 
Exa1nples of these genes include thymosin ~-4 which is represented by 10 small 
subtracted clones and lysozyme which is represented by 6 large subtracted clones. 
88 
Small LTC-DC which are thought to represent DC precursors are here characterised by 
sets of genes related to specific cell functions. Higher expression of two cytoskeletal 
proteins M-a-2-tubulin and ~-actin and proteins involved in the organisation of the 
cytoskeleton including thymosin-~-4 and Cste chaperonin containing TCP (CTT), all 
reflect morphological change in cells. This is consistent with small LTC-DC developing 
into large LTC-DC when transfe1Ted on to ST-X3 stroma. Small cells also have higher 
Hsp90 gene expression in comparison with large LTC-DC. Hsp90 is a chaperone 
involved in the folding of tubulin (Gamier et al., 1998) and the transport of antigenic 
peptides (Li et al., 2002). Clones related to a number of proteins involved in the 
regulation of MHC molecules and compartments, including cystatin C, Atp6f and 
LAMP-1 were also isolated. Increased expression of cystatin C could contribute to the 
lack of MHC Class II observed on the surface of small LTC-DC. Small LTC-DC also 
specifically expressed a number of ribosomal and mitochondrial transcripts which may 
reflect an increase in protein synthesis and energy production prior to differentiation. 
The profile of clones detected in small LTC-DC associate them with monocyte-derived 
DC. Some of the genes identified in small L TC-DC, like M-a-2-tubulin, ~-actin, 
thymosin ~-4 and cystatin C are expressed in immature monocyte-derived DC in higher 
levels than in LPS-activated monocyte-derived DC (Hashimoto et al., 1999; Hashimoto 
et al., 2000). Expression of the fe1Titin light chain transcript, encoding a subunit of the 
metalloprotein that binds non-heme iron in the cytoplasm (Theil, 1987), is also a feature 
of immature monocyte-derived DC (Hashimoto et al., 1999; Hashimoto et al., 2000; Le 
Naour et al., 2001). By contrast, the Hsp90 gene is expressed by monocyte-derived DC 
even after LPS activation (Hashimoto et al., 1999; Hashimoto et al., 2000). 
Consistent with functional capacity as antigen presenting cells (Section 4.2.4 ), large 
LTC-DC express transcripts encoding a range of immunologically functional proteins. 
These include the secreted molecules, lysozyme and osteopontin, the cell surface 
molecules, CD86, MIP-1 a receptor and gp49B and transcripts similar to calnexin and 
cytochrome b-245 ~-polypeptide. Transcripts for MIP-1 a receptor and osteopontin are 
known to be highly expressed in monocyte- and BM-derived DC and are downregulated 
when BM-derived DC are activated with LPS (Chen et al., 2002; Dietz et al., 2000; Le 
Naour et al., 2001). CD86 is detected on the cell surface of mature DC. While CD86 
gene expression is upregulated in 'immature' monocyte-derived DC in comparison with 
monocytes (Le N aour et al., 2001 ), expression is highest in response to stimuli like 
whole bacteria, virus (Huang et al., 2001) or LPS (Chen et al., 2002). Lysozyme is 
expressed strongly by macrophages (Cross et al., 1988; Klockars and Osserman, 1974; 
Klockars and Reitamo, 1975) and is downregulated in monocyte-derived DC in 
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comparison to monocytes (Le Naour et al., 2001). However, it has also been noted that 
transcript levels are higher in day 14 'mature' monocyte-derived DC than day 7 
'imrnature' monocyte-deri ved DC (Le N aour et al., 2001). This finding could mirror the 
comparison between small and large LTC-DC shown here. While this study shows that 
lysozyme is upregulated in large LTC-DC in comparison to small LTC-DC, it does not 
examine expression in relation to other haemopoietic cell types. 
Large L TC-DC were also characterised by the expression of transcripts for regulatory 
molecules such as Rgs 18 whose expression levels decrease with maturation (Park et al., 
2001), TGF-~-inducible protein (TSC-36), lymphoid enhancer binding factor and 
transcription factor S-II. Twenty five selected large clones were classified as 16 distinct 
unclassified transcripts. Functional information could not be gathered for most of these 
clones. However, 5 clones (2 different sequences) were found to have sequence or 
domains hon1ologous with a vacuolar ATP synthase (C/ AC39) subunit, and so they may 
encode part of the vacuolar ATP synthase AC39. Large LTC-DC also expressed an 
unclassified transcript with similarity to proteins containing a bromodomain and so may 
play a role in the regulation of LTC-DC gene expression. These unclassifiable 
transcripts and one additional unclassifiable clone may prove to be novel proteins 
involved in LTC-DC development and function, as well as the focus of further 
investigation. 
Gene expression identified in small and large L TC-DC suggests that LTC-DC resemble 
myeloid-like DC. In particular, numerous genes isolated during this study are highly 
expressed in monocyte-derived DC. However, it is important to consider that most 
published data has been obtained for monocyte-derived DC. It will be important to 
compare gene expression of LTC-DC with other DC subsets as they become available. 
Consistent with functional studies, gene expression in large L TC-DC identifies cells 
displaying properties of both immature and activated DC. 
Further investigation of novel sequences will involve Northern blot analysis to confirm 
differential expression of sequences. It will then be necessary to isolate full-length 
cDNA clones from a cDNA library of LTC-DC that has already been prepared (Le and 
O'Neill, unpublished data). This will allow protein prediction analysis, such as 
similarity, motif and domain searches, to be carried out on the entire sequence. To 
examine the expression profile of the selected genes, Northern blot analysis or real-time 
PCR will be carried out on a range of cell lines and ex vivo cells prepared under 
different conditions. Further tissue expression studies could involve labelled RNA or 
cDNA probes for in situ hybridisation of cryosections of tissue. Functional studies could 
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involve the blocking of gene function using anti-sense RNA and the production of 
recombinant protein and/or antibody. 
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CHAPTERS 
General Discussion 
8.1 THE LTC SYSTEM PRODUCES CDllc+CDllb+MHCII1°CD8cf DC. 
The non-adherent cell population of LTC comprises two major cell subsets of small and 
large LTC-DC. The aim of this study was to characterise the cells within each subset 
and to examine the developmental relationship between them. The interaction between 
L TC-DC and the supporting stromal monolayer was also investigated. This study 
reveals that the LTC system represents an in vitro model highly suitable for study of the 
development of DC from committed precursors. The small LTC-DC subset contains 
committed precursor cells and the large LTC-DC subset represents their progeny. Large 
LTC-DC are CDI lc+CDI lb+MHCII1°CD8cf cells and display many of the properties of 
immature DC. Precursor cells require direct cell-to-cell contact with stromal cells in 
order to develop into DC, whereas fully differentiated DC are dependent on unknown 
soluble stroma-derived factor(s) for survival. Subtracted cDNA libraries have been 
successfully generated from small and large LTC-DC. A number of genes relating to 
LTC-DC development and function have been identified. The LTC system provides an 
opportunity to study aspects of DC development in a controlled in vitro environment in 
the absence of exogenous cytokines. 
In preparation for this study, experiments were undertaken to assess and optimise the 
methods used to collect and sort LTC-DC. Cell cycle analysis and BrdU incorporation 
indicated that both small and large LTC-DC contain subpopulations of dividing cells. 
The 48 hour period following medium replacement was defined as the period of greatest 
proliferation of both small and large L TC-DC, indicating that the optimal time to collect 
non-adherent cells was at 48 hours post medium change. In addition, cells collected at 
this time have maxin1um viability since the number of apoptotic and necrotic cells 
remains consistent between one and three days post medium change. Distinct 
populations of apoptotic and dead cells exist in L TC. These appear to arise from 
turnover of large LTC-DC and from cells of the small LTC-DC subset which fail to 
receive signals for differentiation. High levels of apoptosis within the non-adherent 
small L TC-DC subset result in collection of a low percentage of viable small LTC-DC. 
The highest possible viability amongst sn1all L TC-DC was achieved by optimisation of 
FACS-sorting gates and the careful selection of medium for FACS-sorting and 
collection. Isolation by F ACS-sorting of populations of small and large LTC-DC of 85-
90% viability has been achieved. 
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The two major cell subsets within the non-adherent cell population of established LTC 
differ in size and complexity. The Forward Scatter and Side Scatter profile of small and 
large L TC-DC has remained constant over time and across many L TC established fro1n 
different individual mice at different time points. The constant presence of these two 
subsets within L TC confirms that they are integral to the structure and continuation of 
the LTC system. Previous studies have also noted that stable productive cultures are 
associated with the maintenance of a small number of small-sized cells above the 
stromal cell layer (Ni and O'Neill, 1998). These observations suggest that small LTC-
DC in particular are important for the continuous generation of DC. 
Small and large L TC-DC subsets were examined for expression of multiple DC 
markers. Prior to this study it was difficult to quantitate expression of cell surface 
markers on L TC-DC because of the high autofluorescence associated with these large, 
in vitro cultured cells. Two-colour FACS analysis became possible because of the 
development of a quenching method to reduce background autofluorescence (Ni and 
O'Neill, 2000). The small LTC-DC subset is a heterogeneous population of cells and 
many cells do not resemble typical DC. Small L TC-DC are characterised by expression 
of CDI lb, 33Dl, MHC Class I and CD80 but do not show strong expression of other 
DC markers including CD 11 c, CD86 and MHC Class II. Small L TC-DC appear to be 
relatively undifferentiated since they are small, rounded cells that lack dendrites. Most 
also lack DC functional capacity. By contrast, large LTC-DC display dendritic 
projections and possess numerous cytoplasmic mitochondria and endosomes. They 
uniformly express DC markers including CDI le, CDI lb, 33Dl, CD86, CD80, MHC 
Class I with lower levels of CD205. They show low, but homogeneous expression of 
MHC Class II. In addition to these markers, large LTC-DC express F4/80 and lack 
CD8a, aligning them more closely with CD8a- myeloid-like DC. The uniform 
expression of DC markers by large LTC-DC, in combination with their dendritic 
1norphology and stimulatory capacity in an MLR, confirms that the L TC produce a 
homogeneous population of CD l lc+CD 11 b+MHCII1°CD8a- DC. 
Recent studies have described at least three phenotypically distinct subsets of DC in 
murine spleen (Vremec et al., 2000), including CD8a+ lymphoid-like DC and CD8a-
myeloid-like DC. However, the LTC system appears to support the development of only 
one type of DC that more closely resembles the CD8a- myeloid-like DC. It remains 
unclear why LTC supports production of just one type of DC. The long-term nature of 
LTC suggests that LTC-DC arise from spleen-derived long-term self-renewing 
progenitors that are likely to be primitive HSC. Local environmental signals, both 
soluble and cellular, may then play an important role in shaping the development and 
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phenotype of LTC-DC. In vivo, DC are localised to different regions of the spleen 
(Crowley et al., 1989; Leenen et al., 1998; Pulendran et al., 1997) and so reside in 
specific microenvironments comprised of different stromal cells (Ito et al., 1997), 
immune cells and cytokines. LTC-DC are generated in contact with a spleen-derived 
stromal cell monolayer which has remained consistent over time. The development of 
cells within the uniform stromal environment of LTC may induce a homogeneous 
population of CD 11 c+CD 11 b+MHCII1°CD8cx- DC. The results presented in this study 
highlight the importance of stroma in the development of LTC-DC and previous work 
has demonstrated the strong selective capacity that LTC stroma has over progenitors. 
When BM cells are transferred on to LTC stroma only non-adherent cells resembling 
LTC-DC are generated after the other cell types die (Ni and O'Neill, 1999). 
8.2 LARGE LTC-DC AS IMMATURE DC. 
Large LTC-DC most closely resemble immature DC. They display short dendritic 
projections associated with immature DC and a subset of large cells still has 
proliferative capacity. Large LTC-DC express markers associated with immature DC 
such as CDl 17, CD16/32 (FcyII/IIIR) together with low levels of MHC Class II. They 
also lack expression of CD40. Large LTC-DC are highly endocytic cells, and this high 
endocytic capacity may contribute to low MHC Class II expression through endocytosis 
of MHC Class II from the cell surface (Mellman and Steinman, 2001). Antigen is taken 
up rapidly by large LTC-DC and is then retained for at least 24hours. This is consistent 
with reports that show that in contrast to macrophages that rapidly degrade internalised 
proteins, DC retain antigen for long periods and then use it to form MHC:peptide 
complexes (Turley et al., 2000). However, large LTC-DC do express the costimulatory 
1nolecules CD80 and CD86 and are also potent stimulators of both allogeneic and 
syngeneic spleen responders in MLR. These are properties reflecting mature or 
activated DC. 
However, large LTC-DC do not appear to represent mature or activated DC. This is 
supported by evidence for responsiveness of large LTC-DC to LPS. Following exposure 
to LPS, large LTC-DC show increased levels of CD86, MHC Class I and CD44 
expression, potentially enhancing their capacity to stimulate T cells, to present antigen 
and to migrate, respectively. LPS-activated LTC cells demonstrate increased capacity to 
stimulate allogeneic spleen responders in an MLR. They also upregulate nuclear 
binding RelB (O'Neill, manuscript in preparation), a property associated with DC 
activation (Neumann et al., 2000; Pettit et al., 1997). Results presented here confirm 
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that large LTC-DC can be activated by LPS, demonstrating that they are not mature or 
activated DC in their steady state within LTC. 
LPS does not induce full activation in LTC-DC since their high endocytic capacity and 
surface levels of MHC Class II, CD80 and CD40 do not vary significantly following 
exposure. Reasons for this are unclear at this stage. LPS may be inducing a state of 
activation in L TC-DC that enhances Th 1 type immune responses, consistent with the 
upregulation in MHC Class I and CD86. Alternatively, LTC-DC may express 
insufficient levels of the receptor for LPS, TLR-4, and be unable to fully respond to 
LPS. It was recently shown that human DC subsets respond to different immune stimuli 
as a result of differential expression of TLR (Kadowaki et al., 2001). However, to date, 
LPS has been found to induce the greatest activation response in LTC-DC since cells 
are refractory to stimulation with TNF-a, IFN-y, CD40L or anti-CD40 monoclonal 
antibody (Ni and Quah, unpublished data (O'Neill lab)). LTC-DC may represent cells 
that retain a stable phenotype in response to immune stimuli which could also be a 
result of the stability of long-term in vitro culture. 
The potent endocytic and stimulatory capacity of large L TC-DC indicate that they are 
immunologically functional DC. Results of in vitro functional assays are supported by 
differential gene expression studies. Large LTC-DC have been shown to upregulate the 
expression of several transcripts encoding a range of immunologically functional 
proteins. These include the secreted molecule osteopontin and the cell surface 
n1olecules, CD86, MIP-1 a receptor and gp49B. Higher CD86 gene expression in large 
LTC-DC is consistent with surface expression by FACS analysis. Expression of MIP-
1 a receptor may allow L TC-DC to migrate in response to inflammatory stimuli. 
Secretion of osteopontin could act to enhance Th 1 responses, enhance generation of 
immunoglobulins and proliferation of B cells or induce cellular chemotaxis of T cells 
and macrophages (O'Regan et al., 2000). To elucidate the function of osteopontin in 
L TC-DC, it will be necessary to identify isoforms expressed. This will require isolation 
of full-length cDNA. LTC-DC also express a transcript that encodes a molecule similar 
to calnexin which may play a role in the assembly of proteins for antigen presentation. 
Expression of transcripts like lysozyme and similar to cytochrome b-245 ~-polypeptide, 
suggest that large LTC-DC possess microbicidal capabilities. Large LTC-DC 
specifically express genes that have been observed previously in immature and 
activated, BM- and monocyte-derived DC (Chen et al., 2002; Dietz et al., 2000; Huang 
et al., 2001; Le Naour et al., 2001). 
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The combination of properties identified for large L TC-DC does not support their 
categorisation as either immature or mature DC. However, it is likely that these labels 
have been defined for DC cultured in vitro with cytokines and may be inappropriate for 
normal development in vivo or for development within L TC. Furthermore, it is known 
that maturing DC can maintain some endocytic activity (Coates et al., 1996; Nijman et 
al., 1995; Ruedl et al., 2001) and immature DC exposed to antigen can present antigen 
more efficiently than mature DC (Nijman et al., 1995). The classical model of immature 
and mature DC with defined phenotype and mutually exclusive functions does not 
encompass all observations on DC in vivo nor observations made here in LTC. The 
phenotype and function of DC are likely to be far more diverse as shown by the 
following examples. Recently a new CD1 lc+MHCir+B220+CD40- subpopulation of 
splenic DC was isolated. These cells have very low T cell stimulatory capacity and it 
has been predicted that they may have tolerogenic potential (del Hoyo et al., 2002). DC 
may also transfer antigen to other DC for presentation, either by phagocytosis of the DC 
carrying the antigen (Inaba et al., 1998) or by the release of exosomes, which are 
lysosome-derived vesicles that ca1Ty MHC Class II:peptide complexes (Mellman and 
Steinman, 2001; Zitvogel et al., 1998). 
Large LTC-DC represent a subset of CDl lc+CDl lb+MHCII1°CD8c[ DC. However, they 
differ from published CD8cx- myeloid-like DC in a number of ways. In contrast to 
myeloid-like DC, large LTC-DC express low levels of CD205 and develop 
independently of GM-CSF (Ni and O'Neill, 1997; Ni and O'Neill, 2001; Wilson et al., 
2000). Furthermore, they exhibit different functional capacity. While CD8cx- DC 
preferentially present MHC Class II-restricted antigen to antigen-specific CD4 T cells 
(Pooley et al., 2001) and direct Th2 type immune responses in vivo (Maldonado-Lopez 
et al., 1999b ), LTC-DC have now been shown to have greater capacity to stimulate B 
cell proliferation and antibody production via the secretion of exosomes (Quah and 
O'Neill, manuscript in preparation). This response is unusual since it occurs 
independently of T cell help. 
The unique combination of properties displayed by large L TC-DC may be a result of 
their long-term in vitro culture, but they could also reflect a distinct in vivo subset of 
DC. Existence of a DC subset resembling L TC-DC may have been overlooked in 
previous analyses since ex vivo splenic DC are often selected on the basis of high MHC 
Class II expression (Vremec et al., 2000; Vremec and Shortman, 1997). This appears to 
be the case for recently isolated populations of murine plasmacytoid DC that express 
B220 and Gr-1 (Nakano et al., 2001; Nikolic et al., 2002). They were probably 
overlooked previously due to their expression of B220 and Gr-1 since these markers are 
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used to define B cells (Coffman and Weissman, 1981) and myeloid granulocytes 
(Fleming et al., 1993), respectively. Increasing evidence now shows that the DC lineage 
encompasses a range of cells with varied phenotype and function. 
This raises the question of how an in vivo counterpart of large L TC-DC may function. 
In vivo L TC-DC may represent tolerogenic cells since most express low levels of MHC 
Class II and this does not appear to be significantly upregulated following stimulation 
with LPS. Alternatively, they could represent a DC subset which interacts more 
specifically with CD8 T cells. LTC-DC express high levels of MHC Class I, and this is 
upregulated along with CD86 upon exposure to LPS, a stimulus that favours the 
development of Thl responses (Mellman and Steinman, 2001). LTC-DC have been 
shown to generate CTL responses in vitro and in vivo (O'Neill et al., 1999a), and some 
data suggests that they preferentially activate CD8 T cells, not CD4 T cells, in an MLR 
(Ni, unpublished data (O'Neill lab)). LTC-DC also express high levels of FcyR, an 
antigen receptor known to contribute to cross-presentation by directing antigen to the 
MHC Class I pathway (Regnault et al., 1999; Rodriguez et al., 1999). Finally, since 
LTC-DC show great capacity to activate B cells in preference to T cells in vitro, their in 
vivo counterpart may be a DC which mediates B cell proliferation. 
8.3 DC DEVELOPMENT FROM SMALL LTC-DC PRECURSORS. 
Small LTC-DC appear to represent DC precursors. Their low expression of DC markers 
and their weak functional capacity, identifies them as earlier in development than large 
LTC-DC. It precludes them, however, from being early HPC. It is unclear yet whether 
heterogeneity amongst the small LTC-DC subset reflects the presence of different 
precursors, only one of which differentiates to form DC, or reflects cells at different 
developmental stages. The latter model would be consistent with a subpopulation of 
small L TC-DC being endocytic. Their lower stimulatory capacity in comparison with 
large LTC-DC could mean that the whole population possesses lower stimulatory 
capacity or that a subpopulation is highly stimulatory. Small LTC-DC are responsive to 
LPS, but unlike large L TC-DC, do not upregulate CD44 expression, suggesting that the 
potential of s1nall L TC-DC for cell migration and adhesion is not enhanced by exposure 
to LPS. Gene expression also identifies small L TC-DC as more immature than large 
LTC-DC since many of the transcripts upregulated in small LTC-DC, including a-
tubulin, ~-actin, thyn1osin ~-4, cystatin C, ferritin light chain and Hsp90, are 
characteristic of day 7 'immature' human n1onocyte-derived DC (Hashimoto et al., 
1999; Hashimoto et al., 2000; Le Naour et al., 2001). Unlike large LTC-DC, small 
LTC-DC do not specifically express genes associated with activated DC. 
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Small LTC-DC show higher gene expression of two cytoskeletal proteins, M-a-2-
tubulin and ~-actin, as well as three proteins involved in the organisation of the 
cytoskeleton including thymosin ~-4, Cste chaperonin containing TCP (CTT) and 
Hsp90. Hsp90 may also function as a chaperone for antigenic peptides (Li et al., 2002). 
Small LTC-DC also express transcripts of proteins related to the regulation of MHC 
molecules and their compartments, including cystatin C, Atp6f and LAMP-1. The 
expression of these molecules suggests that small L TC-DC possess machinery for both 
morphological change and MHC presentation. However, they also express molecules 
which limit this capability such as Cystatin C which directs MHC Class II molecules to 
lysosomes rather than to the cell surface (Pierre and Mellman, 1998), and may 
contribute to the lack of MHC Class II on the surface of small LTC-DC. Thymosin ~-4 
sequesters actin as monomers (Safer et al., 1990). Actin disassembly could account for 
the low endocytic capacity of small LTC-DC since macropinocytosis requires the 
integrity of polymerised actin filaments (Lee et al., 2001; Mellman and Steinman, 
2001). This process could also account for the absence of dendritic projections on these 
cells. Small LTC-DC differentially express transcripts for ribosomal and mitochondrial 
proteins, consistent with high level protein synthesis and energy production in 
preparation for differentiation. 
This study provides direct evidence that the small L TC-DC subset contains precursors 
of large L TC-DC. When transfe1Ted on to a ST-X3 stromal monolayer, small LTC-DC 
proliferate and differentiate into a homogeneous population of cells resembling those of 
the large cell subset. Increases in cell number over time demonstrate the ability of small 
LTC-DC to divide. Differentiation is indicated by increases in size and complexity, 
acquisition of dendrites and upregulation of expression of CDI le and CD86 on cells 
that were CDI 1c-11°CD86- before transfer on to the stromal monolayer. Furthermore, it 
indicates that cells within the small L TC-DC subset are committed to developing into 
large LTC-DC. This is evidenced by colony assays in which non-adherent LTC cells 
form clusters containing cells with either undifferentiated or dendritic morphology, even 
after exposure to combinations of defined cytokines known to generate a range of 
haen1opoietic cell lineages from bone marrow precursors (Wilson et al., 2000). 
The development of DC from small L TC-DC is unidirectional. At no time has there 
been evidence to suggest that large LTC-DC can form small LTC-DC. Upon transfer on 
to ST-X3 stromal n1onolayers, large L TC-DC proliferate faster than small L TC-DC. 
Confluent growth is observed after 9-12 days of culture versus 14-19 days for small 
LTC-DC. These observations are supported by data collected from cell cycle and cell 
turnover analysis. In contrast to small LTC-DC, large LTC-DC maintain their size and 
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marker expression following transfer on to ST-X3. Although the levels of CD86 on 
large LTC-DC were marginally higher than that seen on large cells in primary LTC. 
Growth of small LTC-DC requires direct contact with stromal cells. When separated 
from the stromal monolayer in colony assays or transwell assays, small LTC-DC 
display limited proliferative and differentiative capacity. Within LTC, the non-adherent 
small LTC-DC subset contains a population of early apoptotic cells and this early 
apoptotic subpopulation increases in number when small LTC-DC are cultured without 
stroma for 24 hours. These could represent cells which fail to receive appropriate 
environmental signals for differentiation. The non-adherent large LTC-DC subset, 
which is capable of proliferation in the absence of stromal cell contact, does not contain 
this distinct population of early apoptotic cells. 
These experi1nents suggest that the preferred environment for small LTC-DC is in direct 
contact with the stromal monolayer. It is likely that a greater number of small LTC-DC 
exist as adherent cells tightly attached to or buried within the stromal matrix. Splenic 
stroma is known to express a number of surface proteins that mediate adhesion 
including neural cell adhesion molecule (N-CAM) and N-cadherin (Gimble et al., 
1989). As adherent cells, small LTC-DC could receive direct cell-to-cell signals from 
neighbouring cells or soluble stromal-derived factors that are produced in very limiting 
a1nounts or have a short half-life. Some soluble factors are also known to remain 
attached to the surface of stromal cells. The stromal cell surface glycosaminoglycan, 
heparin sulfate, binds active forms of IL-3 and GM-CSF for presentation to 
haemopoietic cells (Roberts et al., 1988). Stromal cells could present high 
concentrations of cytokines locally without releasing significant levels into the 
supernatant. In some cases, the triggering of receptors on stromal cells is necessary to 
stimulate production of cytokines. For example, binding of the surface receptor 
neuropilin-1 on BM stromal cells increases their mRNA expression of Tpo and Flt3L, 
two cytokines important in early haemopoiesis (Tordjman et al., 1999). A similar 
phenomenon is seen with G-CSF (Yoshikubo et al., 1994). In addition, some growth 
factors are known to exist in 111embrane-anchored as well as secreted forms. For 
example, cell surface SCF stimulates target cell proliferation and mediates cell-to-cell 
adhesion (Flanagan et al., 1991). 
Experiments described here indicate that the small LTC-DC population does not contain 
precursors with long-term self-renewal capacity as expected of HSC. Incorporation of 
BrdU confirms that like large LTC-DC, the small LTC-DC subset contains a proportion 
of actively dividing cells. The BrdU pulse data indicates, however, that while 
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replicating large LTC-DC are able to divide more than once, small LTC-DC appear to 
replicate only once during a 4 day period. Following replication, they develop into large 
LTC-DC. This is demonstrated by transfer on to an ST-X3 stromal monolayer, where a 
vast majority, if not all, small LTC-DC differentiate into large LTC-DC within 19 days. 
A non-adherent population of small LTC-DC is not maintained by transfer on to a non-
producing stromal cell layer. Small LTC-DC appear to represent an intermediate stage 
in DC development where they either differentiate into large L TC-DC or die. 
This raises questions as to the nature and location of the long-term self-renewing cells 
in LTC. The fact that this culture system can continue to produce DC for long periods of 
time, up to 9 years, implies that self-renewing cells must be maintained within LTC. It 
is hypothesised that these long-term self-regenerating progenitors are present within the 
stromal matrix itself. Since small L TC-DC require stromal cell contact, if follows that 
more immature progenitors are also stroma-dependent. It has been shown previously 
that primitive HPC adhere to and proliferate in stromal layers and are released into the 
supernatant as differentiation proceeds (Coulombe! et al., 1983; Verfaillie et al., 1990). 
The stro1nal environment represents a rich source of growth factors and provides 
progenitor cells with the signals necessary for survival and division. This model also 
incorporates the need to maintain LTC by passaging of stroma. These progenitors do 
not appear to be present in the stroma of ST-X3 since these cultures are unable to 
generate non-adherent cells. This also predicts that DC progenitors are different from 
those that produce the endothelial or fibroblast cells of the stroma. 
8.4 A MODEL FOR DC DEVELOPMENT WITHIN LTC. 
The LTC system provides an in vitro model for the development of DC from precursor 
cells. At this time it is not known whether cell development in L TC is similar to that 
which occurs when DC are generated from monocyte or BM precursors following 
cytokine stin1ulation. Genes expressed in large L TC-DC are expressed in both 
monocyte- and BM-derived DC. A number of genes expressed by small L TC-DC are 
also shared by 'immature' monocyte-derived DC. This evidence, combined with the 
expression of lysozyme, associates LTC-DC with myeloid-like DC and particularly 
monocyte-derived DC. However, it should be noted that most gene expression studies, 
and the only studies comparing 'immature' DC with their precursors, have been 
conducted using monocyte-derived DC. The developmental plasticity of LTC-DC has 
not been investigated fully. No cell types other than DC have been generated when 
LTC-DC are exposed to combinations of cytokines including GM-CSP, TNF-cx, IL-1, 
IL-3, IL-6, IL-7, SCP and Flt3L (Wilson et al., 2000). To date, LTC-DC have not been 
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cultured with IL-4, M-CSF or TGF-0, cytokines that may be important in the skewing 
of precursors towards particular lineages. 
Based on the evidence obtained in this study, the development of non-adherent 
CDl lc+CDl lb+MHCII1°CD8a- DC within LTC can be proposed to involve at least three 
stages. It is hypothesised that a long-term self-renewing progenitor exists and is most 
likely adherent to cells within the stromal layer of the culture. These progenitors may 
themselves represent separate populations of cells according to progressive loss of 
ability to self-renew. Such cells have not yet been isolated or characterised. However, 
the long-term production of cells in this culture system verifies their existence. Long-
term progenitors may be a difficult population to study since they are likely to represent 
a tiny fraction of the stromal cell number and at this stage there is no specific surface 
marker to identify them. 
Future experiments are in plan to investigate the presence and characteristics of long-
term self-renewing progenitors within the stroma. These experiments will incorporate 
the use of Affymetrix genechips to profile gene expression in the washed stroma from 
DC-producing LTC and the non-productive stroma line ST-X3. ST-X3 stroma 
comprises endothelial cells, fibroblasts and some macrophages, but does not shed DC 
and this may be due to a lack of long-term DC progenitors. Probing a genechip with 
labelled cRNA derived from washed stroma of productive LTC or ST-X3 stroma will 
allow screening of cells for the expression of kno\vn genes and ESTs contained on the 
genechip. Comparative analysis of gene expression profiles of washed stroma from 
productive LTC and ST-X3 stroma could lead to isolation of genes which identify long-
term progenitors. This study may even lead to the identification of genes specifically 
expressed in these cells. Future questions will then be whether LTC-derived long-term 
progenitors are multipotential or committed to the DC lineage. 
A proportion of long-term progenitors must lose self-renewal capacity and develop into 
an intermediate DC precursor population represented by small LTC-DC. These cells can 
be isolated as non-adherent cells within LTC, but their preferred environment appears to 
be in close contact with the stromal cell network. These L TC-DC precursors would be 
positioned late in the DC developmental pathway since they have lost ability to self-
renew and some already express lineage markers and functional capacity. They do not 
stain strongly for these markers, but most express CD 11 b, CD8O, MHC Class I, CD44 
and CD 16/32. LTC-DC precursor heterogeneity most likely arises due to the presence 
of some cells in the small subset that have just started to differentiate into DC. The gene 
expression profile of small LTC-DC is consistent with these findings. LTC-DC 
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precursors express transcripts for proteins that mediate antigen processing and 
morphological change. Furthermore, expression of a number of ribosomal and 
mitochondrial proteins is consistent with high level protein synthesis and energy 
production in preparation for differentiation. Further characterisation of small LTC-DC 
may provide clues for identifying committed DC progenitors in vivo. 
Development of LTC-DC precursors requires direct contact with stromal cells. To date 
the specific nature of the interaction between these precursors and stromal cells is 
unknown. Future stromal cell gene expression studies could provide information on the 
types of receptors expressed and the cytokines produced by stromal cells. This type of 
study could provide important clues on how DC precursors interact with the stromal 
environment in vivo. 
Differentiated DC (large L TC-DC) are released as non-adherent cells into the LTC 
supernatant and represent end-stage development under normal culture conditions in 
LTC. Their survival and proliferation is largely independent of cell-to-cell contact with 
the stroma, but is dependent on soluble stroma-derived factors. Surface marker 
expression, function and gene expression indicate that DC produced in L TC form a 
homogeneous population of cells resembling functional, immature, 
CDI lc+CDl lb+MHCII1°CD8a- DC. LTC-DC display a number of unique properties 
that suggest that they may relate to a unique subset in vivo. The generation of large 
numbers of these cells in vitro provides an opportunity to study the function of this type 
of DC in the absence of exogenous cytokines. 
The presence of both precursors and progeny within LTC has provided a unique 
opportunity to study the development of DC from committed precursors. Genes 
specifically expressed in s1nall and large LTC-DC have been identified and have 
contributed to a 1nodel for L TC-DC development and function. This is the first time that 
gene expression relating to DC development from precursors has been studied in the 
absence of exogenous cytokines. All data indicate that differentially expressed novel 
transcripts isolated from small and large LTC-DC can potentially encode proteins 
important in cell development and function. In addition to further characterising novel 
genes expressed by these cells, new approaches will also be undertaken to gain more 
complete profiles of gene expression in LTC-DC. This will involve the use of 
Affymetrix Genechips to perform a comprehensive analysis of all genes expressed by 
LTC-DC. This should help to further define the lineage and functional capacity of DC 
generated by LTC. Comparative analysis could identify clusters of genes that further 
define functions of sn1all and large LTC-DC. While this type of analysis is viable for 
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large LTC-DC, new methods that amplify cRNA prior to labelling of Affymetrix 
Genechips may be needed to perform a similar analysis of gene expression in small 
LTC-DC. Affymetrix screening has also the potential to identify novel genes, some of 
which may shed light on the unique functional capacity of subsets of LTC-DC. 
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APPENDIX A 
Solutions 
Supplemented Dulbecco's Modified Eagle's Medium (sDMEM) 
To make 1 0L of incomplete sDMEM stock: 
9L ddH2O 
1 satchet DMEM powder (Gibco BRL, Cat# 430-1600) 
40g D-glucose (Ajax Chemicals) 
60mg folic acid (Sigma) 
360mg L-asparagine (Sigma) 
1.16g L-arganine HCI (Sigma) 
Add 400ml 5% NaHCO3 or 20g NaHCO3 . Bring solution to l0L with dd H2O. 
Adjust pH to 7 .4. 
To make 500ml of complete sDMEM: 
450ml sDMEM 
5ml IM Hepes (CSL Biosciences) 
5ml 200mM Glutamine (Gibco BRL) 
250µ1 10-1M 2-mercaptoethanol (final 5x10-5M, BDY Chemicals) 
500µ1 Penicillin( 105U/ml)/streptomycin( 100mg/L) (final 1 00U/ml 
andl00µg/L, Gibco BRL) 
50ml FCS (CSL Biosciences) 
Phosphate Buffered Saline (PBS) 
For IL: 
0.23g NaH2PO4 (anhydrous) (l.9mM) 
1.15g Na2HPO4 (anhydrous) (8. lmM) 
9.00g NaCl (154mM) 
Add ddH2O and adjust to pH 7.2-7.4). 
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Hanks Balanced Salt Solution (HBSS) 
5.4mM KCl 
0.3mM Na2HPO4 
0.4mM KH2PO4 
4.2mM NaHCO3 
1.3mM CaCl2 
0.5mMMgC12 
0.6mMMgSO4 
137mM NaCl 
5.6mM D-glucose 
0.2% phenol red 
Add ddH2O and adjust to pH 7 .4 
lX TE buffer 
1 0mM Tris (pH 7. 6) 
lmMEDTA 
lX TAE buffer 
For lL: 
4.8g Tris base 
0.8g NaC2H3O2.3H2O 
0.37g EDTA 
Adjust pH to 7 .8 with acetic acid. 
lX TNE buffer 
20X SSC 
For lL: 
l0mM Tris-HCl (pH 8) 
l0mM NaCl 
0.ln1M EDTA 
175.3g NaCl 
88.2g Na3C6H5O7.2H2O 
Adjust pH to 7 .0 with HCl 
Hybridisation solution for Southern dot blots 
For lL: 
35g SDS 
39g NaH2PO4 .2H2O 
1ml 0.5M EDTA (pH 8.0) 
Add ddH2O and adjust pH to 7 .2. 
105 
IX LB medium 
For IL: 
1 0g Bacto-Tryptone (Difeo Laboratories) 
5g NaCl 
5g Bacto-Yeast extract (Difeo Laboratories) 
Add ddH20 and adjust pH to 7 .0. Sterilise by autoclaving. Add ampicillin to 
l00µg/ml. 
IX LB plates 
For IL: 
10g Bacto-Tryptone 
5 g B acto-Y east extract 
10g NaCl 
15g Bacto-Agar 
Sterilise by autoclaving. Add ampicillin to 1 00µg/ml. 
2XTY medium 
For IL: 
16g Bacto-Tryptone 
10g Bacto-Yeast extract 
5g NaCl 
Add ddH20 and sterilise by autoclaving. Ampicillin added to 1 00µg/ml. 
IX SOC medium 
For 250ml: 
5g Bacto-Tryptone 
1.25g Bacto-Yeast extract 
1.25g NaCl 
Add ddH20 and 2.5ml of 250mM KCl solution. Sterilise by autoclaving. Just 
prior to use, add 1.25ml of sterile 2M MgC12 and 5ml of sterile 2M glucose 
solution. 
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APPENDIXB 
Addresses of equipment/reagent suppliers · 
Source 
Ajax Chemicals 
Amersham Pharmacia Biotech 
Applied Biosystems (ABI) 
Astral Scientific 
Axygen Scientific 
BDY Chemicals 
Beckman 
Becton Dickinson 
Becton Dickinson Labware 
Canberra Packard 
Clontech Laboratories 
Cohu 
CSL Biosciences 
Division of Plant Industry, 
Commonwealth Scientific and Industrial 
Research Organisation (CSIRO), Black 
Mountain Laboratories 
Division of Entomology, CSIRO, Black 
Mountain Laboratories 
Eppendorf 
Fermentas 
FMC Bioproducts 
Geneworks 
Gibco BRL 
ICN Biomedicals 
Kirkegaard and Pe1Ty Laboratories 
Kodak 
Leica Camera 
Leica Microsystems 
Life Technologies, Gibco ERL 
Linbro 
Millipore 
Location 
Auburn, NSW, Australia 
Buckinghamshire, UK 
Foster City, CA, USA 
Gymea, NSW, Australia 
Union City, CA, USA 
Auburn, NSW, Australia 
Palo Alto, CA, USA 
San Jose, CA, USA 
Franklin Lakes, NJ, USA 
Meridan, CT, USA 
Palo Alto, CA, USA 
San Diego, CA, USA 
Parkville, Vic, Australia 
Canberra, ACT, Australia 
Canberra, ACT, Australia 
Hamburg, Germany 
Hanover, MD, USA 
Rockland, ME, USA 
Adelaide, SA, Australia 
Grand Island, NY, USA 
Aurora, Ohio, USA 
Gaitherburg, MD, USA 
Rochester, NY, USA 
Solms, Germany 
Wetzlar, Germany 
Rockville , Maryland, USA 
McLean, Virginia, USA 
Bedford, MD, USA 
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Source 
MJ Research 
Molecular Probes 
National Institutes of Health (NIH) 
Nunc 
Oxford Molecular Group 
Packard 
Perkin Elmer 
Pharmacia LKB Biotechnology 
Pharmingen 
Progen 
Robbins Scientific 
Roche Diagnostics 
Sarstedt 
Serotec 
Sig1na 
Southern Biotechnology 
TPP 
Verity Software House 
Location 
Waltham, MA, USA 
Eugene, OR, USA 
Bethesda, MD, USA 
Naperville, IL, USA 
Oxford, UK 
Meridan, CT, USA 
Norwalk, Connecticut, USA 
Cambridge, UK 
San Diego, CA, USA 
Darra, Qld, Australia 
Sunnyvale, CA, USA 
Mannheim, Germany 
Numbrecht, Germany 
Oxford, UK 
St Louis, MO, USA 
Birmingham, AL, USA 
Trasadingen, Switzerland 
Topsham, ME, USA 
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